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ABSTRACT 
 Presently there are no reliable statistics available on complication rates associated 
with surgery in gynaecological cancer in the UK, apart from data from small studies 
involving individual centres and clinical trials. This thesis describes the United 
Kingdom Gynaecological Oncology Surgical Outcomes and Complications study 
(UKGOSOC) that was set up to prospectively capture data from ten UK gynaecological 
cancer centres on surgical procedures and complications in a uniform manner using 
agreed definitions so that data could be analysed and compared. A web-based 
database was set up to capture surgery and complications contemporaneously from 
the hospitals, and, consented women were sent a follow-up letter eight weeks 
postoperatively. Intraoperative and postoperative complications were recorded using a 
pre-determined list. Postoperative complications were graded (I-V) in increasing 
severity using the Clavien-Dindo system. Grade I complications were excluded from 
analysis. Univariable and multivariable regression analyses were performed to 
determine the predictors for intraoperative and postoperative complications. The Lasso 
method of penalised regression was used to create a risk-prediction model for 
comparing outcomes between the centres.    
Data on 2948 eligible major surgical procedures were analysed and 1462 follow-up 
letters were received. The overall intraoperative complication rate was 4.7% (95% CI 
4.0-5.6). The hospital-reported postoperative complication rate was 14.4% (95% CI 
13.2-15.7) which increased to 25.9% (95% CI 23.7-28.2) when both hospital and 
patient- reported postoperative complications were included. The predictors for 
intraoperative and postoperative complications were different apart from diabetes 
which was common to both. Risk-adjustment had a modest effect on the complication 
rates for individual centres but allowed for a fairer comparison. There was no 
4 
 
concordance between the ranking order of the centres for intraoperative and 
postoperative complication rates.  
The overall intraoperative (≈5%) and postoperative (≈26%) complication rates and 
funnel graphs derived from this study could be used to benchmark performance of 
gynaecological oncology centres and even individual surgeons if a larger dataset 
becomes available nationally. 
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1 Introduction 
1.1 Overall purpose of the study 
Presently there are no reliable statistics available on complication rates associated 
with surgery in gynaecological cancer apart from data sourced from individual centres 
(case series) and clinical trials. Data from individual centers cannot be easily 
compared as they have been collected in different formats using different definitions. 
The United Kingdom Gynaecological Oncology Surgical Outcomes and Complications 
audit (UKGOSOC) was set up to prospectively capture data from various 
gynaecological cancer centres on a large number of surgical procedures and 
complications in a uniform manner using agreed definitions, so that data from various 
centres could be compared and analysed.  
On the National Health Service (NHS), outcomes of surgery are evaluated using 
surrogate markers such as length of stay, re-admission rates, and post-operative 
mortality. This data from NHS hospitals in England is available through the Hospital 
Episode Statistics (HES). (1) 
HES, is one aspect of the NHS information centre which contains details on all hospital 
admissions in England from 1989 onwards. Each episode of care has a unique record 
in HES containing information on diagnosis, interventions e.g. surgery and other 
aspects of care such as the NHS trust where the care was provided, waiting time, 
length of stay, readmissions etc. The International classification of diseases (ICD) (2) 
codes are used to code for diseases and the OPCS (Office of Population, Census and 
Surveys: Classification of Interventions and Procedures)(3) codes are used to code for 
interventions and surgical procedures.  
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The OPCS codes for the surgical procedures are entered by coding officers who 
obtain the information required from the surgical notes which are hand written in most 
hospitals. The information thus entered into HES may be prone to errors as the coders 
who do not have a clinical background, have to rely on hand written operation notes by 
the surgeon to enter the codes. There is a lack of clinical engagement in this data 
entry as the data entered is not checked for accuracy or completeness by the 
surgeons.  
It is important that the data available on HES is reliable and from a trusted source as it 
has wide implications. This data is used to rate the quality of care by a particular NHS 
trust / consultant team and will be used in future for revalidation of individual doctors in 
the UK. (4) This data is increasingly being used for payment by results and for health 
care commissioning. The data is also available to the public through HES online and 
through websites such as the Dr. Foster Health Guide (5) which provides information 
on the performance of all NHS hospitals in England. The public can, in turn, use this 
information to compare the performance of their local hospital with other hospitals in 
the same region or elsewhere and make an informed choice regarding their health 
care provider.   
Accuracy of surgery data can be improved if the codes were derived from 
electronically entered notes rather than hand written notes and would be even better if 
the codes were entered by surgeons themselves. Information thus entered by the 
surgeons would also be more acceptable to the surgical community.   
The aim of UKGOSOC was to prospectively gather information on gynaecological 
cancer surgery using OPCS codes and on complications arising from surgery in a 
uniform format so that data from various centres was comparable and could be 
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analysed. Collecting data on complications is only one aspect of measurement of 
quality and therefore should not be taken on its own. Therefore in addition to the crude 
rates of complications, the risk adjusted complication rates were also calculated taking 
into account pre-operative and surgical risk factors such as comorbidity, surgical 
complexity etc.  
It is envisaged that the UKGOSOC database will be integrated with the Patient 
Administrative System (PAS) in individual hospitals and eventually pave the way 
towards the formation of a national gynaecological oncology surgery database.   
1.2 Thesis chapter plan 
Chapter 1 is the introduction and contains a brief background and the rationale behind 
this study. Chapter 2 includes a literature review. Chapter 3 covers the methods. 
Chapter 4 describes the baseline characteristics and surgery details. Chapter 5 details 
intraoperative and postoperative complications reported by the hospitals. Chapter 6 
describes patient reported postoperative complications using two formats of follow-up 
letters.  Chapter 7 describes the predictors of intraoperative and postoperative 
complications using both univariable and multivariable regression. Chapter 8 describes 
the development of a risk prediction model and the calculation of observed and 
expected complication rates for individual centres/hospitals. Chapter 9 contains the 
discussion and conclusion.  
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2 Literature review 
This study describes the development of a database, collection of surgery and 
complications data, and, the development of a risk-adjusted model for the purpose of 
benchmarking gynaecological oncology centres in the UK. Surgical outcomes data 
available for gynaecological oncology surgery is sparse. A literature review was 
undertaken prior to developing the database for this study. The review examined the 
definition of a surgical complication, indices used to measure comorbidity, methods for 
grading surgical complexity, databases available in other surgical specialties and risk 
prediction algorithms developed in some of these databases.  
2.1 Definition of a surgical complication  
Since this study was about collating data on surgical complications, it was important to 
define what was meant by a ‘complication’. The dictionary defines a medical complication 
as ‘a secondary disease or condition aggravating an already existing one’. A surgical 
complication may be described as an ‘undesirable result’ of an operation (6, 7).  However 
not all ‘undesirable results’ are necessarily complications of surgery. An example quoted 
by Dindo et al is a surgical scar (8) which even though undesirable, is an expected 
result/sequela of an operation and not a complication per se. One of the definitions by 
Sokol et al states that ‘a complication is an undesirable, unexpected and unintended’ 
result of an operation affecting the patient that occurs as a direct result of the operation’ 
(6). However not all unexpected and undesirable events occur as a direct result of the 
surgery itself. Surgery can exacerbate/worsen pre-existing medical conditions such as 
atrial fibrillation, chronic kidney disease, hypertension, chronic obstructive airway disease 
etc., which may require additional supportive measures in the postoperative period and 
delay recovery. The National Cancer Institute which developed the Common Toxicity 
MD Thesis RI Page 2-21 
  
Criteria to record adverse events following cancer therapy also recognised that not all 
adverse events are a direct result of treatment and by using the term ‘toxicity’ all the 
blame is assigned to therapy. As a result, the word ‘toxicity’ was replaced with 
‘terminology’ in the newer versions, to read Common Terminology Criteria for Adverse 
Events (CTCAE) .(9)  
Although complications are not ‘routine’ in all operations, they are not truly ‘unexpected’ 
either and for this very reason surgeons counsel patients regarding their possibility prior 
to surgery and take precautions to prevent them. However, surgeons are likely to agree 
that complications are ‘unintended’ results of an operation. A revised definition by Sokol 
et al states that ‘a surgical complication is any undesirable, unintended, and direct result 
of an operation affecting the patient, which would not have occurred had the operation 
gone as well as could reasonably be hoped’. The success rate of an operation however, 
is variable and this definition suggests that if a procedure with a high failure rate fails, 
then this would not necessarily be considered a complication of that surgery, but an 
‘expected’ adverse outcome.  
In this study (UKGOSOC) a modified version of the definition suggested by Sokol et al 
was used which stated that a surgical complication was ‘an undesirable and unintended 
result of an operation affecting the patient that occurs as a direct result of the operation’. 
2.2 Classification of complications 
Surgical complications can be classified as intraoperative and postoperative depending 
upon when they occur and be further classified according to the various organ systems 
(e.g. cardiac, respiratory etc.) or the types of complications (infection, bowel obstruction 
etc.). In some studies they have been simply classified as minor and major 
complications. (10)  
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In order for complications to be comparable across different centres or from the same 
centre over a period of time, they need to be uniformly captured using clear definitions. 
For example, a wound infection can vary from something requiring regular dressing to 
debridement under general anaesthesia. Although in both instances the complication is a 
wound infection, this apparent difference cannot be captured unless the severity of the 
‘wound infection’ is also accounted for. Grading of complications helps capture this 
apparent difference as it stratifies complications according to their severity and 
intervention required. There are various systems for complication grading and some of 
them are detailed below.  
The T92 (11) or the Toronto system of grading was developed by Dindo et al and was first 
used to grade postoperative complications after cholecystectomy. There were four 
grades (I-IV) with two subsets in grade II (IIa and IIb). Grade I included those 
complications which either resolved spontaneously or required simple bedside 
intervention requiring minimal or no analgesia. Drugs required included anti-emetics, 
antipyretics, analgesics and anti-diarrhoeals and those required for urinary retention and 
low urinary tract infection. Grade II were those complications which were potentially life 
threatening and therefore required specific intervention. Grade IIa included those 
requiring drug therapy, total parenteral nutrition (TPN) and blood transfusion for 
postoperative haemorrhage. Grade IIb included invasive procedures and operative 
procedures for iatrogenic injuries. Grade III included complications that caused lasting 
disability (e.g. myocardial infarction, cerebrovascular accident with disability). Grade IV 
was death as a result of any complication. (Table 1) 
The T92 was further modified by Dindo et al (8) who classified the complications into five 
grades with two subsets in Grade III and IV. Modifications focused on the reporting of life 
threatening and permanently disabling complications. Grade II complications were 
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restricted to those requiring specific drug therapy, and blood transfusion and TPN were 
included. Grade IIIa were those complications requiring intervention under local 
anaesthesia and IIIb were those requiring general anaesthesia. Grade IVa included those 
complications resulting in single organ failure and Grade IVb those resulting in multi-
organ failure. Grade V was death due to a complication.  
The Accordion Severity Grading System of Surgical Complications (12) was a further  
modification of the T92 and the Dindo classification for use in studies of different sizes 
and complexity. This system has two versions- contracted and expanded. In the 
contracted version, complications are graded into four groups as mild, moderate, severe 
and death and in the expanded version there are three subgroups in the severe category 
(IIIa, IIIb and IV sub-group of the Dindo classification). The authors of the accordion 
system found that in studies that used the Dindo system, there were very few 
complications graded as IVb (multi-organ failure) and therefore this was combined with 
IVa (single organ failure/requiring intensive care management) to form a sub-group of the 
‘severe’ category. (Table 1) 
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Table 1 Grading of complications 
T92 Clavien and Dindo Accordion system 
    Contracted version Expanded version 
Grade 1. Complications 
carrying minor risks. At most 
requires bedside procedure. 
Allowed therapeutic 
regimens are: antiemetics, 
antipyretics, analgesics, 
diuretics, electrolytes and 
physiotherapy. Hospital stay 
required for treatment of 
complication does not 
exceed twice the median 
length of stay for the 
procedure.  
Grade 1. Any deviation from the normal postoperative 
course without the need for pharmacological treatment or 
surgical, endoscopic and radiological interventions. Allowed 
therapeutic regimens are: drugs as antiemetics, antipyretics, 
analgesics, diuretics, electrolytes and physiotherapy. This 
grade also includes wound infections opened at bedside.  
1. Mild complication- Requires only invasive procedures 
that can be done at the bedside such as insertion of 
intravenous lines, urinary catheters and nasogastric tubes, 
drainage of wound and infections. Physiotherapy and the 
following drugs are allowed- antiemeteics, antipyretics, 
analgesics, diuretics, electrolytes, and, physiotherapy.   
1. Mild complication-Requires only invasive 
procedures that can be done at the bedside 
such as insertion of intravenous lines, urinary 
catheters and nasogastric tubes, drainage of 
wound and infections. Physiotherapy and the 
following drugs are allowed- antiemeteics, 
antipyretics, analgesics, diuretics, electrolytes, 
and, physiotherapy.   
Grade 2. Potentially life 
threatening                    
Grade 2A- Requiring 
pharmacological treatment 
with drugs other than such 
allowed for grade 1 
complications. Blood 
transfusions and total 
parenteral nutrition are also 
included. Any patient with a 
complication exceeding 
twice the median length of 
stay for the procedure and 
not falling into a higher 
category.                    
Grade 2. Requiring pharmacological treatment with drugs 
other than such allowed for grade 1 complications. Blood 
transfusions and parenteral nutrition are also included.  
2. Moderate complication- requires pharmacologic 
treatment with drugs other than such allowed for minor 
complications, for instance antibiotics. Blood transfusions 
and total parenteral nutrition are also included.  
2. Moderate complication- requires 
pharmacologic treatment with drugs other than 
such allowed for minor complications, for 
instance antibiotics. Blood transfusions and 
total parenteral nutrition are also included.  
Grade2b. Requiring invasive 
procedures: surgical, 
endoscopic or radiological 
(invasive) intervention 
Grade 3. Requiring surgical, endoscopic or radiological 
intervention                                                                                             
Grade 3A. Intervention not under general anaesthesia                  
Grade 3b. Intervention under general anaesthesia 
3. Severe complication- All complications requiring 
endoscopic or interventional radiologic procedures or re-
operation as well as complications resulting in failure of 
one or more organ systems 
3. Severe: invasive procedure without general 
anaesthesia-Requires management by an 
endoscopic, interventional procedure or re-
operation* without general anaesthesia.                                                                       
4.Severe:operation under general anaesthesia                                                                                 
Grade 3. Complications with 
residual or lasting disability *  
Grade 4 Life-threatening complication (including Central 
Nervous Systems complications)     
(e.g. stroke, organ/limb loss) requiring IC/ICU management     
 Grade 4a. Single organ dysfunction (including dialysis)   5. Severe: organ system failure 
 
Grade 4b. Multi-organ dysfunction     
Grade 4. Death of a patient  Grade 5 Death of a patient 4. Death- Postoperative death 6. Death- Postoperative death 
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2.2.1 Common terminology (toxicity) criteria for adverse events (CTCAE) 
The CTCAE was developed to capture adverse events following chemotherapy and 
radiotherapy for cancer, primarily for use in clinical research and trials. The third 
version of the CTCAE however includes provision to capture surgical complications as 
well.(13) The CTCAE is broadly classified into category (broad classification based on 
anatomy/pathophysiology), adverse event terms (list of adverse events) within each 
category, and short name of the adverse event followed by grades. (Table 2) There 
are five grades according to severity: mild, moderate, severe, life threatening or 
disabling and death related to adverse event. The advantage of the CTCAE is that it 
can be used to record both intraoperative and postoperative complications. However 
since it was primarily developed for capturing complications from chemotherapy and 
radiotherapy, the lists are long and exhaustive and would need to be condensed to be 
more user friendly in a surgical database.  
Table 2 Example for CTCAE classification and grading of a complication 
Gastrointestinal 
Adverse event Short 
Name 
Grade 
1 2 3 4 5 
Ileus, GI (functional 
obstruction of bowel, 
i.e., neuroconstipation) 
Ileus Asymptomatic 
Radiographic 
findings only 
Symptomatic 
Altered GI 
function 
e.g. altered 
dietary habits; iv 
fluids indicated 
<24hours 
Symptomatic and 
severely altered GI 
function; IV fluids, 
tube feeding, or TPN 
indicated ≥24 hrs 
Life-threatening 
consequences 
Death 
REMARK: Ileus, GI is to be used for altered upper or lower GI function (e.g., delayed gastric or colonic emptying). 
In this study (UKGOSOC) the Clavien and Dindo method of complication grading was 
adopted as the list was concise, easy to comprehend and user friendly. (Table 1) Also, 
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this system had been tested in a cohort of 6336 patients undergoing elective surgery 
and was found to be reliable and reproducible.(8) 
2.3 Patient reported complications 
Traditionally complications data are collected from hospital records which are captured 
by the clinicians. The drawback of this method is that only those complications 
occurring in hospital and important to clinicians get recorded and others that occur 
outside of hospital are missed. There are a small number of studies which have looked 
at concordance between surgeon and patient reporting of complications following joint 
replacement surgery. These studies found that patients accurately report clearly 
defined complications such as pulmonary embolism and deep vein thrombosis and 
less accurately when the complication is ill defined, for example, ‘major bleeding’.(14, 15)  
2.3.1 Patient reported outcome measures (PROMs)  
PROMs are another source of obtaining information on outcomes after surgery. As 
they are reported by patients themselves, they may be able to give a better insight into 
the effects of surgery on patients. They are not primarily designed to collect data on 
complications per se, but are useful in assessing symptoms and quality of life after an 
intervention such as surgery. PROMs collect data on health related quality of life 
(HRQOL), functional status, symptom status, overall well-being, satisfaction with care 
and adherence to treatment.(16) The aim of collecting PROMs is to help improve 
delivery of care, and in the UK, they are routinely collected after hip and knee 
replacements, varicose vein surgery and groin hernia repair.(17) A PROM designed for 
a particular intervention should include a generic health questionnaire and a disease 
specific questionnaire. For e.g. a PROM for gynaecological oncology would have three 
components- a generic health questionnaire such as the EQ-5D, a generic cancer 
questionnaire such as the EORTC QLQ C-30 and a cancer specific questionnaire, for 
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e.g. the EORTC QLQ EN-24 for endometrial cancer.(18) Andikyan et al evaluated the 
feasibility of using web-based PROMs for assessing patient recovery after 
gynaecologic cancer surgery.(19) The questionnaire was a combination of an 
adaptation the CTCAE 3.0 to capture surgical complications and the EORTC QLQ C-
30 to measure quality of life. They concluded that this was a feasible approach which 
was also highly acceptable to patients.  
Outcomes data mainly in the form of morbidity and mortality rates are being used to 
benchmark performance of hospitals and individual surgeons. However Varagunam et 
al explored the use of PROMs after elective surgery in the UK and concluded that 
PROMs were a more sensitive method for comparing outcomes between 
consultants.(20)  At present, a PROM specifically for gynaecological cancers has not 
been developed and validated. However in future when routine collection of PROMS  
become mandatory for all cancers, including gynaecological oncology, they may prove 
to be a useful alternative to or complimentary to complications data for  benchmarking 
of centres and individual consultants. 
In this study (UKGOSOC), a patient follow-up letter was designed and sent to patients 
eight weeks following surgery to gather information on postoperative complications 
that may have developed in the community and subsequently treated in primary care 
or in a hospital different to where the initial surgery had been performed. 
2.4 Comorbidity  
Comorbidity refers to coexistent illnesses present in the individual other than the index 
disease or the disease of interest. It was important to account for comorbidity as pre- 
existing diseases in an individual can affect surgical outcome. There are different 
methods for assessing co-morbidity. The easiest is to list the various medical 
conditions (21) or have a list of specific conditions (22) and simply count the total 
number. Although this is easy to perform, this method is prone to error as the criteria 
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to consider a condition as a comorbidity can vary and the definitions of the disease 
conditions can also vary. To overcome this problem, researchers commonly use ICD 
codes (2) to define the various conditions. (21) In addition to listing the various comorbid 
conditions, it would be more informative to assess their severity. For e.g. diabetes can 
vary in severity. A mild form of the disease which is managed by controlling diet alone 
is less likely to have long term sequelae where as a more severe form of the disease 
is  more likely it is to cause end organ damage such as nephropathy and neuropathy. 
Instead of merely listing diabetes as comorbidity, it might be more informative and 
useful to account for its severity as well. Various co-morbidity indices have been 
developed over the years to assess the risk of overall morbidity / mortality. Some of 
the indices assign a score either for individual co-morbidities or particular medical 
conditions for e.g. the Charlson index (23) and some others classify the comorbidities 
according to their respective organ systems and grade them according to severity, for 
e.g. The Cumulative Illness Rating Scale. (CIRS) (24) Some of the indices also assign 
an overall score for an individual that gives a snapshot assessment of the general 
health of the patient, for e.g. the American Society for Anaesthesiologists’ (ASA) 
Grade. (25)  Quantifying co-morbidity in this way is useful in clinical situations where a 
decision has to be made regarding the appropriate treatment for the patient. An overall 
comorbidity score is also useful in statistical analysis as it helps to mathematically 
describe the confounding effects or the relationship between the co-morbidity and the 
outcome being studied.   
de Groot et al systematically reviewed the different methods to assess co-morbidity (26) 
and concluded that the Charlson Index, the CIRS, the ICED (Index of co-existent 
disease) and the Kaplan index were valid and reliable methods to measure co-
morbidity in clinical research. Some of these indices are discussed below.  
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2.4.1 Cumulative Illness Rating Scale (CIRS) 
This scale was developed by Linn and colleagues in 1968. (24) Their aim was to 
develop a ‘comprehensive and reliable instrument for assessing physical impairment’ 
for use in research. In this scale 13 independent organ systems or domains are 
evaluated on a severity scale ranging from 0 to 4 where 0= no impairment, 1= mild, 
2=moderate, 3=severe, 4=extremely severe (life threatening) impairment. Every 
subject would also have a final score which is a sum total of the individual score for 
each organ system. This scale was validated in two studies on elderly patients and the 
authors concluded that the CIRS  performed better than chronological age in 
estimating the life span of an individual (27) (28). Miller et al modified the CIRS for use in 
psychogeriatric patients, added a suffix G for geriatric and named it CIRS-G (29). The 
CIRS has mostly been used to assess morbidity in elderly patients (30, 31). More 
recently, Groome et al (32) used the CIRS-G to assess the comorbidity in prostate 
cancer patients. They found that respiratory and cardiac diseases followed by vascular 
and renal diseases and diabetes were the most common comorbidities in this cohort.  
2.4.2 Charlson Index 
This was developed by Mary Charlson and her colleagues in a cohort of 559 medical 
inpatients who were followed up for a year. A weighted index was developed which 
took into account the type of comorbid illness and the severity. The aim of the study 
was to assess the ability of the index to predict one year survival among these 
patients. Relative risk of mortality was calculated for each condition and those with a 
relative risk (RR) of 1.2 or less were dropped. Conditions with a relative risk of >1.2 
and <1.5 were assigned a weight of 1, conditions with a RR of >1.5 and <2.5 were 
given a weight of 2, those with a RR of >2.5 and <3.5 were given a weight of 3, and 
two conditions with a RR of >6 were given a weight of 6. The index was then further 
validated in a 10 year follow up of 685 patients previously treated for breast cancer 
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(population with a low incidence of comorbidity), to assess the ability of this index to 
predict mortality over a ten year period. In the second study, age was also found to be 
a strong predictor along with comorbidity. The relative risk of mortality with each 
increasing level of comorbidity was 2.3 and with each decade of age, 2.4. With each 
decade of age, the risk of dying from a comorbid disease was equivalent to an 
increase of 1 to the overall comorbidity score. The authors thus recommended taking 
age into account in studies with long periods of follow-up, i.e. 5 years or more.  
The Charlson index has been widely used to assess comorbidity in patients with 
various types of malignancies (33, 34) including gynaecological cancers. A randomised 
controlled trial comparing open with laparoscopic approach for early stage endometrial 
cancer found that higher Charlson index scores was one of the significant risk factors 
associated with an increased incidence of adverse events. (35) 
2.4.3 Kaplan Feinstein Index 
Kaplan and Feinstein developed this index in 1974 to assess the effects of comorbidity 
on maturity onset diabetes mellitus. (36) The study aimed to demonstrate that 
comorbidity is an important confounding variable when assessing the risk of mortality 
from chronic diseases such as diabetes. This study was a retrospective analysis of 
medical records of 188 male patients treated at a Veteran’s Affairs Hospital.  They 
were newly diagnosed diabetics (diagnosed within six months- between 1959 and 
1962) and were followed up for five years. The comorbidities were classified into two 
groups- vascular and non-vascular and were graded using a categorical severity 
scale- 1, 2 and 3 where grade 1 was mild, 2 moderate and 3 severe. Vascular 
conditions included hypertension and its sequelae; cardiac disorders excluding cor 
pulmonale; peripheral vascular disease; retinopathy and cerebrovascular disease. All 
other disease conditions were classified as non-vascular and included diseases of the 
lungs, liver, bones etc. They concluded that the 5 year mortality rate in patients with 
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diabetes was influenced by the type of comorbidity and more importantly, the severity 
of the comorbidity. Since the publications of the original index, it has been used to 
assess comorbidity in diseases other than diabetes including cancers such as prostate 
cancer (37), multiple myeloma (38) and head and neck cancer (39).  
2.4.4 Adult Comorbidity Evaluation-27 (ACE-27) 
The ACE-27 was a modified version of the KFI (the Modified Medical Comorbidity 
Index) developed by Picorillo et al, to prospectively study the incidence and burden of 
comorbidity in a cohort of 3378 patients suffering from different types of cancers 
including head and neck cancer, colorectal, lung, breast and prostate.(40) In the 
modified version, diabetes, AIDS and dementia were added to the disease categories. 
This study concluded that comorbidity was a significant prognostic factor in cancers of 
the head and neck, lung, breast and prostate even after controlling for other factors 
such as age and cancer stage. This study led to the development of the Adult 
Comorbidity Evaluation – 27 (ACE-27) in its present form; an index specifically for 
assessment of comorbidity from chart review, in cancer patients.(41) (Table 3) In this 
system, comorbidity is captured according to the various organ systems like 
cardiovascular, respiratory etc. and the severity is graded as 1 (mild decompensation), 
2 (moderate decompensation) and 3 (severe decompensation). The overall score is 
determined by the highest grade in any organ system/ailment. However if the patient 
scores grade 2 in two or more different organ systems, then the overall grade is 
calculated as 3.  
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Table 3 ACE- 27 
Adult Comorbidity Evaluation-27 
Identify the important medical comorbidities and grade severity using the index. Overall comorbidity score is 
defined according to the highest ranked single ailment, except in the case where two or more Grade 2 ailments 
occur in different organ systems. In this situation the overall comorbidity score should be designated Grade 3.  
Cogent Comorbid Ailment Grade 3 
Severe Decompensation 
Grade 2 
Moderate Decompensation 
Grade 1 
Mild decompensation 
Cardiovascular system 
Myocardial Infarct � MI ≤ 6 months � MI > 6 months ago  � MI by ECG only, age 
undetermined 
Congestive Heart 
Failure (CHF) 
� Hospitalized for CHF within 
past 6 
months 
� Ejection fraction < 20% 
� Hospitalized for CHF >6 
months prior 
� CHF with dyspnoea which 
limits 
activities 
� CHF with dyspnoea which 
has responded to treatment 
� Exertional dyspnoea 
� Paroxysmal Nocturnal 
Dyspnoea (PND) 
Arrhythmias � Ventricular arrhythmia ≤ 6 
months 
� Ventricular arrhythmia > 6 
months 
� Chronic atrial fibrillation or 
flutter 
� Pacemaker 
� Sick Sinus Syndrome 
�Supraventricular tachycardia 
Hypertension � DBP>130 mm Hg 
� Severe malignant papilledema 
or other eye changes 
� Encephalopathy 
� DBP 115-129 mm Hg 
� DBP 90-114 mm Hg while 
taking antihypertensive 
medications 
� Secondary cardiovascular 
symptoms: 
vertigo, epistaxis, headaches 
� DBP 90-114 mm Hg while 
not taking antihypertensive 
medications 
� DBP <90 mm Hg while 
taking antihypertensive 
medications 
� Hypertension, not otherwise 
specified 
Venous Disease � Recent PE (≤R6 mos.) 
� Use of venous filter for PE’s 
� DVT controlled with Coumadin 
or heparin 
� Old PE > 6 months 
� Old DVT no longer treated 
with Coumadin or Heparin 
Peripheral Arterial 
Disease 
� Bypass or amputation for 
gangrene or arterial insufficiency 
< 6 months ago 
� Untreated thoracic or 
abdominal aneurysm (>6 cm) 
� Bypass or amputation for 
gangrene or arterial insufficiency 
> 6 months ago 
� Chronic insufficiency 
� Intermittent claudication 
� Untreated thoracic or 
abdominal aneurysm (< 6 cm) 
� s/p abdominal or thoracic 
aortic aneurysm repair 
Respiratory System 
 � Marked pulmonary 
insufficiency 
� Restrictive Lung Disease or 
COPD with dyspnoea at rest 
despite treatment 
� Chronic supplemental O2 
� CO2 retention (pCO2 > 50 
torr) 
� Baseline pO2 < 50 torr 
� FEV1 (< 50%) 
� Restrictive Lung Disease or 
COPD 
(chronic bronchitis, emphysema, 
or asthma) with dyspnoea which 
limits activities 
 
� FEV1 (51%-65%) 
� Restrictive Lung Disease or 
COPD 
(chronic bronchitis, 
emphysema, or asthma) with 
dyspnoea which has 
responded to treatment 
 
� FEV1 (66%-80%) 
Gastrointestinal System 
Hepatic � Portal hypertension and/or 
oesophageal 
bleeding ≤l6 mos. 
(Encephalopathy, Ascites, 
Jaundice with Total Bilirubin > 2) 
� Chronic hepatitis, cirrhosis, 
portal hypertension with 
moderate symptoms 
"compensated hepatic 
failure" 
� Chronic hepatitis or cirrhosis 
without portal hypertension 
� Acute hepatitis without 
cirrhosis 
� Chronic liver disease 
manifested on 
biopsy or persistently elevated 
bilirubin (>3 mg/dl) 
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ACE 27 continued….  
 
Stomach/Intestine � Recent ulcers( ≤R6 months 
ago) requiring 
blood transfusion 
� Ulcers requiring surgery or 
transfusion > 6 months ago 
� Diagnosis of ulcers treated 
with meds 
� Chronic malabsorption 
syndrome 
� Inflammatory bowel disease 
(IBD) on 
meds or h/o with complications 
and/or 
surgery 
Pancreas � Acute or chronic pancreatitis 
with major 
complications (phlegmon, 
abscess, or 
pseudocyst) 
� Uncomplicated acute 
pancreatitis 
� Chronic pancreatitis with 
minor 
complications (malabsorption, 
impaired glucose tolerance, or 
GI 
bleeding) 
� Chronic pancreatitis w/o 
complications 
Renal System 
End-stage renal disease � Creatinine > 3 mg% with multi-
organ 
failure, shock, or sepsis 
� Acute dialysis 
� Chronic Renal Insufficiency 
with 
creatinine >3 mg% 
� Chronic dialysis 
� Chronic Renal Insufficiency 
with 
creatinine 2-3 mg%. 
Endocrine System (Code the comorbid ailments with the (*) in both the Endocrine system and other organ systems if applicable) 
Diabetes Mellitus � Hospitalization ≤H6 months for 
DKA 
� Diabetes causing end-organ 
failure 
� retinopathy 
� neuropathy 
� nephropathy* 
� coronary disease* 
� peripheral arterial disease* 
� IDDM without complications 
� Poorly controlled AODM with 
oral agents 
� AODM controlled by oral 
agents only 
Neurological System 
Stroke � Acute stroke with significant 
neurologic 
deficit 
� Old stroke with neurologic 
residual 
� Stroke with no residual 
� Past or recent TIA 
Dementia � Severe dementia requiring full 
support for 
activities of daily living 
� Moderate dementia (not 
completely 
self-sufficient, needs 
supervising) 
� Mild dementia (can take 
care of self) 
Paralysis � Paraplegia or hemiplegia 
requiring full 
support for activities of daily 
living 
� Paraplegia or hemiplegia 
requiring 
wheelchair, able to do some self-
care 
� Paraplegia or hemiplegia, 
ambulatory 
and providing most of self-care 
Neuromuscular � MS, Parkinson’s, Myasthenia 
Gravis, or 
other chronic neuromuscular 
disorder and 
requiring full support for activities 
of daily 
living 
� MS, Parkinson’s, Myasthenia 
Gravis, or other chronic 
neuromuscular disorder, but able 
to do some self-care 
� MS, Parkinson’s, 
Myasthenia Gravis, 
or other chronic 
neuromuscular 
disorder, but ambulatory and 
providing most of self-care 
Psychiatric 
 � Recent suicidal attempt 
� Active schizophrenia 
� Depression or bipolar disorder 
uncontrolled 
� Schizophrenia controlled w/ 
meds 
� Depression or bipolar 
disorder 
controlled w/ medication 
Rheumatologic (Incl. Rheumatoid Arthritis, Systemic Lupus, Mixed Connective Tissue Disorder, Polymyositis, Rheumatic 
Polymyositis) 
 � Connective Tissue Disorder 
with 
secondary end-organ failure 
(renal, 
cardiac, CNS) 
� Connective Tissue Disorder 
on 
steroids or immunosuppressant 
medications 
� Connective Tissue Disorder 
on 
NSAIDS or no treatment 
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ACE 27 continued… 
Immunological System (AIDS should not be considered a comorbidity for Kaposi's Sarcoma or Non-Hodgkin's Lymphoma) 
AIDS � Fulminant AIDS w/KS, MAI, 
PCP (AIDS 
defining illness) 
� HIV+ with h/o defining illness. 
CD4+ < 200/μL 
� Asymptomatic HIV+ patient. 
� HIV+ w/o h/o AIDS defining 
illness. 
CD4+ > 200/μL 
Malignancy (Excluding Cutaneous Basal Cell Ca., Cutaneous SCCA, Carcinoma in-situ, and Intraepithelial Neoplasm) 
Solid Tumour including 
melanoma 
� Uncontrolled cancer 
� Newly diagnosed but not yet 
treated 
� Metastatic solid tumour 
� Any controlled solid tumour 
without 
documented metastases, but 
initially diagnosed and treated 
within the last 5 years 
� Any controlled solid tumour 
without 
documented metastases, but 
initially diagnosed and treated 
> 5 years ago 
Leukaemia and 
Myeloma 
� Relapse 
� Disease out of control 
� 1st remission or new dx <1yr 
� Chronic suppressive therapy 
� H/o leukaemia or myeloma 
with last 
Rx > 1 yr prior 
Lymphoma � Relapse � 1st remission or new dx <1yr 
� Chronic suppressive therapy 
� H/o lymphoma w/ last Rx >1 
yr prior 
Substance Abuse (Must be accompanied by social, behavioural, or medical complications) 
Alcohol � Delirium tremens � Active alcohol abuse with 
social, 
behavioural, or medical 
complications 
� H/o alcohol abuse but not 
presently 
drinking 
Illicit Drugs � Acute Withdrawal Syndrome � Active substance abuse with 
social, 
behavioural, or medical 
complications 
� H/o substance abuse but not 
presently 
using 
Body Weight 
Obesity  � Morbid (i.e., BMI ≥M38)  
Overall Comorbidity Score (Circle one)       0-None    1-Mild       2- Moderate      3- Severe          9-Unknown 
Revised November 2003                    Washington University School of Medicine                            Clinical Outcomes Research Office 
 
2.4.5 American Society of Anaesthesiologists’ (ASA) physical status 
classification system  
The ASA grading system was first described by Saklad in 1941.(42) The original 
grading had six classes, ASA 1-6 with one being a healthy person to 4 being someone 
with extreme systemic disorders that is already an imminent threat to life. Class 5 
included emergencies that would otherwise be graded in class 1 or 2 and class 6 
included emergencies that would otherwise be in class 3 and 4. The aim of the scale 
was to address the pre-operative state of the person. In 1963, the scale was modified 
to have 5 grades in which 1 was a healthy person, 2 person with mild systemic 
disease, 3 with severe systemic disease, 4 severe systemic disease which is a 
constant threat to life, 5 a moribund person who is not expected to survive without the 
operation. The suffix E was added to the grade if the surgery was being performed as 
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an emergency. (25) Later on a sixth category was added which was a brain dead 
person whose organs were being removed for donor purposes.  
ASA grade is widely used to assess the general fitness of an individual in nearly all 
specialties and can be easily obtained from the anaesthetic charts. Since it is a 
dynamic assessment of the patient’s fitness at the time of surgery, it is not a fixed 
score and can change from time to time for the same patient depending on their 
current state of health. In gynaecological oncology, Aletti et al found that ASA grade 
was an independent predictor of adverse events in ovarian cancer surgery (43) and 
Kondalsamy-Chennakesavan et al also found that it was a significant predictor of 
morbidity for all gynaecological cancer surgeries. (35) 
2.4.6 Comorbidity data in gynaecological oncology surgery  
In the studies that looked at surgical morbidity in gynaecological oncology, ASA grade 
was captured in both the studies, as mentioned above. In addition, Aletti et al captured 
albumin and creatinine levels when comparing outcomes between three centres for 
ovarian cancer surgery. No other comorbidity index was used. (44)  In the second study 
by Kondalsamy-Chennakesavan et al, which looked at overall morbidity in 
gynaecological oncology surgery, comorbidity was captured according  to various 
organ systems and in addition, laboratory parameters such as levels of liver enzymes 
(including albumin level) and electrolyte levels were also included. (45) Other than ASA 
grade, this study also did not use any other index to capture comorbidity.  
In this study (UKGOSOC), comorbidity was captured according to the various organ 
systems as there was limited evidence for the use of any particular comorbidity index, 
other than ASA grade. In addition to ASA grade ACE-27 was also incorporated into the 
database as the latter had been recommended by the National Cancer Intelligence 
Network (NCIN) for use in all cancers at the time when this study was being designed.  
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2.5 Morbidity data in gynaecological oncology surgery 
Data in gynaecological oncology is limited to single centre studies and a three centre 
study from the US. The POSSUM (Physiological and Operative Severity Score for the 
enumeration of mortality and morbidity) index (46) originally developed to predict 
morbidity and mortality in general surgery was validated in gynaecological oncology by  
Das et al. The P-POSSUM (Portsmouth modification of the Physiological and 
Operative Severity Score for the enUmeration of Mortality and Morbidity) index was 
used to predict mortality in gynaecological oncology surgery.(47) This was a prospective 
single centre study from a UK tertiary gynaecological centre over a 12 month period 
which found that the POSSUM index over estimated mortality. The authors concluded 
that the P-POSSUM could not be used in its current form for gynaecological oncology 
surgery and would require modifications if it were to be used.  
Kondalsamy-Chennakesavan et al prospectively analysed all surgery for suspected 
gynaecological cancer in a tertiary centre in Australia over a 20 month period and 
developed a risk scoring system to predict adverse events. (45) In this study, surgical 
complexity, elevated serum glutamic oxaloacetic transaminase (SGOT), higher 
American Society for Anaesthesiologists’ (ASA) scores and overweight were 
independently associated with adverse events.  
Aletti et al analysed the relationship between surgical complexity, morbidity and overall 
survival in ovarian cancer.(43) This was a single centre US study over a four year 
period which found that  even though complex surgery had an increased risk of 
complications, it had a positive impact on overall survival. In a different study, Aletti et 
al also developed a risk-adjusted model to compare the outcomes for ovarian cancer 
surgery between three tertiary gynaecological oncology centres in the US and found 
that the outcomes were comparable in the three participating centres.(44) Their model 
was based on the National Surgical Quality improvement programme (NSQIP). (48) 
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They concluded that the use of a risk prediction model derived from multivariable 
regression and the use of observed:expected complications ratios was a feasible 
method to compare outcomes between centres.  
2.6 Databases in other surgical specialties  
Various general surgical specialties have their own databases to collect data on 
morbidity and mortality. A brief description of some of the databases is given below.  
2.6.1 National Surgical Quality Improvement Programme (NSQIP) 
The National Surgical Quality Improvement Programme (NSQIP) in the US is one of 
the most successful programmes established in 1994 to provide risk-adjusted 
morbidity and mortality rates for major surgery in the participating Veterans Affairs 
Medical Centres (VAMCs). (48) Data was collected on pre-surgical patient risk factors, 
surgical factors, complications and 30 day mortality. Trained surgical clinical nurse 
reviewers (SCNRs) under the guidance of the chief of surgery of each VAMC were 
responsible for the collection and transmission of data to the coordinating centre. The 
data was transmitted electronically onto a national database. Patients were also sent a 
follow-up letter from the coordinating centre 30 days after the procedure. Logistic 
regression was used to develop a risk prediction model for morbidity and 30-day 
mortality for various surgical specialties. For each VAMC, the expected morbidity and 
mortality rates were calculated using this risk-prediction model and observed to 
expected ratios were calculated. This programme has helped in the considerable 
reduction of morbidity and mortality rates after surgery over the years. (49) Success of 
the programme has been down to the dedicated nurse reviewers, a common electronic 
database for collection and transmission of data, a set of agreed list of complications, 
and a coordinating centre responsible for the smooth running of the study, for all the 
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analyses and for generating outcome reports. Since its inception, the NSQIP now also 
includes non-veteran hospitals including those in the private sector.  
2.6.2 The adult cardiac surgery register 
The Society for Cardiothoracic Surgery (SCTS) of Great Britain and Ireland 
established the adult cardiac surgery register in 1994. (50) This is clinically led and data 
is fed into the Central Cardiac Audit Database (CCAD) which is now a part of the NHS 
information centre. Encrypted data on patient demographics and pre-operative risk 
factors, surgery details and in-hospital postoperative outcomes are entered. Risk-
adjusted mortality data for individual hospitals are available, and, since 2004, 
outcomes for individual surgeons have also been made available, which is accessible 
to the public. The problem of incomplete data with clinician led databases has not 
been an issue with the cardiac register. The missing data for important fields for risk 
stratification has been <5% and for postoperative complications around 15%. (50) This 
register has demonstrated that with the dedication of the participating clinicians, it is 
possible to have a database that consistently generates high quality morbidity and 
mortality data.  
2.6.3 National Bowel Cancer Audit Project (NBOCAP) 
The first bowel cancer audit was published in 2000. The audit captures outcomes of 
colorectal cancer in the UK. Data capture has increased from 30% of the NHS trusts at 
its inception in 2000 to 98% in 2010. (51) Unlike the cardiac surgery register which 
captures real time data, the NBOCAP has relied on information on a minimum dataset 
and collects information on patient demographics, stage of cancer, surgery and  
adjuvant treatment. Main outcome measures are 30-day mortality and length of stay. 
In future the audit aims to collect more details on postoperative complications.  
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2.6.4 The National Joint registry (NJR) 
Established in 2002 in the UK, the NJR collects information on all joint replacement 
surgery including shoulder, elbow, hip and knee and ankle replacements to monitor 
their performance and to assess the effectiveness of different types of surgery.(52)  
Main outcomes data include 90 day mortality and revision rates. Patient reported 
outcome measures (PROMs) are also available for hip and knee replacement 
surgeries. The NJR has recently started publishing data for individual surgeons as 
well.  
2.6.5 Head and neck cancer audit (HANA) 
The UK national head and neck cancer audit publishes outcomes on treatment for 
head and neck cancers.(53) Perioperative mortality and 90 day postoperative mortality 
rates for individual hospitals are published  in addition to details of surgery and 
adjuvant therapy. Risk adjusted mortality rates after accounting for patient comorbidity; 
performance status and stage of the disease are also published.  
2.7 Surgical Complexity 
Surgery for gynaecological cancers often includes procedures for staging and tumour 
debulking. In addition to a hysterectomy and salpingo-oophorectomy, procedures 
commonly performed include lymphadenectomy, omentectomy, appendicectomy, 
bowel resections and ureterolysis. Radical debulking surgery includes additional 
procedures like diaphragm stripping, splenectomy, liver resection etc. Therefore it is 
important to adjust for surgical complexity whilst determining the morbidity from 
surgery. In general surgery the POSSUM index was developed to predict morbidity 
and mortality.(46) In this system surgery was graded as minor, moderate, major and 
major+ depending on the complexity of the procedure. (Table 3) However this 
classification was only for general surgical procedures and did not include any 
gynaecological procedures.  When Das et al adapted the Portsmouth modification of 
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the POSSUM index (P-POSSUM) for predicting mortality in gynaecological oncology 
(47) they classified surgery into three groups- minor, major and complex major. Minor 
included laparoscopy and biopsy. Major included hysterectomy + bilateral salpingo-
oophorectomy, pelvic lymphadenectomy, para-aortic lymphadenectomy, simple 
vulvectomy, omentectomy, appendicetomy, bowel resection + anastomosis, ureteric 
re-anastamosis.  Complex major included radical hysterectomy + pelvic node 
dissection, radical trachelectomy, radical vulvectomy + inguinofemoral 
lymphadenectomy, anovulvectomy, radical debulking surgery (ovary/primary 
peritoneal), exenteration, vascular graft insertion and ileal conduit.  
Kondalsamy-Chennakesavan et al classified gynaecological cancer surgery into three 
groups- categories 0, 1 and 2 for inclusion in a risk prediction model. (45) Complex 
procedures in category 1 included radical hysterectomy, pelvic lymphadenectomy, 
para-aortic lymphadenectomy, omentectomy, adhesiolysis and ureterolysis. Complex 
procedures in category 2 included anterior rectal resection, colonic resection, small 
bowel resection, exenteration, urinary conduit, splenectomy, (sub) total peritonectomy 
and resection of the diaphragm.  
The difficulty with classifying surgery as per the above methods is that it is not feasible 
to account for additional procedures that may sometimes be required to perform with 
an otherwise straight forward procedure. For example, a hysterectomy for extensive 
endometriosis or in a patient with intra-abdominal adhesions as a result of previous 
surgery/infection, may require ureterolysis or adhesiolysis making it a more complex 
procedure when compared to a hysterectomy in a patient with no pelvic pathology. In 
such situations it would be important to account for the additional procedures, and this 
is not possible with the above systems of classifications. Aletti et al adopted a different 
approach to accounting for surgical complexity. (43) In this system, every individual 
component of the overall surgery was given a score. For example, if the surgery 
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included a total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy 
(BSO), omentectomy and pelvic lymphadenectomy, the overall score for the procedure 
was a sum of the scores for the individual procedures- 
TAH+BSO+Omentectomy+pelvic lymphadenectomy. Depending on the overall score 
the surgery was then classified as low (<3), intermediate (4-7) and high (>8) 
complexity. Since this method accounts for every procedure performed as part of the 
whole surgery, it helps to distinguish between easy and difficult procedures as well. In 
this system, the score for a simple hysterectomy would be different to that for a difficult 
one e.g. for severe endometriosis requiring adhesiolysis, ureterolysis etc. An additional 
point would be allocated to the additional procedures such as adhesiolysis and 
ureterolysis thus increasing the total score from 1 for a TAH and BSO to 3 for a TAH, 
BSO with ureterolysis and adhesiolysis. A modified version of the Aletti scoring system 
to include procedures for all gynaecological cancers was used in UKGOSOC and this 
has been detailed in the next chapter.  
2.8 Risk prediction models 
Risk prediction models have been developed in various specialties to predict morbidity 
and mortality. The aim of such models is to be able to predict the outcome as 
accurately as possible whilst accounting for confounding patient and surgical factors. 
The ratio between observed and predicted morbidity/mortality (observed/expected 
ratio) derived from risk prediction models have been used to assess performance of a 
surgical unit or individual surgeon. They have also been used to monitor performance 
of the same unit or surgeon over a period of time. The Observed/Expected (O/E) ratio 
is a better alternative to crude rates when comparing the morbidity and mortality 
across different specialties as well, since the rates for each specialty can vary with 
some specialties in general having high mortality rates, some others high morbidity 
rates and some others with low morbidity and mortality rates.  Generally, an O/E ratio 
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equal to 1 indicates that the performance is as expected, >1 worse than expected and 
<1 better than expected. Some of the risk prediction models developed in different 
surgical specialties are detailed below.  
2.8.1 The POSSUM surgical scoring system  
Copeland et al developed the POSSUM (Physiological and Operative Severity Score 
for the enUmeration of Mortality and Morbidity) index to predict morbidity and mortality 
for all general surgical procedures, excluding cardiac surgery. (46) This is a two part 
scoring system consisting of a physiological part with 12 variables and a surgical part 
with six variables to account for operative severity. (Table 4) Each variable is also 
divided into four grades (one, two, four and eight) of increasing severity and 
complications are recorded according to a pre-determined list. The POSSUM score 
was tested prospectively on 1372 patients admitted for surgery at a single institution, 
using the physiological score pre-operatively and the surgical score at discharge. (46) A 
good correlation was observed between O/E rates for morbidity and mortality. (p 
<0.001) Further studies also found good correlation between O/E rates for various 
surgical specialties and for surgical units in different countries with varying case-mix. 
(54) Since its initial development, the POSSUM score has been modified for use in 
different surgical specialties to improve its predictive ability, for example the CR-
POSSUM (CR-colorectal) for colorectal surgery. A study comparing POSSUM with 
CR-POSSUM found that CR-POSSUM was better at predicting mortality rates for 
individual surgeons for colorectal cancer surgery. (55) However as mentioned 
previously, the POSSUM was found to over predict mortality in gynaecological 
oncology surgery. (47) 
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Table 4 POSSUM Score 
POSSUM Physiological Score 
  Score 
  1 2 4 8 
Age < 60 61-70 >71   
Cardiac signs No failure Diuretic, digoxin, 
antianginal or 
hypertensive therapy 
peripheral oedema, warfarin 
therapy 
Raised jugular venous 
pressure 
Chest radiograph     Borderline cardiomegaly Cardiomegaly 
Respiratory history No 
dyspnoea 
Dyspnoea on exertion Limiting dyspnoea (one 
flight) 
Dyspnoea at rest (rate 
>30/min) 
Chest Radiograph   Mild COAD Moderate COAD Fibrosis or 
consolidation 
Blood pressure (systolic) 
(mmHg) 
110-130 131-170 >171   
    100-109 90-99 <89 
Pulse (beats/min) 50-80 81-100 101-120 >121 
    40-49   <39 
Glasgow Coma Score 15 12-14 9-11 <8 
Haemoglobin (g/100ml) 13-16 11.5-12.9 10.0-11.4 <9.9 
    16.1 - 17.0 17.1-18.0 >18.1 
White cell count (x10
12  
/l) 4-10 10.1-20.0 >20.1   
    3.1-4.0 <3.0   
Urea (mmol/l) <7.5 7.6-10.0 10.1-15.0 >15.1 
Sodium (mmol/l) >136 131-135 126-130 <125 
Potassium (mmol/l) 3.5-5.0 3.2-3.4 2.9-3.1 <2.8 
    5.1-5.3 5.4-5.9 >6.0 
Electrocardiogram Normal   Atrial fibrillation                                                
(rate 60-90) 
Any other abnormal 
rhythm or > 5 
ectopics/min Q waves 
or ST/T wave changes 
Operative severity score 
  Score 
  1 2 4 8 
Operative severity* Minor Moderate Major Major+ 
Multiple procedures 1   2 >2 
Total blodd loss (ml) <100 101-500 501-999 >1000 
Peritoneal soiling None Minor (serous fluid) Local Pus Free bowel content, 
pus or blood) 
Presence of malignancy None Primary only Nodal metastases Distant metastases 
Mode of surgery Elective   Emergency resuscitation of 
>2h possible**                                                                     
Operation <24hrs after 
admission  
Emergency 
(immediate surgery
<2h needed) 
Surgery of moderate severity includes appendicectomy, cholecystectomy, mastectomy, transurethral resection of  
prostate; major surgery includes any laparotomy, bowel resection, cholecytectomy, peripheral vascular procedure   
or major amputation; major + surgery includes any aortic procedure, abdomino perineal resection, pancreatic or  
liver resection, oesophagogastrectomy;      
** indicates that resuscitation is possible even if this period is not actually utilised   
  
2.8.2 The National Surgical Quality Improvement Programme (NSQIP) 
The NSQIP has been described previously (section 2.3.1). Logistic regression was 
used to predict the risk of surgical morbidity and mortality. (48) A predetermined list of 
twenty complications was used to define morbidity and mortality was defined as death 
within thirty days after surgery. Maximum likelihood methods were used to determine 
the intercept term and beta coefficients attached to the independent variables in the 
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model. The most important patient risk factor was first entered into the model followed 
by the second most important factor until all important predictor variables were in the 
model at the α =0.05 level of significance. The model thus developed was used to 
predict the morbidity/mortality for each individual patient, taking into account their 
preoperative risk factors. These probabilities were then summed up to predict the 
number of patients with complications or deaths for each surgical specialty or hospital. 
O/E ratios were then calculated for each surgical specialty and hospital. The very first 
analysis in the NSQIP found that without risk adjustment 25 out of 39 hospitals would 
have been wrongly incriminated as outliers. (48) Various studies looking at trends over 
a period of time have shown that the risk adjusted outcomes data generated by the 
NSQIP have helped to reduce morbidity and mortality in individual hospitals. (49) 
2.8.3  Variable Life-adjusted Display (VLAD) 
Developed initially for cardiac surgery, the VLAD is a graphical display of surgical 
performance over time. The display charts the difference between expected and actual 
outcomes (i.e. mortality/morbidity) over a time period for individual surgeons or 
specialty or surgical units.(56) The formula or algorithm to derive values for expected 
outcomes varies from one specialty to the other. Although initially developed to 
monitor mortality trends in cardiac surgery, it has been used to assess trends in the 
incidence of surgical site infections (SSI), (57) mortality trends in oesophageal cancer 
surgery, (58) neonatal deaths in low resource settings etc. (59) The advantage of a visual 
display is that it helps in easy interpretation of the trends by hospital staff and 
clinicians.   
2.8.4 Surgical Apgar Score (SAS) 
This score was developed to easily and accurately grade a patient’s condition soon 
after surgery and predict the chances of major postoperative complications or death 
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(within 30 days of surgery) after general or vascular surgery. (60) A ten point score was 
developed based on estimated blood loss, lowest heart rate and lowest mean arterial 
pressure. It was developed by analysing 99 intraoperative and postoperative variables 
in patients undergoing colectomy and was then validated in general surgery and 
vascular surgery patients. The aim of the score was to have an easy method of 
identifying patients who were at low and high risk of developing complications after 
surgery to optimise their postoperative care. It was not designed for comparing 
outcomes between hospitals or to monitor outcomes of individual surgeons. Lower 
scores indicated poorer outcomes. The SAS has been validated in prospective studies 
in elective general (61) and spinal surgery (62) and found to be a significant predictor of 
postoperative complications. In a different study following  emergency general surgery 
(63) lower SAS scores were also found to be associated with an increased readmission 
rate.  
2.8.5 Risk scoring systems in gynaecological oncology 
Kondalsamy-Chennakesavan et al developed a clinical risk score to predict adverse 
events in patients undergoing surgery for suspected or proven gynaecological 
cancers. (45)  Patient comorbidity, clinical characteristics, pre-operative lab results, 
surgical complexity, duration of surgery, surgical approach, surgeon’s experience, 
intraoperative and postoperative complications and duration of stay were prospectively 
collected from a single tertiary cancer centre. Postoperative complications were 
graded according to the Clavien and Dindo system. Univariable logistic regression 
analysis was first performed to identify the significant predictors of adverse events 
which were then included into multivariable regression model. To develop the risk 
scoring system coefficients from the multivariable regression model were scaled using 
a factor of 2 and rounded off to the nearest integer. Risk points for each variable were 
determined by these rounded integers. The sum of all the risk points formed the 
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overall risk score. Risk (%) for an adverse event was calculated using the formula, 
100/(1+e(3.697−(risk score / 2))). This model has not yet been validated by external 
datasets.  
Aletti et al developed a risk-adjusted model to compare the outcomes of ovarian 
cancer surgery between three tertiary cancer centres in the US. (44) Patient with FIGO 
Stage IIIC and IV ovarian cancer were included in the study. Patient characteristics 
including age, ASA grade, pre-operative serum albumin and creatinine levels were 
recorded. Surgical parameters included surgical stage and grade, complexity of 
procedure, presence and volume of ascites. Outcomes included length of hospital 
stay, major postoperative morbidity (defined using a pre-determined list), three month 
mortality and inability to receive chemotherapy. Univariate analysis followed by 
multivariable regression was performed to develop a risk prediction model. Observed 
to expected ratios were then calculated for each of the centres for the different 
outcomes. The study found that serum albumin, ASA grade, age and complexity of 
surgery were significant predictors of the outcomes. The O/E ratios for the dependent 
outcome variables were found to be similar for the three centres.  
2.9 Conclusion 
Various surgical specialties have developed databases for ongoing collection and 
publication of outcomes data. Some of them like the cardiac surgery database are 
entirely clinician led and some others like the head and neck cancer database collect 
information both from Hospital Episode Statistics and clinicians. Most databases use 
only hospital reported data and patient reported complications are not used. However, 
studies that have looked at patient-reporting suggest that patients accurately report 
complications, if they are clearly defined. Various indices are available for assessing 
comorbidity and ICD codes are usually used to collect information on various comorbid 
illnesses. The comorbidity indices not only record information about a particular illness 
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but also account for its severity. Some studies have also collected information on 
laboratory results such as liver enzymes, electrolyte levels etc. and incorporated these 
into the risk prediction algorithms. Of the various indices, ACE-27 was specifically 
developed to capture comorbidity in cancer patients from chart review. Complications 
are traditionally recorded according to a pre-determined list. However, grading of 
complications (especially postoperative), helps to account for the severity of a 
complication, which can have implications on extent of surgical morbidity. Surgical 
complexity has been shown to have a significant impact on morbidity. This has been 
accounted for by either grouping the procedures into categories according to their 
complexity or by using a scoring system to account for each individual procedure 
performed as part of the whole surgery.  
There is limited multi-centred data on surgical morbidity in gynaecological oncology 
and currently a national database does not exist.  However the information gathered 
from other surgical databases can be used to develop one for gynaecological 
oncology.  
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3 Methods 
3.1 Study design  
The study was set out to capture data on all consecutive surgeries on consented 
patients, on a gynaecological oncologist’s theatre list. It was designed in such a way 
that data could be entered contemporaneously from the operating theatre and hospital 
wards onto a web-based database. Details of surgery, intra-operative complications 
were entered by the surgeons in the operating theatre. The discharge date and post-
operative complications were entered on the ward by junior doctors. The diagnosis 
was then entered once the pathology results were available. In order to capture 
complications patients may have suffered after being discharged from hospital, 
patients were sent a follow-up letter (FUL) from the coordinating centre (CC). All the 
analysis was carried out centrally at the CC at University College London. (Figure 1) 
Figure 1 Study design 
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3.2 Participants and subjects 
In the UK, surgery for gynaecological cancers in centralised in cancer centres where 
surgery is performed by accredited gynaecological oncologists. This study was 
therefore open for participation to all gynaecological cancer centres in the UK National 
Health Service (NHS). Participation was voluntary and in order to recruit the centres, 
the study proposal was announced at various network and society meetings of 
gynaecological oncologists.  
Women who were being operated upon by gynaecological oncologists were 
approached for consent (Appendix 1) to participate in the study to include their 
identifiers and surgery data in the study. Consent was also obtained for a follow-up 
letter to capture complications post discharge from hospital. However, if women 
preferred not to receive the follow-up letter, they had the option of providing 
anonymised data. Surgery details of those women who declined consent were not 
included in the study.  
3.3 Database 
A web-based custom built database was designed in Microsoft SQL server to 
contemporaneously capture data from the participating centres. It was hosted on a 
secure server at the Trent Cancer Registry and the website was accessible only 
through N3 which is a secure private network service used by NHS hospitals in 
England, Wales and Scotland. The database was accessible to users who were each 
given a unique username and password. The users included administrative staff who 
entered details of consecutive patients on a surgeon’s theatre list onto the database 
and clinicians who entered surgery, complications and diagnosis data. To ease the 
process of data entry and analysis, most of the fields had drop down lists which also 
minimised the use of free text. (Appendix 2, 3, 4, & 5) The database was designed in 
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such a way that data once entered and saved could not be altered unless the local 
clinical teams contacted the CC.  
3.3.1 Training 
Training in the use of the web-based programme was provided by one of the CC team 
members either in person by visiting the centre, or, remotely via web conferencing.  
3.4 Ethical approval 
Ethics approval was sought from the Joint UCL/UCLH Committees on the Ethics of 
Human Research in June 2008, which advised that the project was considered to be 
an audit, not requiring formal ethical review. However since patients were sent a 
follow-up letter (FUL) from the CC at University College London, informed consent was 
obtained to include their personal identifiers. Patients also had the option to provide 
anonymised data if they so preferred.   
3.4.1 Inclusion criteria 
All major surgical procedures performed in a gynaecological oncology theatre list were 
eligible for inclusion in the study. In addition to cancer surgery, the procedures also 
included surgery for benign conditions where there was a high pre-operative suspicion 
of cancer, cases with a complex surgical history that had been referred to the 
gynaecological oncology team and risk reducing/prophylactic surgery.  
3.4.2 Exclusion criteria 
Minor diagnostic procedures such as hysteroscopy, examination under anaesthesia 
loop excision of cervix and diagnostic laparoscopy; surgery for complications arising 
as a result of the primary surgery, and, those major procedures where patients had 
refused consent, were excluded.  
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3.5 Data collection 
Patient identifiers included name, date of birth, address, hospital number and NHS 
number a unique identification number given to every patient treated on the NHS.  
Pre-operative information on patients included age, comorbidity, American Society of 
anaesthesiologists (ASA)  grade (25), Body Mass Index (BMI) and details of any 
previous abdominal surgery (with the exclusion of diagnostic laparoscopy).  
3.5.1 Co-morbidity:  
Comorbidity was captured under specific categories which included autoimmune, 
cardiac, integumentary/dermatology, gastrointestinal, genitourinary, musculoskeletal, 
metabolic/endocrine (excluding diabetes), neurology/psychiatric, respiratory, vascular, 
infections, hypertension, diabetes, low albumin, smoking and other neoplasms. ACE-
27 comorbidity index was built into the database to capture the severity of the 
comorbidities. The severity was graded as 1(mild), 2(moderate), 3 (severe) and 9 
(unknown). (Table 3) However during the course of the study, capturing of ACE-27 
score had to be discontinued due to licensing issues for individual centres. In addition, 
ASA Grade was also recorded which takes into account the patient’s comorbidities 
and their severity, and, overall performance status at the time of surgery.   
3.5.2 Diagnosis 
The diagnosis was recorded using International Classification of Diseases (ICD)10 
codes.(2) The International Federation of Gynecology and Obstetrics (FIGO) system 
was used for staging the cancers.(64, 65) 
For the analysis, the final diagnosis was classified into five groups - ‘Ovarian’ included 
primary ovarian, fallopian tube, peritoneal, synchronous cancers (where one of the 
primary sites was ovary) and cancers of unknown primary (assumed to have been 
ovarian cancer prior to surgery); ‘Uterine’ included cancers of endometrial origin, 
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carcinosarcomas and uterine sarcomas; ‘Cervical’ included primary cervical cancers;  
‘vulval’ included primary vulval and vaginal cancers,  and ‘benign’ included all the 
benign pathology.   
3.5.3 Surgical procedures 
Procedures were captured using the relevant Office of the Population Censuses and 
Surveys (OPCS) codes version 4.5 and 4.6.(66), which are alphanumeric codes used 
by clinical coders to code for interventions and surgical procedures in the NHS.  
3.5.4 Surgical complexity  
In addition to a hysterectomy and salpingo-oophorectomy, surgery for gynaecological 
cancers often involves lymphadenectomy, omentectomy, bowel resection (if there is 
bowel involvement) and upper abdominal procedures like stripping of the diaphragm, 
splenectomy etc, for staging and tumour debulking. In order to account for all the 
procedures performed, a scoring system was developed based on the system 
developed by Aletti et al for ovarian cancer surgery.(43) The modified version also 
included procedures used for uterine, cervical and vulval cancers in addition to those 
for ovarian cancer. (Table 5) 
In this system each individual procedure is given a score and the total score for the 
surgery is the sum of the individual scores. For example, if omentectomy and pelvic 
lymphadenectomy were performed along with a total abdominal hysterectomy (TAH), 
according to this system, there would be a score of 1 for TAH, 1 for omentectomy and 
2 for pelvic lymphadenectomy giving a total score of 4. Based on the overall score, 
Aletti et al classified the surgery as low (<3), intermediate (4-7) or high complexity 
(>8). In UKGOSOC, the surgeries were categorised into five groups (total complexity 
score of 1& 2= group 1; 3&4=group 2; 5&6=group 3; 7&8 = group 4; >8=group 5) as 
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surgical complexity was found to be a significant predictor of intraoperative 
complications during preliminary analysis. 
In addition to the surgical procedure, the grade of operating surgeon (consultant, sub-
specialty trainee, general obstetrics and gynaecology trainee), duration of surgery (in 
minutes), surgical approach (open/laparoscopic/vaginal) and estimated blood loss 
(<500mls, 500-1500mls, >1500-2500mls, >2500mls) were also recorded.  
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Table 5 Surgical complexity scoring 
Procedure Points 
Laparoscopic approach 1 
Total hysterectomy +/- Bilateral Salpingo-oophorectomy  1 
Bilateral Salpingo-oophorectomy 1 
Radical hysterectomy +/- Bilateral Salpingo-oophorectomy 4 
Radical trachelectomy 3 
Simple trachelectomy 1 
Cervical stumpectomy 2 
Ureterolysis (mobilisation of ureter from tumour / adhesions) 1 
Re-implantation of ureter 2 
Omental Biopsy / Staging Infracolic Omentectomy 1 
Supracolic + Infracolic Omentectomy 2 
Adhesiolysis (any code for adhesiolysis) 1 
Pelvic Lymphadenectomy 2 
Para aortic Lymphadenectomy 2 
Peritoneum resection / stripping 1 
Large bowel resection with primary anastomosis 3 
Large bowel resection with stoma 2 
Small bowel resection with anastomosis  2 
Small bowel resection with end small bowel stoma 1 
Appendicectomy 1 
Diaphragm stripping / resection 2 
Splenectomy 2 
Liver resection (s) 2 
Wide local excision of vulva 1 
Simple vulvectomy 1 
Radical vulvectomy 2 
Sentinel node biopsy 1 
Inguinofemoral Lymphadenectomy 2 
Posterior Exenteration 5 
Anterior exenteration +/- urinary conduit 7 
Total exenteration 7 
Surgical Complexity Score  
Complexity Score Group Points 
1  <3 
2  3-4 
3  5-6 
4 7-8 
5 >8 
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3.5.5   Complications 
To capture intraoperative and postoperative complications, a pre-determined list of 
complications was compiled by reviewing the literature and following several group 
discussions involving the participating surgeons.  
3.5.5.1 Intraoperative complications 
Intraoperative complications captured included injury to various organs such as 
bladder, bowel, ureters and major blood vessels such as the iliac vessels, aorta, 
inferior venacava and renal vessels. If the estimated blood loss was more than 2.5 
litres, then this was considered as an Intraoperative complication. In cases of injury to 
bladder and bowel, a full thickness injury was considered to be a complication. (Table 
6)  
Table 6 Intraoperative complications 
Intra-operative complications  
Anaesthetic complications    
Cardiac e.g. Cardiac arrythmias, Intra-operative cardic arrest 
Respiratory e.g. Aspiration, pneumothorax, pulmonary oedema 
Allergic reactions Allergic reactions including anaphylaxis 
Injury to viscera   
Uterine perforation Perforation of uterus during instrumentation 
Vascular injury 
Injury to major blood vessel e.g. superior and inferior 
mesenteric, renal, aorta, Inferior vena cava, iliacs, femorals, 
GI tract injury – Stomach 
Accidental injury involving complete penetration Into the lumen: 
Stomach 
GI tract injury – Small bowel 
Accidental injury involving complete penetration Into the 
lumen:Small bowel 
GI tract injury – Large bowel 
Accidental injury involving complete penetration Into the lumen: 
Large bowel 
Bladder injury Accidental bladder injury (full thickness) 
Ureteric injury Ligation / Transection / Diathermy burn 
Intra-operative Haemorrhage Estimated blood loss >2.5l 
Other intra-operative 
complications (give details) 
 Other intraoperative complications not included in the list 
3.5.5.2 Postoperative complications 
Postoperative complications were captured as per the pre-determined list (Table 7).  
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Table 7 Postoperative complications 
Post-operative complications 
Abscess/Haematoma Pelvic or abdominal abscess / haematoma 
Anastomotic leak 
Anastomotic leak: Small bowel 
Anastomotic leak: Large bowel 
Ileus Post op Ileus requiring NG tube / Total parental nutrition 
Bowel obstruction Bowel Obstruction – small bowel 
  Bowel Obstruction – large bowel 
Bowel perforation Small / large bowel 
Bowel - other Constipation / Diarrhoea / faecal incontinence/urgency 
Bladder  
Urinary retention requiring catheterisation 
Urinary obstruction 
Incontinence- stress / urge  
Cardiac Atrial fibrillation, Myocardial infarction, Cardiac failure & other 
cardiac problems 
DVT Confirmed DVT on imaging / Doppler 
PE Confirmed PE on imaging 
Fistula 
Enterocutaneous 
Enterovaginal 
Vesicovaginal 
Ureterovaginal 
Other types of fistula 
Hernia Hernia as a result of surgery  
Infection 
Pyrexia (>38.5°C on 2 separate occasions) after 48 hours post 
op requiring antibiotics or infection confirmed by culture 
MRSA/ C. difficile 
Lymphocyst/Lymphoedema 
Lymphoedema  
Lymphocyst 
Neurological Neuropathic pain/ paraesthesia / nerve palsy 
Psychiatric unexpected psychiatric problems postoperatively e.g. Delirium, 
Psychosis, Depression and other  
Primary haemorrhage Haemorrhage within 24 hours of surgery  
Secondary haemorrhage Haemorrhage after 24hours  of surgery  
Respiratory 
Pulmonary oedema, Pneumothorax, Atelectasis, Pleural 
effusion and other respiratory problems excluding pneumonia 
(to be included in infections) 
Ureteric Obstruction Ureteric obstruction postoperative  
Wound breakdown 
Wound breakdown: Superficial - skin & subcutaneous tissue 
Wound breakdown: Deep - involving fascia / muscle 
Burst abdomen requiring repair under anaesthesia 
Other Other postoperative complications not included in the list  
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Complications were graded based on their severity and intervention required using the 
Clavien and Dindo system.(8) In this system, complications were graded from I to V 
(with two subsets each in Grade III and IV) according to severity and intervention 
required. Grade 1 included ‘any deviation from the normal post-operative course, not 
requiring any pharmacological/surgical/radiological intervention’, such as pain and 
nausea. Grade II complications included those requiring specific pharmacological 
intervention (e.g. infections requiring antibiotic therapy). Grade III were those 
complications requiring intervention (IIIa not requiring  general anaesthesia and Grade 
IIIb requiring general anaesthesia), Grade IV were life threatening complications 
requiring intensive care management (IVa - single organ failure, IVb - multi-organ 
failure) and Grade V was death. For the final analysis, Grade 1 complications being 
the least severe and more likely to be subject to individual variation were excluded 
from the analysis.  
3.5.6 Follow-up letters 
The women who had given consent, were sent a FUL from the CC to capture any 
complications they may have suffered since leaving the hospital. They were requested 
to provide their contact phone numbers for any clarification. Initially a free text 
questionnaire (Appendix 7) was sent and the participants were asked to choose one of 
the two statements – ‘No, I did not have a complication following my gynaecological 
surgery’ or ‘yes; I had a complication following my gynaecological surgery’. If the 
answer was yes, then they were asked to provide details. During the latter half of the 
study, a structured follow-up questionnaire (Appendix 8) was developed containing a 
list of complications and specific questions regarding the management of the 
complication to aid in easier grading of the complications according to the Clavien and 
Dindo system (detailed in chapter 6).   
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In cases where the women had mentioned complications with sequelae such as 
readmission, re-operation and admission to intensive care, confirmation was sought 
from the hospitals. All the replies were analysed by an independent clinician (RI) at the 
CC and graded according to the Clavien and Dindo system as mentioned previously. 
All Grade II-V complications were included in the analysis.  
3.6 Data Analysis: 
Descriptive statistics were used to characterise the cohort. Surgery was used as the 
denominator for all the analyses as there were women who had undergone two 
separate procedures as part of their treatment (repeat surgeries for complications 
were excluded). In addition it was possible that age, comorbidity and ASA grade could 
change over time in an individual woman.  
The crude or unadjusted intraoperative and postoperative complications rates (CRs) 
were calculated. Two types of postoperative CRs were calculated: Hospital-reported 
and hospital- and-patient reported. All eligible surgeries were included to calculate the 
crude intraoperative and hospital-reported postoperative CRs. To calculate the 
hospital-and-patient reported postoperative CR, only those surgeries with a reply to 
the follow-up letter were included.  
Statistical analysis was performed using STATA version 12.1 (StataCorp 2012). 
Multivariable regression was used to determine significant predictors of Intraoperative 
and Postoperative complications. This is detailed in chapter 7.  
The penalised (Lasso) method of regression was used to develop risk prediction 
models. Observed and risk-adjusted expected CRs for individual centres (hospitals) 
were calculated to benchmark the performance of individual centres against the overall 
CR. The observed/expected complication rate ratio for individual centres was also 
calculated. A ratio of >1 suggested that the complication rates in that centre were 
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higher and a ratio of <1 suggested that they were lower than expected.  The Lasso 
regression methodology and the calculation of observed/expected ratio are detailed in 
chapter 8. (67) 
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4 Baseline characteristics and Surgery details 
Ten accredited gynaecological oncology centres participated in the study. Eight 
centres were from England, one each from North Wales and Scotland. (Figure 2) 
During the pilot phase between 1st April 2010 and 31st January 2011, four centres 
participated. Six additional centres joined the main phase of the study which lasted for 
a thirteen month period from 1st February 2011 to 29th February 2012.  
Figure 2 UKGOSOC centres 
 
Including the pilot and the main phase, a total of 3026 operations were captured. 78 
operations were excluded - 54 diagnostic procedures and 24 surgeries for 
complications. The remaining 2948 operations were analysed which included 373 
anonymised and 2575 surgeries with patient identifiers. (Figure 3) These 2948 
surgeries were performed on 2910 women with 38 women having had two surgeries 
each.  
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Figure 3 Number of surgeries 
 
Follow-up letters: Out of the 2575 surgeries where women had given consent to 
receive an FUL, 2152 were sent and 1462 replies were received (68%). (Figure 3) 
4.1 Baseline characteristics:  
The baseline characteristics are detailed in Table 8. Surgery was used as the 
denominator for all calculations as there were 38 women who had undergone two 
surgeries as part of their treatment. The median age was 62 years (Inter quartile range 
[IQR] - 50-71). The median BMI was 27 (IQR- 23.8-32.4) and was >30 in 35% of the 
surgeries. (Figure 4) Comorbidities were present in 62.5% of the surgeries and 
hypertension was the commonest comorbidity (33%). The ASA grade was < 2 in 
79.4% and >3 in 20.4% of cases.  
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Figure 4 BMI distribution 
 
 
4.2 Surgery  
Majority of the operations were performed by consultants (n=2191, 74.3%) followed by 
trainees specialising in Gynaecological Oncology (n=573, 19.4%). (Table 9) 70% of 
procedures (n=2069) were performed through the open approach, 23% 
laparoscopically (n=681) and 7% were vulval / vaginal procedures (n=198). 1.6% of 
the laparoscopic procedures (n=11) required an emergency laparotomy. The mean 
duration of surgery in minutes was 120 (IQR- 90-167) for open procedures, 120 (IQR 
85-170) for laparoscopic procedures and 87 (IQR 50-148) for vulval/vaginal 
procedures.  
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Table 8 Baseline characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Total no. of eligible surgery  2948 
Age (in years, Median, IQR) 62 (50-71) 
BMI   
BMI (median, IQR) 27.4 (23.8-32.4) 
BMI Category n (%) 
Underweight (<18.5) 41 (1.4) 
Normal (18.5-24.9) 897 (30.4) 
Overweight (25-29.9) 895 (30.4) 
Obese (30-39.9) 805 (27.3) 
Morbidly obese (> 40) 236 (8) 
Missing 74 (2.5) 
ASA Grade n (%) 
1&2 2341 (79.4) 
>3 600 (20.4) 
Missing 7 (0.2) 
Co-morbidity n (%) 
0 1105 (37.5) 
1 - 3 1716 (58.2) 
>3 127 (4.3%) 
Type of co-morbidity n (%) 
Hypertension 973 (33) 
Cardiac 308 (10) 
Diabetes 298 (10) 
Respiratory 287 (10) 
Musculoskeletal 261 (9) 
Neurology/Psychiatric 208 (7) 
Other Neoplasms 148 (5) 
Coagulation/Thrombosis 116 (4) 
Gastrointestinal 104 (4) 
Smoking 95 (3) 
Vascular 86 (3) 
Genitourinary 52 (2) 
Autoimmune 37 (1) 
Integumentary/Dermatology 30 (1) 
Infections 13 (0.4) 
Low Albumin 11 (0.4) 
Previous abdominal surgery 1025 ( 34.7) 
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The median length of stay in days was 4 (IQR 3-6) for open procedures, 2 (IQR 1-2) 
for laparoscopic procedures and 4 (IQR 2-7) for vulval/vaginal procedures.  
Figure 5 Key procedures performed 
 
 
 
Staging procedure including bilateral salpingo-oophorectomy+/-total abdominal 
hysterectomy and pelvic/para-aortic lymphadenectomy+/- omentectomy+/-
appendicectomy+/-peritonectomy was the commonest procedure performed followed 
by a simple open hysterectomy and bilateral salpingo-oophorectomy. Total 
laparosopic/laparoscopically assisted vaginal hysterectomy was the third commonest 
procedure performed. (Figure 5)   
1202 
TAH- Total abdominal hysterectomy; BSO- Bilateral salpingo-oophorectomy; Oment- omentectomy; App- Appendicectomy; 
Lymph- Lymphadenectomy; perit- peritonectomy; USO- Unilateral Salpingo-oophorectomy; TLH- Total Laparoscopic 
Hysterectomy; LAVH- Laparoscopically Assisted Vaginal Hysterectomy; OmBx-Omental Biopsy; Rad hyst- Radical 
hysterectomy; Om-Omentectomy; Lap Rad Hyst- Laparoscopic Radical Hysterectomy; abd- abdominal 
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Table 9 Surgery details 
Grade of operating surgeon n (%) 
Consultant 2191 (74.3) 
Sub-specialty trainee 573 (19.4) 
General Obstetrics & Gynaecology Trainee 108 (3.7) 
Missing  76 (2.6) 
Diagnosis  
Ovarian* 989 (33.5) 
Uterine** 820 (27.8) 
Cervical 207 (7.0) 
Vulval*** 176 (6.0) 
Benign 756 (25.7) 
Surgical approach n (%) 
Open 2001 (67.9) 
Laparoscopic elective proceed to laparotomy 68 (2.3) 
Laparoscopic emergency proceed to laparotomy  11 (0.3) 
Laparoscopic**** 670 (22.7) 
Vulval/Vaginal procedures 198 (6.7) 
Duration of surgery (minutes) Median, IQR 
Open procedures 120 (90- 167) 
Laparoscopic procedures 120 (85- 170) 
Vulval/Vaginal procedures 87 (50 -148) 
Surgical Complexity n (%) 
Group 1 (Complexity score 1&2) 1398 (47) 
Group 2 (Complexity score 3&4) 982 (33) 
Group 3 (Complexity score 5&6) 430 (15) 
Group 4 (Complexity score 7&8) 93 (3) 
Group 5 (Complexity score >8) 45 (2) 
Surgical procedures n (%) 
TAH+/-BSO+Omentectomy 
/Appendicectomy/Lymphadenectomy/peritonectomy 1202 (40.8) 
TAH+/-BSO /USO 448 (15.2) 
Radical hysterectomy+/- BSO+/- Lymphadenectomy 106 (3.6) 
TAH/BSO/ Omentectomy+Bowel resection 94 (3.2) 
TAH+BSO+Omentectomy+Upper abdominal surgery 58 (2.0) 
Exenterations +/- Conduits 16 (0.5) 
Open Lymphadenectomy 14 (0.5) 
Exploratory/Abandoned procedure 29 (1.0) 
Other open procedures 105 (3.6) 
TLH/ LAVH+BSO 306 (10.4) 
TLH or LAVH +/- Omental biopsy+ Lymphadenectomy 262 (8.9) 
Laparoscopic  Radical hysterectomy +/-Lymphadenectomy 65 (2.2) 
Laparoscopic Lymphadenectomy 30 (1.0) 
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Table 9 Surgery details continued….. 
Other Laparoscopic procedures 18 (0.6) 
Vulvectomy (Radical/simple) 113 (3.8) 
Vulvectomy + Inguinofemoral lymphadenectomy 46 (1.6) 
Inguinofemoral lymphadenectomy 18 (0.6) 
Vaginectomy 12 (0.4) 
Other vulval/vaginal procedures 6 (0.2) 
Length of Stay Days, Median (IQR) 
Open procedures 4 (3-6) 
Laparoscopic  2 (1-2) 
Vulval/Vaginal procedures 4 (2-7) 
 
*Includes primary ovarian, fallopian tube, primary peritoneal, 
synchronous, non-gynae primary cancers 
**Includes primary endometrial cancer, carcinosarcoma & sarcoma of the 
uterus 
***Includes primary vulval and vaginal cancers 
****Includes total laparoscopic and laparoscopic and vaginal procedures 
 
TAH- Total abdominal hysterectomy 
 BSO- Bilateral salpingo-oophorectomy 
 USO- Unilateral salpingo-oophorectomy 
 TLH- Total laparoscopic hysterectomy 
 LAVH- Laparoscopic assisted vaginal hysterectomy 
 
 
989 operations (33.5%) were performed for ovarian and related cancers. This group 
included primary ovarian, fallopian tube and primary peritoneal cancers and those 
cases where the suspected primary had been ovarian prior to surgery (unknown 
primary, non-gynae primary and synchronous cancers, n=70). 733 (74.1%) were 
debulking procedures that comprised of hysterectomy with bilateral salpingo-
ooporectomy with omentectomy / lymphadenectomy / appendicectomy /peritonectomy, 
81 (8.2%) were debulking procedures requiring bowel resection with anastomosis / 
stoma and 57 (5.8%) were procedures requiring upper abdominal debulking involving 
the diaphragm, spleen, liver etc.   
820 operations were for ‘uterine’ cancers (27.8%) and this included primary 
endometrial adenocarcinomas, carcinosarcomas and uterine sarcomas. Total 
abdominal hysterectomy (TAH), bilateral salpingo-oophorectomy (BSO) with 
lymphadenectomy (n=284, 34.6%) was the commonest procedure followed by 
MD Thesis RI Page 4-67 
  
laparoscopic hysterectomy (n=211, 25.7%), TAH with BSO (n=168, 20.5%), and 
laparoscopic hysterectomy with lymphadenectomy (n= 97, 11.8%).  
207 operations were for primary cervical cancer (7%). Open radical hysterectomy (and 
lymphadenectomy) was the commonest procedure (n=69, 33.3%) followed by 
laparoscopic radical hysterectomy (and lymphadenectomy) (n= 59, 28.5%).  
There were 176 surgeries for ‘vulval’ cancer (6%) which included primary vulval and 
vaginal cancers. Vulvectomy (radical/simple) was the commonest procedure (n=95, 
54%) followed by vulvectomy with inguinofemoral lymphadenectomy (n=46, 26.1%).   
There were 756 operations for benign pathology (25.6%). TAH, BSO with 
omentectomy/lymphadenectomy/appendicectomy (n=318, 42.1%) was the commonest 
procedure followed by TAH with BSO (n=178, 23.5%) and laparoscopic hysterectomy 
with BSO (n= 117, 15.5%).  
4.3 Discussion:  
Majority of the patients were in the older age group with the average age being 62 
years. A third of the patients were obese and more than half of the patients had one or 
more comorbidities.  Even though uterine cancers are commoner than ovarian cancers 
in the general population, in this study, there were more ovarian than uterine cancers. 
This could have been due to the early stage low grade (Stage 1A, Grade1) 
endometrial cancers being operated upon in the local hospitals (cancer units) rather 
than at the cancer centres that participated in the study. Overall there were 919 
operations performed for primary ovarian/tubal/primary peritoneal cancers. In addition, 
operations performed for synchronous cancers (where one of the primary sites was 
ovary), cancers of unknown primary and non-gynaecological primary cancers were 
included in the ‘ovarian cancer’ category (n=70) as pre-operatively the primary had 
been assumed to be ovary in these cases and also, the surgery performed was very 
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similar to that for ovarian cancer.  This further increased the number of surgeries 
performed for ‘ovarian cancer’ to 989. It was very much a consultant led service with 
the consultant being the primary surgeon in three out of four (74%) cases. Only four of 
the ten centres had trainees specialising in gynaecological oncology and therefore 
they were the primary surgeons in just 19% of the operations.  
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5 Intraoperative and hospital-reported postoperative complications  
This chapter summarises hospital-reported complications which include intraoperative 
and those postoperative complications reported/entered by the clinicians.    
5.1  Method 
Intraoperative complications were entered by the surgeons soon after the surgery, 
preferably in the operating theatre and the postoperative complications were recorded 
by the clinical teams as when they occurred on the ward using a predetermined list. 
(Table 6 & 7) The Clavien and Dindo system was used to grade the postoperative 
complications according to their severity and intervention required. (Table 10) (8) Only 
Grade II-V complications were included in the analysis. Grade 1 complications were 
excluded as they were by definition ‘any deviation from the normal post-operative 
course not requiring any pharmacological/surgical/radiological intervention’. They were 
therefore likely to be subject to individual variation and to have minimal impact on the 
post-operative course.    
Table 10 Clavien and Dindo’s Classification of complications 
Grade 1 
Any deviation from the normal postoperative course without the need for pharmacological 
treatment or surgical, endoscopic and radiological interventions 
Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgesics, diuretics, 
electrolytes, and physiotherapy. This grade also includes wound infections opened at the 
bedside 
Grade II  Requiring pharmacological treatment with drugs other than such allowed for grade I 
complications. Blood transfusions and TPN are also included 
Grade III  Requiring surgical, endoscopic or radiological intervention 
IIIa  Intervention not under general anaesthesia 
IIIb  Intervention under general anaesthesia 
Grade IV  Life-threatening complication (including CNS complications- excludes TIA)* requiring IC/ICU 
management 
IVa  Single organ dysfunction (including dialysis) 
IVb  Multiorgan dysfunction 
Grade V  Death of a patient 
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5.1.1 Complication rate  
Intraoperative complication rate (CR) was calculated by dividing the number of 
surgeries with intraoperative complications by the total number of eligible surgeries.  
Hospital reported postoperative CR was calculated by dividing the number of surgeries 
with Grade II-V postoperative complications by the total number of eligible surgeries.  
5.2 Results 
5.2.1 Intraoperative complications 
There were 143 intraoperative complications in 139 surgeries (two complications each 
in two surgeries). Therefore the overall Intraoperative complication rate (CR) in 2948 
surgeries was 4.7% (139/2948; 95% CI 4.0 - 5.6). Intraoperative haemorrhage (1.4%) 
followed by bladder and small bowel injury (0.7%) were the most frequently occurring 
intraoperative complications. (Table 11) 
For those operations resulting in a cancer diagnosis, there were 121 complications in 
118 out of 2192 operations giving an Intra Op CR of 5.4% (95% CI 4.5 – 6.4) for 
cancer surgery.  
5.2.1.1 Intraoperative complications by diagnostic category 
Ovarian cancer: The highest Intraoperative CR was seen for ovarian cancer surgery 
(78/989; 7.9%, 95% CI – 6.4 - 9.7). (Table 11)Two out of the three exenterations had 
an Intra-op complication (66.8%). The Intra-op CR was 19.8% (16/81) for procedures 
with bowel resection and 14% (8/57) for procedures involving upper abdominal 
surgery.  
Cervical cancer:  The second highest Intra-op CR (10/207, 4.8%; 95% CI 2.6-8.7) 
was seen for cervical cancer surgery. (Table 11) The Intra-op CR for the subset of 
open radical hysterectomies was 5.5% (3/55) and was almost double (10%, 5/50) for 
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laparoscopic radical hysterectomies. Emergency laparotomy was required for only one 
(2%; 1/50) of the laparoscopic radical hysterectomies. 
Uterine cancer: 28 out of 820 surgeries for uterine cancer had Intraoperative 
complications (3.4%, 95% CI 2.4 - 4.9). (Table 11) Intraoperative haemorrhage was 
again the commonest complication (n=8, 1%) followed by vaginal tear during 
laparoscopic hysterectomy (n=5, 0.6%) and small bowel injury (n=4, 0.5%). (Table 12) 
Open vs laparoscopic hysterectomy:  Since hysterectomy or hysterectomy with pelvic 
lymphadenectomy is the main surgical procedure for most uterine cancers, 
comparisons were made between the open and laparoscopic approach. Out of a total 
738 hysterectomies, 431 were open (58.4%) and 307 laparoscopic (41.6%).  The 
intraoperative complication rate was 2.6% for open (n=11) and 3.6% for the 
laparoscopic approach (n=11). Emergency laparotomy was required in five out of 307 
(1.6%) laparoscopic hysterectomies. Pelvic lymphadenectomy was performed with 166 
(38.5%) of open and 82 (38.9%) of laparoscopic hysterectomies. For the subset of 
hysterectomies with lymphadenectomy, the intraoperative complication rate was 1.8% 
for open (n=3) and 7.3% (n=6) for the laparoscopic approach.  
Intraoperative haemorrhage was the most common complication for ovarian, uterine 
and cervical cancer surgery. (Table 12) 
Vulval cancer: There were only two surgeries with an intraoperative complication for 
vulval cancer (2/176, 1.1%) and both were bladder injuries. (Table 12) 
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Table 11 Intraoperative complication rate for each diagnostic category 
Primary site (diagnosis) No. of surgery with 
complications/Total no. of surgery 
Rate 
(%) 
Ovary 78/989 7.9 
Uterine 28/820 3.4 
Cervix 10/207 4.8 
Vulva 2/176 1.1 
Benign 21/756 2.8 
 
Table 12 Types of intraoperative complications 
Intraoperative Complications (No. of surgery = 2948) 
Complication category Total              
No. (%) 
Primary cancer site 
Benign Ovary
1
 Uterine
2
 Cervix Vulva
3
 
Intra-operative Haemorrhage 41 (1.4) 27 8 3 
 
3 
Bladder injury 22 (0.7) 11 3 2 2 4 
GI tract injury- Small bowel 22 (0.7) 16 4 
  
2 
GI tract injury- Large bowel 11 (0.4) 4 2 1 
 
4 
Vascular Injury 13 (0.4) 7 2 1 
 
3 
Vaginal tear 7 (0.2) 
 
5 
  
2 
Cardiac 6 (0.2) 2 
 
1 
 
3 
Diaphragmatic injury 5 (0.2) 5 
    
Ureteric Injury 5 (0.2) 1 2 1 
 
1 
Splenic injury 3 (0.1) 3 
    
Gall bladder injury 1 (0.03) 
 
1 
   
Liver laceration 1 (0.03) 1 
    
Nerve injury 1 (0.03) 
  
1 
  
Respiratory 1 (0.03) 1 
    
Uterine perforation 1 (0.03) 
 
1 
   
Anaphylaxis 1 (0.03)  1    
Other 2 (0.07) 1 1    
Total intraoperative complications 143  79  30  10  2  22  
Total no. of Surgery 2948 989 820 207 176 756 
1- Includes primary ovarian, fallopian tube, primary peritoneal, synchronous, non-gynae primary and 
unknown primary cancers 
2- Includes primary endometrial cancer, carcinosarcoma & sarcoma of the uterus 
3- Includes primary vulval and vaginal cancers 
 
Benign diagnosis: Of the 756 operations for benign conditions, there were 21 
surgeries with Intraoperative complications (2.8%). (Table 11) Bladder and large bowel 
injury were the most commonly occurring complications (n=4, 0.5%), followed by 
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Intraoperative haemorrhage, vascular injury and cardiac complications (n=3, 0.4% 
each). (Table 12) 
 Overall, intraoperative haemorrhage was the most frequently occurring complication 
(n=41, 1.4%) followed by bladder and small bowel injury (n=22, 0.7%) (Table 12) 
The intraoperative CR increased with increasing surgical complexity with rates of 2.9% 
(41/1398) for a surgical score of <3, 4.4% (43/982) for a score of 3-4, 7.9% (34/430) 
for a score of 5-6, 12.9% (12/93) for a score of 7-8 and 20% (9/45) for a score of >8. 
Overall, procedures with bowel resection had the highest intraoperative complication 
rate (18 out of 94, 19.1%) followed by exenterations (3 out of 16, 18.8%), debulking 
surgery requiring upper abdominal resections (8 out of 58, 13.8%) and laparoscopic 
radical hysterectomy (6 out of 65, 9.2%). (Figure 6) 
Figure 6 Intraoperative complications for individual surgical procedures 
 
 
 
 
TAH- Total abdominal hysterectomy; BSO- Bilateral salpingo-oophorectomy; abd- abdominal, lap- laparoscopic, Lap Rad 
Hyst- Laparoscopic Radical Hysterectomy; Lymph- Lymphadenectomy; USO- unilateral salpingo-oophorectomy; Omen bx- 
omental biopsy; App- Appendicectomy; perit- peritonectomy; TLH- Total Laparoscopic Hysterectomy; LAVH- Laparoscopically 
Assisted Vaginal Hysterectomy 
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5.2.2 Hospital reported postoperative complications 
Hospitals reported 481 Grade II-V postoperative complications in 424 out of the total 
2948 surgeries resulting in a postoperative CR of 14.4% (95% CI 13.2-15.7). The 
highest postoperative CR was noted for Vulval cancer surgery (51/176, 29% 95% CI – 
22.7 – 36.0). (Table 13) 
For those operations resulting in a cancer diagnosis, 398 Grade II-V complications 
were recorded in 349 out of 2192 operations giving a postoperative Op CR of 15.9% 
(95% CI 14.4 – 17.5). 
Table 13 Hospital-reported postoperative complication rate for each diagnostic category 
Primary site (diagnosis) No. of surgery with complications/Total 
no. of surgery 
Rate (%) 
Ovary 167/989 16.9 
Uterine 87/820 10.6 
Cervix 44/207 21.3 
Vulva 51/176 29.0 
Benign 75/756 9.9 
 
Infections (131/2948, 4.4%) and wound breakdown (114/2948, 3.87%) were the most 
common complications. (Table 14) 
5.2.3 Grade of hospital-reported postoperative complications 
Out of the total 481 complications, 380 (79%) were Grade II, i.e. requiring medical 
intervention only. Remaining 101 (21%) were Grade III or worse, i.e. requiring some 
radiological/surgical intervention/ management in intensive care (15 Grade IIIa, 60 
Grade IIIb, 21 Grade IVa and five Grade V).  (Table 15) 
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Table 14 Hospital-reported postoperative complications 
Hospital-reported Grade II-V postoperative complications (No. of surgery = 2948) 
Complication category 
Total           
(% of total 
surgery) 
Primary cancer site 
Benign 
Ovary Uterine Cervix Vulva 
Infection 131 (4.4) 47 30 20 12 22 
Wound breakdown 114 (3.9) 34 27 3 29 21 
Abscess/Haematoma 25 (0.8) 9 5 3 1 7 
Bladder 22 (0.7) 4 6 4 1 7 
Lymphocyst/Lymphoedema 20 (0.7) 3 3 3 11   
PE 10 (0.3) 8 2       
DVT 2 (0.1) 2         
Primary haemorrhage 9 (0.3) 4 2 1   2 
Secondary haemorrhage 14 (0.5) 7 3 1   3 
Ileus 21 (0.7) 14 3     4 
Bowel obstruction 10 (0.3) 6 2 1   1 
Bowel perforation 6 (0.2%) 3 1   1 1 
Bowel - other 11 (0.4) 7 1     3 
Fistula 10 (0.3) 6 1 3     
Anastomotic leak 5 (0.2%) 4   1     
Respiratory 13 (0.4) 7 4 1   1 
Cardiac 11 (0.4) 6 3   1 1 
Neurological 7 (0.2) 1 1 2 2 1 
Psychiatric 7 (0.2) 4     1 2 
Hernia 1 (0.03)         1 
Hydronephrosis 1 (0.03) 1         
Other 31 (1.1) 17 5 2 1 6 
Total 481 194 99 45 60 83 
Total no. of surgery 2948 989 820 207 176 756 
 
Re-operation/return to theatre was required following 63 operations (60 Grade IIIb and 
three Grade IVa; 2.1%), admission to intensive care following 21 (0.7%) and 
readmission following 56 operations (1.9%).  
 There were five (0.2%) peri-operative deaths, i.e. deaths within thirty days of surgery 
reported by the hospitals. Two deaths were from septicaemia, one each from chest 
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infection, adult respiratory distress syndrome and acute renal failure leading to multi-
organ failure.   
Table 15 Grade of hospital-reported postoperative complications 
Grade of hospital reported complications (No. of surgery = 2948) 
Complication category 
Complication Grade II-V 
Total II IIIa IIIb IV V 
Infection 123 1   4 3 131 
Wound breakdown 97   16 1   114 
Abscess/Haematoma 15 5 5     25 
Bladder 21   1     22 
Lymphocyst/Lymphoedema 20         20 
PE 8 1   1   10 
DVT 2         2 
Primary haemorrhage     9     9 
Secondary haemorrhage 11 1 1 1   14 
Ileus 21         21 
Bowel obstruction 5   5     10 
Bowel perforation     5 1   6 
Bowel - other 8 1 2     11 
Fistula 1 1 8     10 
Anastomotic leak     4 1   5 
Respiratory 6 1   5 1 13 
Cardiac 10     1   11 
Neurological 7         7 
Psychiatric 7         7 
Hernia 1         1 
Hydronephrosis   1       1 
Other 17 3 4 6 1 31 
Total 380 15 60 21 5 481 
 
5.3 Discussion 
The overall intraoperative complication rate was 4.7% (95% CI 4.0 - 5.6) and 5.4% 
(95% CI 4.5 – 6.4) when limited to confirmed malignancies.  
The overall intraoperative complication rate of 4.7% was lower than the 8% reported 
from a tertiary gynaecological oncology centre in Australia (Kondalsamy 
Chennakesavan et al, 2009), which was probably influenced by the small sample size 
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of 381 women in their study compared to nearly 3,000 in UKGOSOC. (45)  Rates for 
gynaecological malignancy alone were lower than intraoperative complication rates in 
women undergoing pelvic surgery for rectal cancer (12%).(68) Lower complication rates 
in surgeries for gynaecological compared to colorectal cancer are likely to be related to 
the lower rates of bowel resection and possible anastomosis and resultant lower 
incidence of anastomotic leaks, peritonitis or other bowel complications. In UKGOSOC 
only 4.2% (91/2192) of the cancer surgeries required a bowel resection. 
The lower incidence of intraoperative complications was paralleled by the lower (1.6%) 
laparoscopic to emergency laparotomy conversion rates compared to the Australian 
study (2.4%) and the  rectal cancer surgery multi-centre trial (16%).(68) Although only 
25% of all the abdominal procedures were performed using the laparoscopic 
approach, for endometrial cancer, this approach was used in 41.8% of the 
hysterectomies. The intra-operative complication rates in the open and laparoscopic 
groups were similar but there was a higher postoperative complication rate for open 
compared to laparoscopic procedures. These findings were similar to that reported in 
two randomised controlled trials comparing laparoscopic and open approaches for 
hysterectomy+/- lymphadenectomy for endometrial cancer (69) (70). For laparoscopic 
radical hysterectomies, the conversion to laparotomy rate was 2%, similar to the 1.7% 
reported in a Korean study comparing open vs laparoscopic approaches for early 
stage cervical cancer. (71) 
The hospital reported postoperative CR was 14.4% (95% CI 13.2-15.7) for the entire 
cohort and 15.9% when limited to confirmed malignancies (95% CI 14.4 – 17.5). 
These rates were slightly lower than the 21% quoted in the Australian study. The rate 
of 3.3% for Grade III & IV complications was however was similar to that in the 
Australian study (3.5%). (45) 
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Vulval cancer surgery had the highest postoperative CR (29%) with a 17% wound 
infection/breakdown rate and a 7% lymphoedema rate. The wound infection rate was 
comparable to the 17 - 39% reported in a review of complications of vulval cancer 
surgery but the lymphoedema rate was much lower compared to the 14 - 49% 
reported in the same review.(72) This discrepancy is likely due to these complications 
occurring following discharge from hospital and therefore not recorded by the 
centre/hospital where the initial surgery was performed.  
Surgery for cervical cancer had the second highest postoperative complication rate of 
21%.   All the three fistulae and three out of the four bladder complications had 
occurred following laparoscopic radical hysterectomies. The fistula rate of 1.5% was 
comparable to the 1.7% for laparoscopic radical hysterectomies in the Korean 
study.(71) For uterine cancers, the overall hospital reported wound infection rate was 
3.3% and all of them were as a result of open surgery. This rate was comparable to 
the 4% wound infection rate seen in a randomised controlled trial comparing open and 
laparoscopic approaches for endometrial cancer surgery. (70) 
MD Thesis RI Page 6-79 
  
6 Patient follow-up and postoperative complications 
Surgical complications data are conventionally collected from review of hospital case 
notes or from administrative data such as Hospital Episode Statistics (HES). The 
former is time consuming and resource intensive and the latter can lead to errors from 
miscoding of complications by administrative staff. (73) Also, complications that occur 
following discharge can be missed as patients tend to consult their general practitioner 
or their local hospital for their treatment. This is more likely after cancer surgery which 
is centralised in accredited centres in the UK. Therefore in UKGOSOC, patients were 
sent a follow-up letter (FUL) six to eight weeks postoperatively with the aim of 
specifically capturing these complications.  
There is limited literature on the additional value of patient-reported complications 
following surgery. Three studies (14, 15, 74) examining concordance of clinical and 
patient-reported complications, in elective hip and knee replacement surgery were 
found. These suggested variable rates of correct reporting for different complications 
with good concordance for clearly defined complications such as deep vein thrombosis 
(DVT) and pulmonary embolism (PE) and poor concordance for those less clearly 
defined such as ‘major bleeding’.  
In UKGOSOC two types of FUL letters were used to capture complications data- a 
free-text format and a questionnaire format. Concordance between hospital and 
patient reporting and the difference in the estimates of overall postoperative morbidity 
according to data source were calculated.  
6.1 Method  
Patient consent was obtained to send FUL postoperatively. Initially a free text format of 
FUL was sent to patients. The women were asked an open ended question- ‘Have you 
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had a complication following your gynaecological surgery? If so, please give details’ 
(Appendix 7). They were also requested to provide their telephone numbers so that 
they could be contacted for any clarifications.  
Interim analysis of the FUL was undertaken in July 2011 to elucidate the common 
postoperative complications experienced by women following which a closed format 
questionnaire was developed to capture data in a uniform fashion that could be easily 
interpreted and analysed. A list of 11 common postoperative complications was 
derived which included wound breakdown, infections, pelvic/abdominal 
abscess/haematoma, heavy vaginal bleeding, lymphoedema, lymphocyst, 
constipation, other bowel problems, bladder problems (including incontinence, urinary 
retention), DVT and PE. Every complication was briefly described and the questions 
included a sub-set on management (whether readmission or reoperation had been 
necessary). Space was provided after each question for the patient to add any 
additional details if they so wished. Women were also asked questions about the main 
language spoken in their home, whether the questionnaire was in a language that they 
could easily understand, and their educational status. The responses were kept to 
simple ‘yes/no’ answers, with a view to minimising free text. (Appendix 8) 
Initially two formats of the questionnaire were designed. These were then circulated 
among eight non-medical female colleagues and two lay volunteers. They were asked 
to comment on the questions and the format of the questionnaire. In the first format, 
women were asked if they had suffered a particular complication from surgery. 
Following the main question, space was provided to enter details regarding the 
management. In the second format, the main question was followed by a subset of 
specific questions regarding management with yes/no answers. Seven out of the ten 
women who had been asked to evaluate the questionnaire preferred the second 
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format as the questionnaire though longer than the first was easier to complete with 
minimum writing required. Hence this latter format was adopted (Appendix 8). 
All replies were entered on the central audit database. The data was cleaned and 
analysed by a single clinician (RI), who also contacted the women for clarification of 
equivocal replies. The postoperative complications were once again classified 
according to the Clavien and Dindo system from Grade I to V (with two subsets each 
in Grade III and IV), based on their severity and the intervention required (8) (Table 9). 
Grade I complications being the least severe (not requiring any specific 
pharmacological / surgical / radiological intervention) were excluded from future 
analysis as it was felt these could be subject to individual variation. Clinical teams 
were contacted for individual confirmation of all Grade II-V Postoperative 
complications not previously reported by the hospital. Patient-reported readmissions, 
reoperations, and admissions to intensive care were forwarded as soon as the replies 
were received and all other patient-reported complications were forwarded at quarterly 
intervals. 
The postoperative complication rate (CR) was calculated as the proportion of eligible 
surgeries with a Grade II-V postoperative complication. Concordance was calculated 
as proportion of Grade II-V patient-reported complications that were verified by the 
hospital clinician.  
Those complications that could not be graded but were included in the analysis were 
grouped with Grade II complications when calculating Postoperative complication 
rates, concordance and sensitivity according to complication Grade.  
6.2 Results  
A total of 2575 FULs were sent to consented women (423 not sent- 399 missing or 
incomplete address, 24 deceased) and 1462 (68%) replies were received. (Figure 3) 
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The final diagnosis in the 1462 surgeries included ovarian cancer in 481, uterine 
cancer in 427, cervical cancer in 80, vulval cancer in 79 and benign pathology in 395.  
In 256 of 265 (97%) questionnaire format replies, women reported that English was 
the main language spoken at home. Of the remaining nine (3%) only two women 
reported having difficulty understanding English and requiring help to complete the 
questionnaire. 30% of the women had left school before 15 years of age and 15% had 
completed a bachelor’s degree (Table 16 ).  
Table 16 Details of women who replied to questionnaire format of follow-up letter 
  Number  % 
Main Language spoken at home* (n=265) 
English 256 97 
Other** 9 3 
Questionnaire in a language that could be understood* (n=265) 
Yes 263 99 
No 2 1 
Help required to complete questionnaire* (n=265) 
Yes 2 1 
No 263 99 
Educational status* (n=265) 
Finished school at or before 15 years of age 79 30 
Completed GCSEs, O levels or equivalent 67 25 
Completed A levels or equivalent 21 8 
Completed further education but not a degree 45 17 
Completed a bachelor's degree/master's degree/PhD 41 15 
Other (Please specify) 5 2 
Missing  7 3 
Total  265   
**5 Welsh, 2 Polish, 1 Greek, 1 French 
  
 
6.2.1 Hospital reported complications 
In 172 of these 1462 surgeries, hospitals reported 200 Grade II-V Postoperative 
complications. The commonest complications reported were infections (51, 26%), 
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wound breakdown (48, 24%), ileus (13, 7%) and bladder related complications such as 
urinary retention (13, 7%). 
6.2.2 Patient-reported complications  
6.2.2.1 Free-text format FUL 
In 1787 of the 2152 surgeries (1st Nov 2010 to 31st December 2011), FUL was sent 
using the free-text format (Figure 7). Replies were received for 1197 (67%). There 
were 289 patient-reported complications in 265 surgeries. 91 were excluded as they 
were Grade I Postoperative complications (67), intra-operative (four) or related to 
chemo/radiotherapy or care in hospital (20).  
Figure 7 Follow-up letters that used free text format  
 
 
 
Patient-reported Grade II-V complications: There were 198 complications related to 
188 surgeries which included 26 re-admissions, 22 reoperations, four complications 
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urinary tract and chest infections) and lymphocysts/lymphoedema (Table 17). 57 (53 
surgeries) of the 198 patient-reported complications had already been reported by the 
hospitals. 
Patient-only-reported complications: The remaining 141 complications (135 surgeries) 
were reported solely on FUL. They included 125 Grade II, two Grade IIIa, nine Grade 
IIIb, three Grade IVa complications.(Table 17 ) In reply to the FUL, the family members 
of two patients informed the CC of their relatives’ perioperative deaths (Grade V), one 
due to cardiac failure and the other due to bowel perforation. In this subgroup of 
patient-only-reported complications, the commonest complications were wound 
breakdown, infections and lymphocysts/lymphedema. (Table 17) 
Hospital-only-reported complications: For this cohort, there were an additional 113 
Grade II-V complications in 104 surgeries reported by hospitals but not reported by 
patients on FUL, with the commonest being infections followed by wound breakdown 
and lymphocysts / lymphoedema. This included 10 readmissions, 3 re-operations and 
3 admissions to intensive care. (Table 17) 
Patient comments: Women were able to add comments on the follow-up letters. Three 
of 1787 women commented that they were unsure of what was meant by a 
‘complication’. One woman also felt that the question had been ‘too poorly defined to 
answer’. 
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Table 17 Grade II-V postoperative complications from free-text format follow-up letters 
Complication category 
Patient reported complications- All (Only reported by patient ) Only reported by 
hospital 
Overall Total  
Total Grade II Grade IIIa Grade IIIb Grade IVa Grade V 
Wound breakdown 73 (54) 63 (47)   9 (6) 1(1)   22 95 
Infection 42 (32) 42 (32)         35 77 
Lymphocyst/Lymphoedema 19(18) 19(18)         8 27 
Abscess/Haematoma 8 (4) 5 (3) 2 (1) 1     4 12 
Bladder problems 5 (4) 5 (4)         6 11 
Ileus 5 (2) 5 (2)         6 11 
Bowel obstruction 2 (1) 1   1 (1)     3 5 
Bowel perforation 1(1)         1(1) 0 1 
Bowel - other 4 (2) 4 (2)         2 6 
Fistula 4 (1)     4 (1)     2 6 
Primary haemorrhage 4 (1)     3 1 (1)   1 5 
Secondary haemorrhage 2 2         4 6 
Deep Vein Thrombosis 2 (2) 2 (2)         1 3 
Pulmonary Embolism 2 (2) 2 (2)         2 4 
Cardiac 3 (1) 2       1 (1) 4 7 
Respiratory 2 (2)   1 (1)   1(1)   4 6 
Neurological 3 (2) 3 (2)         1 4 
Hernia 3(3) 3(3)         0 3 
Anastomotic leak 2     2     0 2 
Psychiatric 1 (1) 1 (1)         1 2 
Other complications 11 (8) 8 (7)   2 (1) 1   7 18 
Total  198 (141) 167 (125) 3 (2) 22 (9) 4 (3) 2 (2) 113 311 
 Complications reported by both hospital and patients = All patient reported – those only reported by patient 
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6.2.2.2 Questionnaire format FUL 
Following 365 surgeries between January and February 2012, FUL were sent using 
the closed questionnaire format (Figure 8). 265 (72%) replies were received. 217 
complications were reported in 165 surgeries. 99 complications were excluded as they 
were Grade I (94), intraoperative complications (4) and not related to surgery (1). The 
latter was one where the family had reported death of the patient due to progression of 
cancer, as a postoperative complication.  
Figure 8 Follow-up letters that used questionnaire format 
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this sub-group, once again the commonest complications were infection, wound 
breakdown and lymphocyst/lymphoedema (Table 18).  
Hospital-only-reported complications: For this cohort, there were an additional 24 
complications in 21 surgeries that were reported by the hospitals but not by patients 
with the commonest being infections, bladder problems and wound breakdown. This 
included three readmissions, three re-operations and one admission to intensive care. 
(Table 18) 
Patient comments: Women were asked to for their views on how the questionnaire 
could be improved. Two women felt inclusion of “Gynaecological Cancer Research 
Centre” in the return address (printed at the back of the envelope), breached 
confidentiality about their diagnosis. The other comments included the question on 
educational status being inappropriate, request for larger print size and for the 
questionnaire to be sent soon after surgery to avoid surgical complications being 
confused with those related to chemo/radiotherapy. 
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Table 18 Grade II-V postoperative complications from follow-up letters which used questionnaire format 
Complication category 
Patient reported complications - All (Only reported by patient) Only 
reported by 
hospital 
Overall Total 
Total Grade II Grade IIIa Grade IIIb Grade IVa 
Infection 44 (43) 43 (43)     1 5 49 
Wound breakdown 41 (38) 40 (37)   1 (1)   4 45 
Lymphocyst/Lymphoedema 12 (12) 12 (12)       0 12 
Bladder problems 1 1       5 6 
Ileus 1 (1) 1 (1)       4 5 
Bowel obstruction 1 (1) 1 (1)       1 2 
Bowel perforation           1 1 
Bowel - other 3 (3) 3 (3)       2 5 
Fistula 1 (1) 1 (1)       0 1 
Secondary haemorrhage 4 (3) 3 (3)   1   0 4 
Abscess/Haematoma 2 (2) 2 (2)       0 2 
Deep Vein Thrombosis 2 (2) 2 (2)       0 2 
Pulmonary Embolism 1 (1) 1 (1)       0 1 
Hernia 1 (1) 1(1)       0 1 
Ureteric Obstruction 1 (1)   1(1)     0 1 
Other complications 2 (2) 1(1)     1(1) 2 4 
Total 117 (111) 112 (108) 1 (1) 2 (1) 2 (1) 24 141 
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6.2.3 Concordance of complications 
Grade III-V complications: There were 36 patient-reported complications with 
significant sequelae such as reoperations, admissions to intensive care and 
perioperative deaths of which 17 had been previously reported by the hospitals. The 
Grade of the remaining patient-only reported 19 complications was confirmed by the 
clinicians resulting in 100% concordance for complication Grade.  The details of one of 
these 19 patient-only reported complications were found to be incorrect. This was a 
case of patient-reported vault dehiscence requiring re-suturing in theatre when in fact 
the vault was intact and only an examination under anaesthesia had been performed. 
This resulted in 97.2% (35/36) concordance for complication Type for Grade III-V 
patient-reported complications.  
Grade II complications:  
There were 280 patient-reported Grade II complications of which 46 had been 
previously reported by the hospitals.  The remaining 234 patient-only reported 
complications were forwarded to the respective centres for the clinicians to verify from 
hospital records. Case notes for 221 (94.4%) of these complications were checked 
and the complication grade and type was confirmed for 113. These included 34 
infections (25 urinary tract infections, five pyrexia of unknown origin, one each of chest 
infection, cellulitis, gastroenteritis and clostridium difficile diarrhoea), 33 wound 
breakdowns, nine lymphoedema, six lymphocysts, five haematomas, four DVTs, four 
PEs, three secondary haemorrhages, three readmissions to hospital with vomiting and 
abdominal pains (no obvious cause found), two cases of ileus, two cases of severe 
constipation, two hernias, one case each of dural tap, colovaginal fistula, urinary 
retention, pressure sore, haematemesis (secondary to stress ulcer) and allergic 
reaction to antibiotics. One case of PE had been wrongly reported by the patient as a 
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postoperative complication when in fact it had occurred prior to surgery and therefore 
was excluded. The concordance for complication Grade for patient-reported Grade II 
complications was 56.4% (46+112=158/280). Excluding the incorrectly reported PE, 
279 patient-reported Grade II complications were included in further analysis.   
 In the case of allergic reaction, the patient had reported allergy to antibiotics when in 
fact the allergy was transfusion-related to pooled platelets. There was also a case of 
readmission for diarrhoea which was confirmed by the clinician. Although the 
complication type was correctly reported, the causative agent was not Clostridium 
difficile as reported by the patient. This resulted in 55.7% (156/280) concordance for 
complication Type for patient-reported Grade II complications.   
The centres were unable to confirm the remaining 108 Grade II complications which 
included 43 wound breakdowns, 39 infections (25 urinary tract infections, eight chest 
and six pyrexia of unknown origin), nine lymphoedema (five treated with compression 
stocking and four treated with physiotherapy), five lymphocysts (drained in the 
outpatients department), four bowel related complications (two cases of severe 
constipation requiring readmission and enemas, one case of ileus requiring 
nasogastric tube insertion, one case of bowel obstruction requiring readmission and 
steroids), three bladder related complications (two cases of urinary retention requiring 
re-catheterisation and  one case of extreme urge incontinence requiring treatment by 
urologists), two hernias, one case each of neuropathic pain, depression and pressure 
sores.  
6.2.4 Postoperative complication rate  
6.2.4.1 Postoperative complication rate for all surgery  
A postoperative Grade II-V complication was reported in 379 of the 1462 surgeries. 
This included a total of 452 (402 Grade II which includes four hernias, 50 Grade III-V) 
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complications. Of the 379 surgeries with a reported postoperative Grade II-V 
complication, 172 had at least one hospital-reported complication - 231 had at least 
one patient-reported complication of which 124 were verified and 107 were not (Table 
19). 
On hospital-reporting, the proportion of surgeries with a postoperative complication 
was 11.8% (172/1462; 95% CI 11–14) and on patient-only-reporting it was 15.8% 
(231/1462; 95% CI 14 –17.8). Using hospital and hospital verified FUL data, this rate 
increased to 19.4% (283/1462; 95% CI 17.4- 21.4). Using hospital and all FUL data, 
the rate was 25.9% (379/1462; 95% CI 24-28).  
Excluding Grade II complications, the hospital reported Grade III-V postoperative CR 
was 2.0% (29/1462; 95% CI 1.4-2.8). Using hospital and hospital verified FUL data, 
this rate increased to 3.3% (48/1462; 95% CI 2.5-4.3). Since all the Grade III-V 
patient-only reported complications had been confirmed and found to be correct, this 
rate was the same when all FUL data was included.  
 
Table 19 Proportion of surgeries with a Grade II-V postoperative complication 
Post-operative complications 
Highest 
grade of 
complication  
Hospital-
reported 
Patient- reported  
Hospital and 
patient 
verified 
All hospital 
and patient 
reported 
Verified on 
hospital notes 
review 
Not verified on 
hospital notes 
review 
Total 
II 143 105 107 212 235 331 
III-V  29 19 0 19 48 48 
Total 
surgery  
172 124 107 231 283 379 
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6.2.4.2 Post-op complication rate for cancer surgery 
The hospital reported Grade II-V postoperative CR for gynaecological cancer surgery 
(1067) after excluding surgery for benign disease (395) was 14% (146/1067; 95% CI 
12-17). Using hospital and hospital verified FUL data, this rate increased to 21.5% 
(229/1067; 95% CI 19-24). Using hospital and all FUL data, the rate was 27% 
(289/1067; 95% CI 25-30).  
Excluding Grade II complications, the hospital reported Grade III-V postoperative CR 
for gynaecological cancer surgery (1067) was 2.3% (24/1067; 95% CI 1.5-3.3). Using 
hospital and hospital verified FUL data, this rate increased to 3.5% (37/1067; 95% CI 
2.5-4.7). Since all the Grade III-V patient-only reported complications had been 
confirmed and found to be correct, this rate was the same when all FUL data was 
included.   
6.2.5 Sensitivity for detection of postoperative complications 
The sensitivity of hospital reporting for detection of all 379 surgeries with Grade II-V 
postoperative complications was 44% (200/452; 95% CI 40-49) and that of patient 
reporting was 70% (252/1462; 95% CI 65-74) . When the free-text format was used for 
FUL, sensitivity for hospital reporting was 55% (95% CI 49-60) and 64% (95% CI 58-
69) for patient reporting. With the questionnaire format, sensitivity of hospital reporting 
of complications was 21% (95% CI 15-29) and with patient reporting 83% (95% CI 76-
88).  (Table 20) 
Excluding the 121 (108 Grade II and 13 notes not checked) complications not 
confirmed by the hospital, the sensitivity for patient reporting was 59% (194/331; 95% 
CI 53-64) using both questionnaire formats and 60% (200/331; 95%CI 55-66) for 
hospital reporting. (Table 20) 
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Table 20 Sensitivity of patient and hospital reporting for Grade II-V postoperative complications 
Data  source 
No. of Grade II-V 
complications 
Sensitivity (95%CI) 
Patient 
reporting 
  
Hospital 
reporting 
All Grade II-V complications 
Patient reporting using free-text format 
Patient-reported alone 141 
64% 
(58-69) 
 
55% 
(49-60) 
 
Patient & Hospital reported 57 
Hospital reported alone 113 
Total 311 
Patient reporting using questionnaire format 
Patient-reported alone 111 
83% 
(76-88) 
21% 
(15-29) 
Patient & Hospital reported 6 
Hospital reported alone 24 
Total 141 
Patient reporting using both formats 
Patient-reported alone 252 
70% 
(65-74) 
44% 
(40-49) 
Patient & Hospital reported 63 
Hospital reported alone 137 
Total 452 
Patient reporting using both formats excluding complications not confirmed 
by the hospital (n=121*) 
Patient reported alone 131 
59% 
(53-64) 
60% 
(55-66) 
Patient & Hospital reported 63 
Hospital reported alone 137 
Total 331 
Grade III-V Complications only 
Patient reporting using both formats 
Patient-reported alone 19 
72% 
(58-83) 
62% 
(48-74) 
Patient & Hospital reported 17 
Hospital reported alone 14 
Total 50 
*108 Grade II, 13 notes not checked 
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Grade II complications accounted for 402 (89%) (275 Grade II and 4 hernias patient-
reported, 123 hospital-only reported) out of the total 452 complications.  Excluding 
these, the overall sensitivity of hospital reporting for detection of Grade III-V 
postoperative complications was 62% (31/50; 95% CI 48 -74) and patient reporting 
was 72% (36/50; 95% CI 58 - 83) (Table 20). 
6.2.6 Types of complications reported by hospital and patients  
Hospital reporting appeared to be better for cardiac complications, ileus, bladder 
complications, bowel obstruction, and respiratory complications. (Table 21) 
Table 21 Types of complications reported by hospital and patients 
Complication category Total 
Reported by hospital Reported by patients 
No. % No. % 
Wound breakdown 140 48 34 114 81 
Infection 126 51 40 86 68 
Lymphocyst/Lymphoedema 39 9 23 31 79 
Bladder 17 13 76 6 35 
Ileus 16 13 81 6 38 
Abscess/Haematoma 14 8 57 10 71 
Bowel – other 11 6 55 7 64 
Secondary haemorrhage 10 7 70 6 60 
Cardiac 7 6 86 3 43 
Bowel obstruction 7 5 71 3 43 
Fistula 7 5 71 5 71 
Respiratory 6 4 67 2 33 
Primary haemorrhage 5 4 80 4 80 
Pulmonary Embolism 5 2 40 3 60 
Deep Vein Thrombosis 5 1 20 4 80 
Neurological 4 2 50 3 75 
Hernia 4 0 0 4 100 
Anastomotic leak 2 2 100 2 100 
Psychiatric 2 1 50 1 50 
Bowel perforation 2 1 50 1 50 
Ureteric obstruction  1 0 0 1 100 
Other 22 12 55 13 59 
Total  452 200 44 315 70 
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Patients were better at reporting hernia, wound breakdown, DVT, 
lymphocysts/lymphoedema, neurological complications, pelvic/abdominal abscess / 
haematoma. Both hospital and patients had similar reporting rates for anastomotic 
leak, fistula, primary haemorrhage, bowel perforation and psychiatric complications. 
(Table 21) The numbers were too small for any formal statistical comparisons. 
6.3 Discussion:      
This is the first study to use both hospital and patient-reported information to estimate 
overall postoperative morbidity in gynaecological oncology surgery. Concordance of 
patient-reported complications with hospital case note review was 100% for Grade III-
V and 56.4% for Grade II postoperative complications. The hospital reported 
postoperative Grade II-V complication rate for major surgery undertaken in 
gynaecological oncology centres of 11.8% increased to 19.4% if hospital verified 
patient-reported complications were also included and 25.9% on inclusion of all 
patient-reported complications. The hospital and patient verified Grade III-V 
postoperative CR was 3.3%. Overall, sensitivity for patient-reporting was 70% and 
hospital-reporting was 44%. During the study a closed format questionnaire was 
developed that enabled more accurate capture of complication rates. The 
questionnaire and the process set up in UKGOSOC could therefore better inform 
future data capture of complications in gynaecological oncology surgery. 
 Patients reported a higher proportion of the overall 452 Grade II-V complications 
when compared to hospitals (55.8% vs 44.2%). A survey of patients following radical 
prostatectomy also noted that patients reported more complications in comparison to 
previous hospital/clinician reported rates. (75) However, the sensitivity of patient and 
hospital reporting was similar (59% versus 60%) when the 121 Grade II complications 
not confirmed on hospital case note review, were excluded. Patients were better at 
MD Thesis RI Page 6-96 
  
reporting complications that had occurred following discharge such as wound 
breakdown, pelvic abscess/haematoma, DVT,  lymphocysts / lymphoedema and 
hernias while hospitals seemed better at reporting complications that had occurred 
during the hospital stay such as ileus, bowel obstruction, bladder (e.g. urinary 
retention), cardiac (e.g. atrial fibrillation) and respiratory complications (e.g. pulmonary 
oedema).   
Hospital notes of 94.8% (240/253) of those with patient-reported complications 
previously undocumented by the clinical staff were reviewed. The clinical team 
confirmed all Grade III-V patient-reported complications. This probably reflects the fact 
that these were complications with significant sequelae requiring secondary care 
management. Grade II complications such as infections treated with antibiotics and 
lymphoedema treated with compression stockings and physiotherapy were less likely 
(concordance 56.4%) to be confirmed. While it is unlikely that patients incorrectly 
reported use of antibiotics or compression stockings, the possibility cannot be entirely 
ruled out. However the more likely explanation is that the surgical teams did not 
manage these complications. A significant proportion was probably managed in 
primary care. The wording of patient consent meant that the coordinating centre team 
was unable to request review of primary care records.  In addition some of the 
readmissions are likely to have involved local hospitals, different from where the initial 
surgery had been performed. Both these issues were noted in the elective hip and 
knee replacement studies in which about half the surgical complications were 
managed outside the institution where the initial surgery was undertaken (14, 15) and 
would have been missed if only clinician reported data was used. Logistic issues may 
also have contributed to clinicians not entering some of the post discharge Grade II-V 
complications that they were aware of. As it is medical treatment that defines a 
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complication as Grade II, the issue of variation in threshold for prescription of 
antibiotics for postoperative infections also needs to be considered. 
The open free-text format for collecting patient data proved time consuming to 
analyse, requiring a clinician’s input to decipher and enter the complications into the 
database. A minority of women did not understand what was meant by a complication 
and some women mentioned complications related to non-surgical treatments or 
detailed problems related to their care in hospital. The structured questionnaire 
(closed) format for patient reporting developed in the course of the study allowed 
easier interpretation and grading of the complications. It comprised of specific 
questions pertaining to the management of 11 common postoperative complications 
that were highlighted on analysis of the free-text format of follow-up letters. Every 
question included a brief description of the complication with management options 
clearly specified. Simple Yes/No answers also probably made completion easier for 
women. The closed format also decreased the number of replies with complications 
not related to surgery. The proportion of replies reporting a complication was higher 
with this format (63% vs 22%) when compared to the free-text format.  However, a 
large proportion (44% vs 25%) were Grade I complications, with the commonest being 
constipation requiring diet changes / laxatives and urinary incontinence not requiring 
any medication. This was probably related to the inclusion of specific questions 
regarding bowel and bladder problems. At present there is no nationally agreed list of 
complications that could be used to audit surgical outcomes in gynaecological 
oncology. It might be feasible to shorten the list of complications in the closed format 
from eleven to five or six core complications for use in future local and or national 
audits. The reliability of this approach would however have to be tested in a further 
prospective study. 
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In this study, the overall response rate was 68% with a similar rate (72% vs 68%) 
associated with use of a closed versus free-text format for postal follow-up. Studies 
investigating patient-reported postoperative complications following elective surgery 
have reported response rates ranging from 80% (hip and knee replacement surgery), 
73% for hernia repair and 65% for varicose vein surgery (15, 74, 76). These studies also 
used a questionnaire format containing questions regarding specific postoperative 
complications and simple yes/no answers. It is likely that response rates could have 
been improved by sending reminders to non-responders. 
Strengths of this study include the size, multicentre design and prospective online data 
collection by clinical teams, 68% patient response rate, the same clinician undertaking 
all patient interviews where data was equivocal, hospital case note review of patient 
only reported complications and central independent data analysis. The main limitation 
was that the CC could not contact the primary care teams to verify complications that 
were not managed by the surgical team. Only those women who had provided 
telephone numbers could be contacted directly for clarification. In the absence of a 
validated questionnaire on postoperative complications in gynaecological oncology, a 
new one was designed to capture more accurate and precise information regarding 
complications. Although it was piloted and women provided feedback on its content, it 
requires further validation in future studies. In common with all questionnaire studies, 
one could speculate that women were more likely to respond to the questionnaire if 
they had experienced a complication.   
Finally though the intention was to send the FULs eight weeks postoperatively this was 
not always possible due to delays in receiving updates from the hospitals regarding 
any patients who might have died or were terminally ill. The latter step was essential to 
avoid causing unnecessary distress to family members. Despite this, four (0.2%) FUL 
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were sent to deceased patients and one of the families complained prompting a written 
apology. Delays in sending the follow-up letter probably contributed to recall bias 
causing some women to confuse surgical complications with side effects from 
chemo/radiotherapy (commenced usually within six weeks of surgery).  
There is growing interest in using Patient Reported Outcome Measures (PROMs) to 
assess outcomes of cancer treatment (77). PROMs are designed to assess the quality 
of life and long term disability from treatment and not surgical complications in 
particular. A recent study (19) in gynaecological cancer looked at the feasibility of 
capturing patient-reported symptoms electronically in the immediate six week 
postoperative period following major surgery. The authors concluded that this method 
was highly acceptable to the women and provided useful information regarding 
problems experienced by patients which could be helpful to the clinicians in providing 
timely and appropriate interventions where required. The Royal College of 
Obstetricians and Gynaecologists (RCOG) also have published a scientific impact 
paper evaluating the use of PROMs in gynaecology and gynaecological oncology (18). 
It is envisaged that in future PROMs will routinely be collected in the UK for all 
gynaecological cancer patients. Linking or combining our follow-up questionnaire to 
PROMs would be a cost effective method of collecting data on postoperative 
complications.  
 
MD Thesis RI Page 7-100 
  
7 Predictors of surgical complications 
This chapter describes the identification of significant predictors of Intraoperative and 
Postoperative complications using univariable and multivariable logistic regression.  
7.1 Method for regression analysis 
Statistical analysis was performed using STATA version 12.1 (StataCorp 2012). To 
identify predictors for intraoperative complications, all eligible surgeries (n=2948) were 
included and for postoperative complications only those surgeries with both hospital 
and patient follow-up data (n=1462) were included as these surgeries were more likely 
to have complete information on the postoperative course.    
7.1.1 Univariable logistic regression 
To assess how each potential predictor affected the complication rate (CR) 
individually, univariable (UV) logistic regressions were performed separately for all 
predictors.  
For intraoperative complication as the outcome (yes/no), the independent variables 
included age (continuous variable), number of comorbidities (continuous variable), 
type of comorbidities (binary variable- yes/no), BMI (continuous variable and 
categorical - underweight, normal, overweight, obese and morbidly obese), ASA grade 
(categorical- 1-4), previous abdominal surgery (binary variable-yes/no), grade of 
operating surgeon (categorical – consultant, sub-specialty trainee, general obstetrics 
and gynaecology trainee), approach for surgery (categorical - laparotomy/ 
laparoscopy), surgical complexity (categorical – 1-5; Complexity score 1&2=group 1, 
3&4=group 2, 5&6=group 3, 7&8=group 4, >8=group 5) and final diagnosis 
(categorical- ovarian, uterine, cervix, vulva and benign).  
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For postoperative complication as the outcome (yes/no), the independent variables 
included all the above and, duration of surgery (continuous, in minutes) and estimated 
blood loss (categorical, <500mls, 500-1000mls, >1000-2500mls, >2500mls).  
7.1.2 Multivariable regression 
For both intraoperative and postoperative complication analyses the same procedure 
was applied. To create a risk prediction model for both the intraoperative CR and 
postoperative CR, useful predictors were identified in a multivariable (MV) logistic 
regression model by running a stepwise regression with backward elimination, with p 
(removal) = 0.05. Categorical predictors with more than 2 categories were retained 
complete rather than drop any insignificant categories. Goodness of fit was assessed 
using the Hosmer-Lemeshow test (with the data split into 10 groups based on 
estimated probabilities). Formally, the data should be considered longitudinal because 
38 women had repeated outcomes, so a random effects logistic regression model was 
also fitted using the identified predictors to check that the standard errors did not 
change substantially i.e. that the predictors were still significant when the correlated 
structure was accounted for.  
In the absence of a suitable external validation set it was necessary to test the risk 
prediction model using cross-validation (CV) methods. Specifically, a leave-one-out 
(LOO) CV method was employed where, for each subject, the predicted probability of 
complication was estimated based on a prediction model that excluded that subject in 
the parameter estimation. These LOO predicted probabilities could be used to 
estimate the sensitivity and specificity of the risk prediction model at various cut-offs. A 
receiver operating characteristic (ROC) curve plotted all possible cut-offs of the 
predicted probabilities.  
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7.2 Results 
7.2.1 Predictors of intraoperative complications 
7.2.1.1 Univariable analysis 
For intraoperative complication as the outcome, diabetes (Odds Ratio [OR] 1.63, 95% 
CI 1.006 - 2.630), other metabolic/endocrine disorders (OR 0.383, 95% CI 0.168 - 
0.876) and previous abdominal surgery (OR 1.74, 95% CI 1.239- 2.455) were found to 
be statistically significant. Among the categorical predictors, surgical complexity and 
final diagnosis were found to be statistically significant. (Table 22) 
Table 22 Predictors of intraoperative complications in univariable analysis 
Variable Odds ratio 95% Confidence Interval  p value 
Surgical complexity group 1 to 5     
 Group 1 1     
 Group 2 1.516 0.980 – 2.344 0.061 
 Group 3 2.841 1.779 – 4.539 0.000 
 Group 4 4.903 2.481 – 9.690 0.000 
 Group 5 8.274 3.741 – 18.301 0.000 
Joint significance for all the categories    0.000 
Final Diagnosis       
Ovary 1     
Uterine 0.413 0.265 – 0.643 0.000 
Benign 0.334 0.204 – 0.546 0.000 
Vulva 0.134 0.033 – 0.551 0.005 
Cervix 0.593 0.302 – 1.166 0.130 
Joint significance for all the categories  0.000 
Previous abdominal surgery 1.74 1.239-2.455   0.001 
Comorbidity       
Diabetes 1.627 1.006 – 2.630 0.047 
Metabolic / Endocrine 0.383 0.168 – 0.876 0.023 
Other neoplasms 1.857 1.003 – 3.440 0.050 
Low Albumin  4.542 0.972 – 21.222 0.054 
Autoimmune 2.418 0.846 – 6.913 0.099 
Hypertension 1.265 0.891 – 1.798 0.189 
Cardiac 1.381 0.838 – 2.274 0.205 
Respiratory 0.709 0.368 – 1.364 0.303 
Coagulation / Thrombosis 1.313 0.599 – 2.877 0.495 
Vascular 0.724 0.226 – 2.321 0.588 
 
MD Thesis RI Page 7-103 
  
Table 22 Predictors of intraoperative complications in univariable analysis continued… 
 
Variable Odds ratio 95% Confidence Interval  p value 
Gastrointestinal 1.248 0.537 - 2.898 0.606 
Integumentary / Dermatology 1.449 0.342 - 6.149  0.614 
Infections 1.689 0.218 - 13.082 0.616 
Genitourinary 0.806 0.194 - 3.345 0.766 
Neurology / Psychiatric 0.908 0.455 - 1.811 0.784 
Smoking 0.885 0.320 - 2.445 0.814 
Musculoskeletal 0.971 0.529 - 1.781 0.925 
Age 1.003 0.991 - 1.014 0.661 
Body Mass Index (categorical variable)     
Normal (19.9 - 24.9) 1     
Underweight (<19.9) 0.509 0.683 - 3.792 0.510 
Overweight (25 - 29.9) 0.927 0.594 - 1.449 0.741 
Obese (30 - 39.9) 1.149 0.743 - 1.777 0.533 
Morbidly obese (>40) 0.714 0.331 - 1.543 0.392 
Body Mass Index (Continuous variable) 0.993 0.968 - 1.019  0.608 
ASA Grade        
ASA Grade 1 1     
ASA Grade 2  1.467 0.934 - 2.304 0.097 
ASA Grade >3 1.682 0.998 - 2.836 0.051 
Surgeon grade       
General O & G Trainee 1     
Sub-specialty trainee 0.877 0.248 - 3.103 0.838 
Consultant 2.064 0.646 - 6.597 0.222 
Approach for surgery       
Open 1     
Laparoscopic 0.833 0.545 - 1.272  0.397 
 
For surgical complexity, groups- 3 (OR 2.841, 95% CI 1.779 - 4.539), 4 (OR 4.903, 
95% CI 2.481- 9.690) and 5 (OR 8.274, 95% CI 3.741 - 18.301) were significant 
whereas group 2 (OR 1.516, 95% CI 0.980 - 2.344) was not found to be significant 
when compared to the reference category- group 1. For the final diagnosis category - 
uterine (OR 0.413, 95% CI 0.265 - 0.643), vulva (OR 0.134, 95% CI 0.033 - 0.551) and 
benign (OR 0.334, 95% CI 0.204 - 0.546) diagnoses were significant whereas cervix 
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was not statistically significant (OR 0.593, 95% CI 0.302 - 1.166) when compared to 
the reference category- ovary. (Table 22) 
7.2.1.2 Multivariable regression:  
In multivariable regression analysis, the same factors were found to be statistically 
significant predictors of an intraoperative complication.  (Table 23) Diabetes (2.015, 
95% CI 1.223 - 3.324) and previous abdominal surgery (OR 1.561, 95% CI 1.099-
2.219) were found to increase the risk of a complication whereas metabolic/endocrine 
disorders (excluding diabetes) (OR 0.351, 95% CI 0.152 - 0.809) were found to be 
protective.   
Table 23 Significant predictors of intraoperative complications in multivariable regression  
 
Surgical complexity groups 3 (OR 2.311, 95% CI1.396 - 3.826), 4 (OR 3.397, 1.660 -  
6.951) and 5 (OR 5.399, 95% CI 2.335 - 12.48) were statistically significant when 
compared to group 1 (reference category). Even though group 2 was not statistically 
significant (OR 1.302, 95% CI 0.834 - 2.033), it was retained as it was part of the same 
Variable 
Odds 
ratio 
95% Confidence 
Interval  
Standard 
Error p value 
Diabetes 2.015 1.223 - 3.324 0.514 0.006 
Metabolic/Endocrine disorders  
(excluding diabetes) 0.351 0.152 - 0.809 0.150 0.014 
Previous abdominal surgery 1.561 1.099 - 2.219 0.280 0.013 
Surgical complexity group 
1 1       
2 1.302 0.834 - 2.033 0.296 0.246 
3 2.311 1.396 - 3.826 0.594 0.001 
4 3.397 1.660 - 6.951 1.241 0.001 
5 5.399 2.335 - 12.48 2.309 0.000 
Final diagnosis 
Ovary 1       
Uterine 0.555 0.348 - 0.887 0.133 0.014 
Cervix 0.599 0.296 - 1.212 0.215 0.154 
Vulva 0.193 0.046 - 0.805 0.141 0.024 
Benign 0.468 0.278 - 0.787 0.124 0.004 
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categorical variable. In the categorical variable final diagnosis, when compared to the 
reference group ovary, other diagnostic categories namely uterine (OR 0.555, 95% CI 
0.348 - 0.887), vulva (OR 0.193, 95% CI 0.046 - 0.805) and benign (OR 0.468, 95% CI 
0.278 - 0.787) were found to be protective and statistically significant. Cervix (OR 
0.599, 95% CI 0.296 - 1.212), although not statistically significant, was retained.  
(Table 23)  
7.2.2 Predictors of postoperative complications 
7.2.2.1 Univariable analysis  
In univariable analysis, age (OR 1.013, 95% CI 1.002-1.026), comorbidity status (OR 
1.477, 95%CI 1.049 - 2.077), comorbidity categories namely coagulation/thrombosis 
(OR 2.228, 95% CI 1.174 - 4.229) and diabetes (OR 1.916, 95% CI 1.233 - 2.977), 
and, duration of surgery (OR 1.486, 95% CI 1.320-1.672) were found to be significant 
predictors of postoperative complications. (Table 24) 
Among the categorical variables, laparoscopic (OR 0.506, 95% CI 0.326 - 0.787), 
when compared to the open approach, was protective. ASA grade 2 (OR 1.623, 95% 
CI 1.042 - 2.527) and ASA grade >3 (OR 2.178, 95% CI 1.315 - 3.608) when 
compared to the reference group ASA 1, were statistically significant predictors. For 
surgical complexity, group 2 (OR 1.719, 95% CI 1.196 - 2.469), group 3 (OR 1.896, 
95% CI 1.198 - 3.002), group 4 (OR 2.652, 95% CI 1.218 - 5.774) and group 5 (OR 
6.562, 95% CI 2.454 - 17.543) were statistically significant when compared to the 
reference group 1.  
 For estimated blood loss, categories, 500-1000mls (OR 2.554, 95% CI 1.7367 - 
3.756) and >1000-2500mls (OR 2.443, 95% CI 1.381 - 4.319), >2500mls (OR 4.049, 
95% CI- 1.383-11.852) were statistically significant when compared to the reference  
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Table 24 Predictors of postoperative complications in univariable analysis 
Variable 
Odds 
ratio 
95% Confidence Interval p value 
Age 1.014 1.002 - 1.026 0.027 
Body Mass Index (Categorical variable) 
Underweight (<19.9) 1     
Normal (19.9 - 24.9) 0.709 0.156 - 3.231 0.657 
Overweight (25 - 29.9) 0.888 0.196 - 4.017 0.877 
Obese (30 - 39.9) 1.359 0.302 - 6.120 0.689 
Morbidly obese (>40) 0.948 0.193 - 4.652 0.947 
Joint significance for all the categories 0.037 
Body Mass Index 
(Continuous variable) 
1.023 1.001 - 1.045 0.039 
ASA Grade (1 to 3) 
ASA Grade 1 1     
ASA Grade 2  1.623 1.0422 - 2.527 0.032 
ASA Grade >3 2.178 1.315 - 3.608 0.002 
Joint significance for all the categories 0.008 
Comorbidity 
Comorbidity status (yes/no) 1.477 1.049 - 2.077 0.025 
Diabetes 1.916 1.233 - 2.977 0.004 
Coagulation / Thrombosis 2.228 1.174 - 4.229 0.014 
Neurology / Psychiatric 0.41 0.164 - 1.025 0.057 
Respiratory 1.444 0.888 - 2.348 0.138 
Cardiac 1.365 0.856 - 2.177 0.191 
Metabolic / Endocrine 1.323 0.823 - 2.125 0.248 
Integumentary/Dermatology 2.142 0.584 - 7.858 0.251 
Musculoskeletal 1.2889 0.803 - 2.069 0.294 
Hypertension 1.176 0.854 - 1.618 0.321 
Gastrointestinal 0.621 0.221 - 1.747 0.366 
Smoking 1.382 0.569 - 3.361 0.475 
Other neoplasms 1.142 0.608 - 2.144 0.680 
Genitourinary 1.184 0.406 - 3.451 0.758 
Infections 1.181 0.141 - 9.862 0.878 
Autoimmune 0.943 0.214 - 4.158 0.938 
Vascular 1.011 0.391 - 2.616 0.981 
Previous abdominal surgery 1.465 1.068 – 2.011 0.018 
Grade of operating surgeon 
General O & G Trainee 1     
Sub-specialty trainee 0.92 0.402 - 2.106 0.844 
Consultant 1.251 0.588 - 2.664 0.560 
Approach for surgery 
Open 1     
Laparoscopic 0.506 0.326 - 0.787 0.002 
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Table 24 Predictors of postoperative complications in univariable analysis continued… 
Variable 
Odds 
ratio 
95% Confidence Interval p value 
Surgical complexity group 1 to 5 
 Group 1 1     
 Group 2 1.719 1.196 - 2.469 0.003 
 Group 3 1.896 1.198 - 3.003 0.006 
 Group 4 2.652 1.218 - 5.774 0.014 
 Group 5 6.562 2.454 - 17.543 0.000 
Joint significance for all the categories 0.000 
Estimated Blood Loss 
<500 mls 1     
500 - 1000mls 2.554 1.737 - 3.756 0.000 
>1000 - 2500 mls 2.443 1.381 - 4.319 0.002 
>2500 mls 0.797 0.102 - 6.226 0.829 
Joint significance for all the categories 0.000 
Duration of surgery 1.496 1.324 - 1.690 0.000 
Final Diagnosis 
Ovary 1     
Uterine 0.609 0.407 - 0.914 0.016 
Cervix 1.623 0.908 - 2.901 0.102 
Vulva 2.024 1.158 - 3.535 0.013 
Benign 0.41 0.258 - 0.652 0.000 
Joint significance for all the categories 0.000 
 
category <500mls. For the final diagnosis variable, when compared to the reference 
category ovary, uterine (OR 0.61, 95% CI 0.407 - 0.914) and benign (OR 0.41, 95% CI 
0.258 - 0.652) diagnoses were protective, vulva (OR 2.024, 95% CI 1.158 - 3.535) was 
found to increase postoperative complication risk and cervix (OR 1.623, 95% CI 0.908 
- 2.901) was not statistically significant. 
7.2.2.2 Multivariable regression 
Comorbidity status i.e. presence/absence of comorbidity (OR 1.338, 95% CI 1.012 - 
1.769), diabetes (OR 1.642, 95% CI 1.113 - 2.421), age (OR 0.989, 95% CI 0.979 - 
1.000) and duration of surgery (OR 1.285, 95% CI 1.149 - 1.439) were statistically 
significant predictors. Laparoscopic (OR 0.653, 95% CI 0.469 - 0.909), when 
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compared to the open approach, was protective. Among the categorical variables only 
final diagnosis was a significant predictor in multivariable regression. When compared 
to the reference group ovary, vulva was statistically significant (OR 2.398, 95% CI 
1.438 - 3.999). Although uterine (OR 0.998, 95% CI 0.716 - 1.392), cervix (OR 1.664, 
95% CI 0.958 - 2.891) and benign (OR 1.046 95% CI 0.738 - 1.481) diagnoses were 
not statistically significant, they were retained as part of the final diagnoses categorical 
variable. (Table 25)  
Table 25 Significant predictors of postoperative complications in multivariable regression  
Variable 
Odds 
ratio 
95% Confidence Interval 
Standard 
Error 
p value 
Comorbidity status (Yes/No) 1.338 1.012 - 1.769 0.191 0.041 
Diabetes 1.642 1.113 - 2.421 0.325 0.012 
Age  0.989 0.979 - 1.000 0.005 0.052 
Laparoscopic approach 0.653 0.469 - 0.909 0.110 0.012 
Duration of surgery 1.285 1.149 - 1.439 0.074 0.000 
Final diagnosis 
Ovary 1   
 
  
Uterine 0.998 0.716 - 1.392 0.169 0.992 
Cervix 1.664 0.958 - 2.891 0.469 0.071 
Vulva 2.398 1.438 - 3.999 0.626 0.001 
Benign 1.046 0.738 - 1.481 0.186 0.802 
 
7.3 Discussion: 
Previous abdominal surgery, diabetes, surgical complexity and final diagnosis were 
significant predictors of increased intraoperative complication risk. The only common 
predictors of both intraoperative and postoperative complications were diabetes and 
final diagnosis. Other significant associations with postoperative complications were 
age, presence of comorbidity, surgical approach and duration of surgery. 
In 10% of surgeries, patients had Metabolic/Endocrine disorders other than diabetes. 
This mainly included hypercholesterolaemia and thyroid dysfunction and was a 
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predictor of reduced intraoperative complication rate. The reason for this is not clear, 
and, as previous studies have not looked at this separately, there is no data for 
comparison. Some pre-operative biochemical markers such as serum albumin and 
liver enzymes which have been reported to be predictors of surgical complications (44, 
45, 48, 54) could not be included as they are not routinely assayed in all patient 
undergoing gynaecological oncology surgery in UK.   
Previous abdominal surgery was a significant predictor of intraoperative complications 
probably due to intra-abdominal adhesions following previous surgery. This is in 
keeping with results of a prospective multi-centre centre Finnish study (FINHYST) of 
over 5000 hysterectomies for benign indications (78) which found that prior laparotomy 
(OR=1.1) but not caesarean section or laparoscopy increased the risk of major 
complications. In the latter study, adhesiolysis during surgery was the strongest single 
risk factor (OR=2.4). In bowel surgery, previous three or more laparotomies have been 
found to increase risk of enterotomy by tenfold (OR=10.4) (79). The other comorbidity 
that significantly increased intraoperative complication risk was diabetes (OR=2). 
While several studies have demonstrated the association of diabetes with increased 
postoperative morbidity (80-82), this is the first study to demonstrate its effect specifically 
on intraoperative complications. 
Intraoperative complication rates increased with surgical complexity with highest rates 
for those procedures with an overall surgical complexity score of >8. In Aletti’s study 
on ovarian cancer surgery as well as in the Australian study (45), surgical complexity 
was found to be a significant predictor of overall morbidity. In order to capture 
complexity accurately in UKGOSOC, the surgical complexity scoring system for 
ovarian cancer developed by Aletti et al (43, 44)  was modified to include procedures for 
all gynaecological cancers and stratified into five rather than the three originally 
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described (low, intermediate and high) groups as preliminary analysis had 
demonstrated it to be a key predictor. 
Similar to studies comparing open versus laparoscopic approaches for endometrial 
and cervical cancer surgery (70, 71) , the latter reduced the likelihood of a postoperative 
complication in UKGOSOC as well. This is probably one of the main drivers of 
increasing laparoscopic surgery in gynaecological oncology. Surgical complexity 
however was not a significant predictor of postoperative unlike intraoperative 
complications. Instead duration of surgery (OR=1.3) was significant. This has been 
noted particularly for postoperative infections in total knee arthroplasty. (83) 
In addition to being a significant predictor of intraoperative complications, diabetes 
(OR=1.6) was also found to be significant in predicting postoperative complications. In 
the Australian study, while diabetes was significant in univariable analysis, it was not 
found to be so in multivariable analysis (45). However studies in other specialties such 
as plastic surgery (breast reconstruction surgery) and orthopaedic surgery have shown 
diabetes to be a significant predictor of surgical complications particularly wound 
infections (81, 82, 84). Diabetes has also been found to increase the risk of postoperative 
complications following coronary artery bypass surgery (80). Our data indicates that the 
presence of any comorbidity (OR=1.3) predicted postoperative complications on 
multivariable analysis. Performance status as measured by ASA grade was significant 
only on univariable analysis. This is in contrast to the Australian study and Aletti’s 
study where ASA grade was a significant independent predictor for overall morbidity 
(43, 45).   
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8 Benchmarking of surgical complications in gynaecological 
oncology surgery 
 
There is a drive within the National Health Service (NHS) to increase transparency and 
improve quality and safety. To this end, one of the initiatives in surgery has been to 
publish outcomes data for hospitals and more recently for individual surgeons which 
have been sourced from national clinical audits in some specialties and in most from 
administrative data. (85, 86) 
While surgical data on a national level has been collected in  specialties such as 
cardiothoracic (50) and orthopaedic (86) surgery and  certain cancers such as lung (87), 
colorectal (51) and head and neck (88), there is paucity of such data in gynaecological 
oncology.  
As mentioned in previous chapters, the overall unadjusted intraoperative complication 
rate (CR) was 4.7% (89) and the postoperative CR was 25.7%. (90) However use of such 
observed complication rates (CRs) for centre level comparisons does not take into 
account patient comorbidity, underlying disease or surgical complexity, all of which can 
impact on the risk of a complication. (89) The use of unadjusted crude CRs has resulted 
in significant unease amongst surgeons and hospitals due to the variations in 
prevalence of surgical risk factors. Concerns have been raised that it might deter 
surgery being undertaken in ‘high-risk’ patients with significant comorbidity. This 
chapter explores the impact of risk-adjustment of surgical CRs on benchmarking of 
gynaecological oncology surgery at the participating hospitals.  
8.1 Statistical Methods 
All methods described apply to both intraoperative and postoperative comparisons. 
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8.1.1 Data description 
Cross-tabulations of outcome and categorical risk predictors by hospital were 
performed. To assist in the easy identification of covariate imbalance across hospitals, 
chi-squared test statistics and p-values were included in the tables. The p-values were 
not used as a formal test measure for the predictors with small category counts (<5) at 
any hospital. Continuous predictors were summarised by within-hospital means and 
standard deviations and F test statistics and p-values from an analysis of variance 
similarly used to aid judgement on hospital variation.  
8.1.2 Risk prediction and penalised regression 
Logistic regression models were a natural choice for the risk prediction, though 
parameter estimates were based on a penalised method (lasso) (91) rather than 
maximum likelihood (ML). A fundamental issue involved in prognostic model 
construction is that of ‘events per variable’ (EPV) (92), where the number of ‘events’ in a 
binary regression model is taken as the total of the less common outcome. A standard 
rule of thumb is that a fitted model should have an EPV of at least 10(93, 94), where the 
variable count includes all estimated levels of a categorical variable. The EPV 
requirement should hold even if variable selection (stepwise methods) is performed, so 
that the variable count is based on the full model. 
A limited sample size (in the EPV sense) can cause potential problems when using 
ML, as the model becomes over-fitted and prediction error is inflated. This is why 
many prediction models fail to be successfully validated. (92)  Penalised methods that 
deliberately bias the regression estimates toward zero can give predictions that reduce 
the mean square error (MSE). The MSE of an estimator, which quantifies prediction 
error, is a function of the variance as well as the bias of the estimator. Therefore a 
penalised method can provide better prediction than ML, in spite of the intentional 
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bias, by using a more ‘efficient’ estimator and may prove a more appropriate strategy, 
dependent on the primary goal of the analysis. With model selection procedures there 
is known selection- or omission-bias (95), whereby weakly significant variables will be 
infrequently selected, dependent on chance variation, and when selected, they will 
typically have overestimated coefficients.  
The lasso (least absolute shrinkage and selection operator) estimator (91) employs a 
penalty term in the likelihood function that is then maximised subject to a constraint on 
the (absolute) sum of the regression coefficients. The penalty term is a function of a 
shrinkage parameter (λ) chosen by the investigator, which when equal to zero reduces 
to ML estimation and when tending to infinity results in estimates tending to zero. In 
contrast to the similar ridge regression method, where all the coefficients of the full 
model are partially shrunk, the lasso actually performs a type of variable selection. 
Strong and moderate predictors are shrunk by a certain amount dependent on λ, whilst 
weak predictors may be shrunk to exactly zero and so drop out of the model. The 
choice of λ here was based on a grid search that minimised the generalised cross-
validation error. (91) The user-written Stata commands plogit and plsearch were used to 
fit lasso-shrunk logistic models. Note that inference, such as confidence intervals and 
p-values, based on standard errors from the lasso variance-covariance matrix should 
be treated with caution and used only for approximate guidance. Standard errors are 
not particularly meaningful for (deliberately and quite strongly) biased estimates as 
they will exclude the inaccuracy caused by bias. (91) Equivalent models fitted by ML are 
presented for comparison. 
From the fitted model with chosen λ, McFadden’s R2 was used to assess improvement 
on the null model. Model fit was assessed using the Hosmer-Lemeshow test (with the 
data split into 10 groups based on estimated probabilities). Model specification was 
considered using the link test, which refits the model using only the linear predictor 
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from the original model and its square. Significance of the latter term suggests model 
misspecification. A receiver operating characteristic (ROC) curve plotted the 
performance characteristics for all possible cut-offs of the predicted probabilities 
generated by leave-one-out cross-validation (LOO-CV). LOO-CV predicts the risk for 
each subject in turn based on a model fitted with that subject excluded. Overall 
performance (discrimination) may be assessed by the area under the curve (AUC). By 
regressing the outcome on bootstrapped linear predictions (log odds) for each subject, 
the calibration slope (92, 93) could be estimated as the mean slope (beta) of 1000 
bootstrap samples, where a slope close to 1 suggests good calibration and (much) 
less than one implies over-fitting of the model. An over-fitted model will give 
predictions that are too narrow. 
8.1.3 Hospital rate adjustments 
A prediction model may typically be used to help quantify the risk of surgery for a new 
individual (or at least modify the baseline risk) using suspected risk factors. In addition, 
we can use them to enable fairer comparisons of complication rates (CR) across 
different hospitals, by using the model to predict the expected CR for a given set of 
confounders. A standard approach to institutional comparison is a funnel plot (96, 97), 
where the hospital’s observed CR is plotted against sample size and assessed with 
respect to confidence bands (which narrow with sample size) that signify unusually 
high or low complication rates. The funnel plots presented here show 95 and 99% 
confidence bands that are smoothed ‘exact’ confidence limits, rather than symmetric 
normal-based confidence limits.  
The prediction model was used to produce expected CRs for each hospital by 
calculating the predicted risk of each surgery, averaging over the surgeries within each 
hospital, and multiplying by the number of surgeries per hospital. Note, this will not 
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equal the sum of predicted risks within hospitals if missing data meant predicted risks 
could not be calculated for certain surgeries. An alternative method to funnel plots, for 
assessing hospitals of potential concern, is to compare the expected CR with the 
observed CR, and if the confidence interval for the observed to expected CR ratio 
does not contain one, then the hospital may be deemed as having an unusually high 
(or low) CR.(98, 99) Methods that calculate confidence intervals for observed to expected 
ratios typically treat the expected value as ‘fixed’ and ignore any uncertainty in its 
estimation, such as standardised mortality ratios where the expected rate is taken from 
published national statistics. Additionally, they are often normal-based (98, 99) which can 
lead to a lower limit of below zero for a low ratio. To incorporate the uncertainty 
involved in estimating the expected CR, the sampling distribution of the observed to 
expected CR ratio was estimated by taking 1000 bootstrap samples of the full dataset. 
For each bootstrap sample the new ‘observed’ CR was compared with the new 
expected CR, based on a refitting of the lasso model, to calculate the bootstrap 
sample CR ratio for each hospital. A 95% confidence interval for the ratio was based 
on the appropriate bias-corrected centiles of the bootstrap derived sampling 
distribution. Note, the grid-search for lambda was performed for each bootstrap 
sample and so the uncertainty involved in the selection of lambda was also 
represented in the CR ratio confidence intervals. 
8.2 Results 
8.2.1 Intraoperative complications 
Table 26 shows the primary outcome and risk factor distribution across the 10 
hospitals. There is variation across hospitals for most predictors, but particularly for 
laparoscopic approach, surgeon grade, surgical complexity, final diagnosis, smoking 
and ASA grade. Despite ranging from 2.0% to 8.0%,  there was not strong evidence 
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that overall the proportion of intraoperative complications varied significantly between 
hospitals (p=0.052). 
8.2.1.1 Modelling and fit 
Of the 2948 surgeries 139 had at least one intraoperative complication. However, 
when fitting the full model, missing data meant only 132 were included out of 2709 
surgeries, meaning an EPV of 4.1 given the 32 variables. The grid search yielded a 
lambda value of 3.4 and resulted in 4 variables out of the 32 being shrunk completely 
to zero (BMI, and the 3 comorbidities musculoskeletal, neurology-psychiatric and 
integumentary-dermatology). The resulting lasso-shrunk odds ratios are presented in 
Table 27, which also give the ML estimates for comparison. As stated in the methods it 
is unwise to give too much credence to the p-values and confidence intervals but it is 
apparent that the strongest predictor is surgical complexity (risk increases with 
complexity), with previous abdominal surgery, diabetes (both increase risk), metabolic-
endocrine (decreases risk) and final diagnosis (all cancer types reduce risk relative to 
ovarian cancer) also predictive of intraoperative complication (all with p-values <0.05 
when estimated by ML). McFadden’s R2 was only 0.066, suggesting that the outcome 
was largely unrelated to the identified risk factors, though the ML version was not 
much larger at 0.089. Both the goodness of fit test (p=0.502) and the misspecification 
test (p=0.754) suggested the model was acceptable with regard to these criteria.
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Table 26 Full dataset used for intra-operative complications analysis (n=2948) 
 
Hospital 
Overall 
chi2 df pvalue A B C D E F G H I J 
N % N % N % N % N % N % N % N % N % N % N % 
Intraoperative complications 13 5.7 17 3.5 10 4.0 44 5.3 14 7.7 4 2.0 6 6.6 11 4.6 8 2.8 12 8.0 139 4.7 16.8 9 0.0517 
Postoperative complications (hospital 
reported) 
40 17.4 56 11.4 30 12.0 159 19.3 18 9.9 26 12.9 16 17.6 25 10.3 32 11.3 22 14.7 424 14.4 32.0 9 0.0002 
Previous abdominal surgery 83 36.1 168 34.1 64 25.5 306 37.1 42 23.2 84 41.8 33 36.3 109 45.0 117 41.2 19 12.7 1,025 34.8 75.6 9 0.0000 
Low Albumin 0 0.0 5 1.0 0 0.0 1 0.1 0 0.0 0 0.0 1 1.1 3 1.2 0 0.0 1 0.7 11 0.4 17.7 9 0.0391 
Coagulation-thrombosis 9 3.9 16 3.3 12 4.8 24 2.9 8 4.4 9 4.5 6 6.6 17 7.0 9 3.2 6 4.0 116 3.9 11.9 9 0.2180 
Diabetes 21 9.1 52 10.6 30 12.0 94 11.4 12 6.6 15 7.5 5 5.5 30 12.4 18 6.3 21 14.0 298 10.1 17.2 9 0.0455 
Cardiac 17 7.4 55 11.2 32 12.8 75 9.1 21 11.6 23 11.4 7 7.7 29 12.0 27 9.5 22 14.7 308 10.5 10.5 9 0.3081 
Respiratory 21 9.1 58 11.8 21 8.4 74 9.0 14 7.7 20 10.0 5 5.5 37 15.3 21 7.4 16 10.7 287 9.7 16.6 9 0.0553 
Gastrointestinal 10 4.4 10 2.0 6 2.4 21 2.6 9 5.0 17 8.5 6 6.6 13 5.4 3 1.1 9 6.0 104 3.5 35.2 9 0.0001 
Genitourinary 2 0.9 5 1.0 2 0.8 7 0.9 6 3.3 5 2.5 0 0.0 14 5.8 8 2.8 3 2.0 52 1.8 37.2 9 0.0000 
Musculoskeletal 15 6.5 23 4.7 15 6.0 98 11.9 13 7.2 19 9.5 4 4.4 34 14.1 21 7.4 19 12.7 261 8.9 38.7 9 0.0000 
Neurology-psychiatric 18 7.8 37 7.5 12 4.8 65 7.9 8 4.4 15 7.5 7 7.7 17 7.0 22 7.8 7 4.7 208 7.1 6.7 9 0.6652 
Vascular 4 1.7 18 3.7 5 2.0 18 2.2 3 1.7 9 4.5 4 4.4 8 3.3 11 3.9 6 4.0 86 2.9 9.5 9 0.3916 
Infections 2 0.9 8 1.6 2 0.8 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.4 0 0.0 13 0.4 24.9 9 0.0031 
Auto-immune 4 1.7 8 1.6 2 0.8 6 0.7 3 1.7 5 2.5 0 0.0 2 0.8 5 1.8 3 2.0 38 1.3 8.5 9 0.4874 
Metabolic-endocrine 25 10.9 47 9.5 25 10.0 67 8.1 15 8.3 27 13.4 15 16.5 35 14.5 35 12.3 11 7.3 302 10.2 18.7 9 0.0282 
Integumentary-dermatology 4 1.7 2 0.4 3 1.2 6 0.7 1 0.6 3 1.5 0 0.0 8 3.3 3 1.1 0 0.0 30 1.0 19.7 9 0.0199 
Hypertension 61 26.5 186 37.7 72 28.7 257 31.2 66 36.5 78 38.8 19 20.9 110 45.5 71 25.0 53 35.3 973 33.0 48.4 9 0.0000 
Smoking 1 0.4 25 5.1 15 6.0 3 0.4 5 2.8 10 5.0 16 17.6 14 5.8 1 0.4 5 3.3 95 3.2 113.7 9 0.0000 
Other neoplasms 24 10.4 15 3.0 6 2.4 40 4.9 11 6.1 6 3.0 5 5.5 16 6.6 19 6.7 6 4.0 148 5.0 27.4 9 0.0012 
Surgeon grade 
                      
302.4 18 0.0000 
General Obstetrics & Gynaecology Trainee 3 1.3 22 4.6 3 1.3 15 1.8 25 15.0 3 1.5 0 0.0 2 0.9 30 11.1 5 3.4 108 3.8 
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Table 26 Full dataset used for intra-operative complications (n=2948) continued…. 
Sub-specialty trainee 87 37.8 95 19.9 65 27.2 172 20.9 8 4.8 3 1.5 23 25.3 80 35.1 35 12.9 5 3.4 573 20.0 
   
Consultant 140 60.9 360 75.5 171 71.6 638 77.3 134 80.2 192 97.0 68 74.7 146 64.0 206 76.0 136 93.2 2,191 76.3 
   
Laparoscopic approach 109 47.4 40 8.1 44 17.5 208 25.2 8 4.4 11 5.5 26 28.6 62 25.6 152 53.5 21 14.0 681 23.1 373.2 9 0.0000 
ASA Grade 
                      
145.5 27 0.0000 
ASA grade 1 44 19.2 142 28.8 107 43.3 194 23.5 32 17.7 58 28.9 23 25.3 19 7.9 97 34.2 38 25.3 754 25.6 
   
ASA grade 2 149 65.1 262 53.1 115 46.6 438 53.1 93 51.4 101 50.3 56 61.5 156 65.0 138 48.6 79 52.7 1,587 54.0 
   
ASA grade 3+ 36 15.7 89 18.1 25 10.1 193 23.4 56 30.9 42 20.9 12 13.2 65 27.1 48 16.9 33 22.0 599 20.4 
   
Surgical complexity 
                      
228.9 36 0.0000 
Complexity score 1&2 97 42.2 149 30.2 160 63.8 395 47.9 118 65.2 72 35.8 48 52.8 124 51.2 181 63.7 54 36.0 1,398 47.4 
   
Complexity score 3&4 79 34.4 199 40.4 62 24.7 276 33.5 38 21.0 88 43.8 39 42.9 79 32.6 70 24.7 52 34.7 982 33.3 
   
Complexity score 5&6 41 17.8 111 22.5 17 6.8 105 12.7 23 12.7 37 18.4 3 3.3 35 14.5 19 6.7 39 26.0 430 14.6 
   
Complexity score 7&8 9 3.9 24 4.9 5 2.0 34 4.1 2 1.1 4 2.0 1 1.1 3 1.2 6 2.1 5 3.3 93 3.2 
   
Complexity score >8 4 1.7 10 2.0 7 2.8 15 1.8 0 0.0 0 0.0 0 0.0 1 0.4 8 2.8 0 0.0 45 1.5 
   
Final diagnosis 
                      
274.2 36 0.0000 
Ovarian 94 40.9 123 25.0 99 39.4 305 37.0 57 31.5 82 40.8 27 29.7 78 32.2 64 22.5 60 40.0 989 33.6 
   
Uterine 70 30.4 119 24.1 73 29.1 243 29.5 56 30.9 51 25.4 37 40.7 60 24.8 62 21.8 49 32.7 820 27.8 
   
Cervical 18 7.8 19 3.9 20 8.0 82 9.9 16 8.8 9 4.5 5 5.5 16 6.6 11 3.9 11 7.3 207 7.0 
   
Vulval 3 1.3 18 3.7 14 5.6 69 8.4 12 6.6 12 6.0 4 4.4 20 8.3 12 4.2 12 8.0 176 6.0 
   
Benign 45 19.6 214 43.4 45 17.9 126 15.3 40 22.1 47 23.4 18 19.8 68 28.1 135 47.5 18 12.0 756 25.6 
   
Estimated blood loss 
                      
246.2 27 0.0000 
<500ml 155 67.4 400 82.0 196 78.7 709 87.4 93 51.4 161 80.9 69 75.8 198 81.8 261 93.2 93 62.0 2,335 79.9 
   
500ml-1000ml 50 21.7 49 10.0 33 13.3 62 7.6 69 38.1 23 11.6 12 13.2 31 12.8 11 3.9 38 25.3 378 12.9 
   
1000ml-2500ml 19 8.3 33 6.8 16 6.4 37 4.6 17 9.4 15 7.5 7 7.7 10 4.1 7 2.5 13 8.7 174 6.0 
   
>2500ml 6 2.6 6 1.2 4 1.6 3 0.4 2 1.1 0 0.0 3 3.3 3 1.2 1 0.4 6 4.0 34 1.2 
   
 
mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd F df* pvalue 
Age at surgery 58.6 13.8 59.5 15.4 58.4 15.7 60.6 15.0 63.2 12.1 63.1 13.6 57.2 12.0 63.3 16.0 59.6 14.4 64.1 14.0 60.6 14.8 5.2 9 0.0000 
BMI 27.6 6.7 28.8 6.9 28.2 8.3 29.1 7.2 30.0 6.8 28.5 6.1 29.6 8.4 29.2 6.7 28.9 6.4 28.4 6.7 28.8 7.0 2.1 9 0.0304 
Duration of surgery (hrs) 141 59.1 114 53.7 151 85.1 159 83.4 116 52.0 122 57.0 136 56.8 121 58.8 101 47.9 128 55.9 133.3 69.9 31.4 9 0.0000 
MD Thesis RI Page 8-119 
  
Table 27 Risk prediction model for intra-operative complications 
Variables 
Lasso Maximum Likelihood 
Shrinkage 
OR p-value* L95% CI* U95% CI* OR p-value 
L95% 
CI U95% CI 
Age at surgery 1.000 0.977 0.985 1.015 1.001 0.859 0.986 1.017 -84.0% 
BMI removed       1.003 0.867 0.974 1.032 -100.0% 
Previous abdominal surgery 1.426 0.058 0.988 2.057 1.459 0.045 1.008 2.111 -6.0% 
Low albumin 3.916 0.118 0.709 21.645 4.461 0.080 0.836 23.799 -8.7% 
Coagulation-thrombosis 1.052 0.910 0.436 2.540 1.148 0.755 0.483 2.729 -63.1% 
Diabetes 1.804 0.032 1.052 3.095 1.923 0.018 1.118 3.306 -9.7% 
Cardiac 1.462 0.205 0.812 2.632 1.572 0.128 0.878 2.814 -15.9% 
Respiratory 0.676 0.266 0.339 1.348 0.573 0.133 0.277 1.185 -29.8% 
Gastrointestinal 1.065 0.893 0.425 2.668 1.188 0.703 0.490 2.879 -63.5% 
Genitourinary 0.699 0.679 0.129 3.805 0.486 0.483 0.065 3.651 -50.4% 
Musculoskeletal removed       1.091 0.791 0.574 2.071 -100.0% 
Neurology-psychiatric removed       1.028 0.940 0.501 2.109 -100.0% 
Vascular 0.849 0.775 0.276 2.607 0.675 0.527 0.199 2.286 -58.3% 
Auto-immune 1.968 0.253 0.617 6.282 2.132 0.191 0.685 6.642 -10.6% 
Metabolic-endocrine 0.412 0.027 0.187 0.906 0.329 0.010 0.141 0.768 -20.3% 
Integumentary-dermatology removed       0.964 0.965 0.191 4.873 -100.0% 
Hypertension 1.239 0.325 0.808 1.899 1.279 0.263 0.831 1.969 -13.0% 
Smoking 0.978 0.969 0.323 2.961 0.828 0.760 0.246 2.788 -88.2% 
Other neoplasms 1.506 0.246 0.755 3.004 1.590 0.182 0.805 3.140 -11.8% 
Laparoscopic approach 1.021 0.935 0.618 1.689 1.240 0.403 0.749 2.051 -90.2% 
ASA                   
ASA grade 1 1       1         
ASA grade 2 1.103 0.699 0.670 1.816 1.250 0.401 0.742 2.106 -56.0% 
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Table 27 Risk prediction model for intraoperative complications continued… 
Variables 
Lasso Maximum Likelihood 
Shrinkage OR p-value* L95% CI* U95% CI* OR p-value 
L95% 
CI U95% CI 
ASA grade 3+ 1.039 0.908 0.539 2.003 1.183 0.628 0.599 2.336 -77.0% 
Surgeon grade                   
Consultant 1       1         
Sub-specialty trainee 0.716 0.604 0.202 2.535 0.614 0.460 0.168 2.243 -31.6% 
General Obstetrics & Gynaecology Trainee 1.286 0.673 0.399 4.144 1.243 0.720 0.378 4.083 15.8% 
Surgical complexity                   
Complexity score 1&2 1       1         
Complexity score 3&4 1.097 0.692 0.695 1.731 1.263 0.325 0.794 2.009 -60.4% 
Complexity score 5&6 1.905 0.016 1.130 3.212 2.208 0.003 1.298 3.756 -18.6% 
Complexity score 7&8 2.666 0.012 1.242 5.725 3.080 0.004 1.434 6.612 -12.8% 
Complexity score >8 4.005 0.003 1.626 9.865 4.561 0.001 1.850 11.242 -8.6% 
Final diagnosis                   
Ovarian  1       1         
Uterine 0.600 0.050 0.360 1.001 0.504 0.011 0.296 0.856 -25.5% 
Cervical  0.834 0.636 0.393 1.769 0.696 0.361 0.320 1.514 -49.9% 
Vulval 0.289 0.049 0.084 0.993 0.195 0.026 0.046 0.826 -24.1% 
Benign 0.567 0.041 0.329 0.976 0.508 0.017 0.291 0.887 -16.2% 
Constant 0.033 0.000 0.007 0.146 0.025 0.000 0.004 0.145 -32.8% 
* for approximate guidance only 
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The ROC curve based on leave-one-out cross validation produced an AUC= 0.663 
(95% CI: 0.616-0.710), which was only slightly larger than an equivalently generated 
AUC using ML=0.659 (95% CI: 0.611-0.706), although ROC curves are affected only 
by rank order and not magnitude. The mean bootstrapped calibration slope of 0.871 
suggested a slight narrowness of predictions, although the 2.5th-97.5th centile of the 
slopes (0.717-1.068) did contain the optimum value of one. In contrast, a ML 
equivalent slope=0.712 (95% CI: 0.364-0.887) indicated that the prediction range was 
very limited, and hence the model over-fitted, without parameter shrinkage. 
8.2.1.2 Hospital rate adjustments 
Figure 9a shows the funnel plot allowing a simple comparison of observed 
intraoperative CRs by hospital. Hospital F, outside the 95% confidence bounds, would 
appear to have an unusually low CR; whereas, although Hospitals J and E are clearly 
higher than the overall CR, the moderate number of surgeries performed at these 
hospitals (150 and 181, respectively) means that one may be less sure of their outlier 
status.  
Figure 9b shows the observed to expected CR ratio, based on the prevalence of the 
risk factors amongst the 10 hospitals. Actual values can be found in Table 28, and 
show the spread of expected CRs for hospitals is between 3.9% and 5.4%. In Figure 
9b Hospital F is confirmed as having an unusually low intraoperative CR. The 
confidence interval for Hospital E is entirely above the line of equality 
(observed=expected), marking it out as a high CR of potential concern. The ratio for 
Hospital G is also high at 1.8, though has wide confidence intervals. Hospital J, which 
had the highest crude (observed) CR, only has the 3rd highest ratio, indicating that its 
high CR is partially mitigated by a relatively high risk case-mix of surgeries. 
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Figure 9 Observed and expected intraoperative complication rates for individual hospitals 
 
 
Figure 9c displays this adjustment process by plotting the rankings over the 10 
hospitals for the observed intraoperative CR (left axis) and the observed:expected 
intraoperative CR ratio (right axis) with the placement on each axis reflective of the 
standardised differences in values. For example, although there is little change in 
terms of rank order, hospital G can be seen to have a notably higher CR ratio than 
observed CR, relative to the other hospitals.  
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Table 28 Summary of intraoperative complications by hospital 
Hospital 
No. of 
surgeries 
No. of IO
1
 
complications 
Observed 
IO CR
2
 
Expected 
number IO 
complications 
Expected 
IO CR 
O/E
3
 IO 
CR ratio 
Lower 95% CI
4
 
for O/E ratio 
Upper 95% CI 
for O/E ratio 
A 230 13 5.7% 11.7 5.1% 1.116 0.689 1.698 
B 493 17 3.4% 25.6 5.2% 0.664 0.390 0.977 
C 251 10 4.0% 11.6 4.6% 0.865 0.389 1.307 
D 825 44 5.3% 41.7 5.1% 1.055 0.826 1.333 
E 181 14 7.7% 8.0 4.4% 1.761 1.072 2.554 
F 201 4 2.0% 10.2 5.1% 0.393 0.102 0.804 
G 91 6 6.6% 3.6 3.9% 1.681 0.481 3.189 
H 242 11 4.5% 10.6 4.4% 1.035 0.598 1.659 
I 284 8 2.8% 12.6 4.4% 0.635 0.298 1.081 
J 150 12 8.0% 8.1 5.4% 1.479 0.838 2.313 
1-Intra-operative complications; 2-Complication Rate; 3-Observed/Expected ratio; 4-Confidence interval 
 
8.2.2 Post-operative complications 
Table 29 repeats the by-hospital statistics of Table 26 but restricted to the subset 
(n=1462) used for the postoperative analysis. The findings are similar to those for the 
full dataset and estimated blood loss and duration of surgery also vary notably by 
hospital. BMI is not significantly different however, and neither is the postoperative 
complication rate (p=0.096) even though they vary from 15.6% to 36.2%. 
Modelling and fit 
Of the 1462 surgeries where both patient and hospital records were available, 376 had 
at least one postoperative complication. However, when fitting the full model missing 
data meant only 346 events were included out of 1371 surgeries, meaning an EPV of 
9.9 given the 35 variables. Low albumin could not be included in the model as there 
was only one instance of it amongst the 1462 surgeries. The grid search yielded a 
lambda value of 12.2 and resulted in 15 variables out of the 35 being shrunk 
completely to zero (the comorbidities: cardiac, respiratory, genito-urinary, auto-
immune, metabolic-endocrine, smoking, integumentary-dermatology, hypertension, 
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other neoplasms; both ASA grade levels, both surgeon grade levels, benign diagnosis 
and surgical complexity score 5-6). The resulting lasso-shrunk odds ratios are 
presented in Table 30, which also give the ML estimates for comparison. Only duration 
of surgery appears to be a strong predictor of postoperative complications, though 
from the ML model coagulation-thrombosis, diabetes, musculoskeletal (all increase 
risk), laparoscopic approach (decreases risk) and final diagnosis (cervical and vulval 
cancer increase risk relative to ovarian cancer) were significant at the 5% level and still 
retain some predictive power in the lasso model. McFadden’s R2 was just 0.027, whilst 
the ML version was 0.056. Both the goodness of fit test (p=0.130) and the 
misspecification test (p=0.385) suggested the model was acceptable with regard to 
these criteria. 
The ROC curve based on leave-one-out cross validation produced an AUC= 0.659 
(95% CI: 0.585-0.733), significantly larger than an equivalently generated AUC using 
ML=0.569 (95% CI: 0.487-0.652) as tested using a method by DeLong et al (100) 
(p=0.0003). By way of contrast, ROC curves based on full sample estimates (no cross-
validation) generated a smaller AUC of 0.644 for the lasso penalised model, but a 
considerably larger AUC of 0.630 for the ML-based model. The mean bootstrapped 
calibration slope for the lasso-based model of 1.008 (95% CI: 0.799-1.264) suggested 
near perfectly calibrated predictions. However, the ML-based calibration slope=0.689 
(95% CI: 0.562-0.835) strongly indicated that the prediction range was too narrow, and 
hence the model was over-fitted. 
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Table 29 Subset used for postoperative complication analysis where both hospital and patient-reported data was available n=1462 
 
Hospital 
Overall 
chi2 df pvalue A B C D E F G H I J 
N % N % N % N % N % N % N % N % N % N % N % 
Intraoperative complications 3 3.7 10 3.5 2 5.6 22 5.6 10 7.8 3 2.7 3 6.7 8 4.9 5 3.2 2 3.5 68 4.7 7.1 9 0.6276 
Postoperative complications (hospital 
and patient reported) 
20 24.4 76 26.7 12 33.3 110 27.9 30 23.3 29 25.7 7 15.6 44 27.2 27 17.1 21 36.2 376 25.7 14.8 9 0.0960 
Previous abdominal surgery 23 28.1 99 34.7 13 36.1 141 35.8 30 23.3 42 37.2 14 31.1 70 43.2 66 41.8 9 15.5 507 34.7 27.9 9 0.0010 
Low Albumin 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 0 0.0 0 0.0 1 0.1 8.0 9 0.5311 
Coagulation-thrombosis 3 3.7 9 3.2 2 5.6 12 3.1 7 5.4 3 2.7 3 6.7 11 6.8 5 3.2 1 1.7 56 3.8 8.3 9 0.4997 
Diabetes 7 8.5 28 9.8 5 13.9 43 10.9 6 4.7 7 6.2 3 6.7 22 13.6 13 8.2 11 19.0 145 9.9 15.8 9 0.0713 
Cardiac 5 6.1 36 12.6 10 27.8 29 7.4 15 11.6 12 10.6 3 6.7 17 10.5 18 11.4 8 13.8 153 10.5 20.4 9 0.0157 
Respiratory 7 8.5 40 14.0 3 8.3 26 6.6 9 7.0 11 9.7 2 4.4 22 13.6 10 6.3 4 6.9 134 9.2 19.0 9 0.0254 
Gastrointestinal 1 1.2 3 1.1 1 2.8 12 3.1 8 6.2 7 6.2 5 11.1 7 4.3 1 0.6 4 6.9 49 3.4 26.7 9 0.0016 
Genitourinary 2 2.4 2 0.7 0 0.0 2 0.5 4 3.1 1 0.9 0 0.0 11 6.8 6 3.8 0 0.0 28 1.9 34.3 9 0.0001 
Musculoskeletal 7 8.5 17 6.0 2 5.6 57 14.5 8 6.2 11 9.7 3 6.7 28 17.3 13 8.2 7 12.1 153 10.5 26.4 9 0.0017 
Neurology-psychiatric 5 6.1 14 4.9 1 2.8 22 5.6 5 3.9 7 6.2 2 4.4 12 7.4 16 10.1 4 6.9 88 6.0 8.0 9 0.5329 
Vascular 2 2.4 9 3.2 1 2.8 6 1.5 3 2.3 4 3.5 2 4.4 5 3.1 6 3.8 2 3.5 40 2.7 4.1 9 0.9046 
Infections 0 0.0 6 2.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 0 0.0 7 0.5 20.8 9 0.0136 
Auto-immune 1 1.2 3 1.1 1 2.8 4 1.0 3 2.3 2 1.8 0 0.0 1 0.6 2 1.3 0 0.0 17 1.2 4.4 9 0.8794 
Metabolic-endocrine 9 11.0 22 7.7 4 11.1 32 8.1 12 9.3 14 12.4 7 15.6 23 14.2 22 13.9 5 8.6 150 10.3 11.3 9 0.2567 
Integumentary-dermatology 2 2.4 0 0.0 1 2.8 1 0.3 1 0.8 1 0.9 0 0.0 6 3.7 1 0.6 0 0.0 13 0.9 23.7 9 0.0048 
Hypertension 25 30.5 113 39.7 12 33.3 127 32.2 47 36.4 47 41.6 12 26.7 74 45.7 51 32.3 17 29.3 525 35.9 17.2 9 0.0458 
Smoking 0 0.0 14 4.9 0 0.0 1 0.3 2 1.6 2 1.8 7 15.6 9 5.6 1 0.6 1 1.7 37 2.5 58.1 9 0.0000 
Other neoplasms 10 12.2 9 3.2 1 2.8 27 6.9 6 4.7 3 2.7 3 6.7 13 8.0 10 6.3 5 8.6 87 6.0 15.6 9 0.0768 
Surgeon grade 
                      
201.5 18 0.0000 
General Obstetrics & Gynaecology Trainee 2 2.4 17 6.2 1 2.9 6 1.5 21 17.8 3 2.7 0 0.0 2 1.3 19 12.5 3 5.3 74 5.2 
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Table 29 Subset used for postoperative complication rate analysis where both hospital and patient-reported data was available continued….. 
Sub-specialty trainee 35 42.7 55 20.2 16 47.1 82 20.8 5 4.2 1 0.9 15 33.3 58 38.2 21 13.8 1 1.8 289 20.4 
   
Consultant 45 54.9 201 73.6 17 50.0 306 77.7 92 78.0 107 96.4 30 66.7 92 60.5 112 73.7 53 93.0 1,055 74.4 
   
Laparoscopic approach 37 45.1 21 7.4 4 11.1 99 25.1 8 6.2 6 5.3 15 33.3 43 26.5 91 57.6 9 15.5 333 22.8 220.3 9 0.0000 
ASA Grade 
                      
49.1 18 0.0001 
ASA grade 1 10 12.4 80 28.1 12 33.3 90 22.8 23 17.8 29 25.7 9 20.0 15 9.3 45 28.5 17 29.3 330 22.6 
   
ASA grade 2 58 71.6 155 54.4 21 58.3 230 58.4 70 54.3 64 56.6 32 71.1 106 65.8 82 51.9 29 50.0 847 58.0 
   
ASA grade 3+ 13 16.1 50 17.5 3 8.3 74 18.8 36 27.9 20 17.7 4 8.9 40 24.8 31 19.6 12 20.7 283 19.4 
   
Surgical complexity 
                      
125.8 36 0.0000 
Complexity score 1&2 36 43.9 89 31.2 25 69.4 179 45.4 87 67.4 41 36.3 22 48.9 84 51.9 106 67.1 21 36.2 690 47.2 
   
Complexity score 3&4 30 36.6 115 40.4 9 25.0 143 36.3 27 20.9 46 40.7 20 44.4 53 32.7 38 24.1 23 39.7 504 34.5 
   
Complexity score 5&6 11 13.4 60 21.1 1 2.8 50 12.7 13 10.1 22 19.5 2 4.4 23 14.2 10 6.3 14 24.1 206 14.1 
   
Complexity score 7&8 3 3.7 16 5.6 0 0.0 15 3.8 2 1.6 4 3.5 1 2.2 2 1.2 1 0.6 0 0.0 44 3.0 
   
Complexity score >8 2 2.4 5 1.8 1 2.8 7 1.8 0 0.0 0 0.0 0 0.0 0 0.0 3 1.9 0 0.0 18 1.2 
   
Final diagnosis 
                      
163.5 36 0.0000 
Ovarian 39 47.6 70 24.6 17 47.2 157 39.9 39 30.2 46 40.7 11 24.4 54 33.3 34 21.5 14 24.1 481 32.9 
   
Uterine 25 30.5 68 23.9 13 36.1 124 31.5 40 31.0 33 29.2 22 48.9 41 25.3 40 25.3 21 36.2 427 29.2 
   
Cervical 7 8.5 7 2.5 0 0.0 29 7.4 12 9.3 4 3.5 3 6.7 10 6.2 3 1.9 5 8.6 80 5.5 
   
Vulval 0 0.0 14 4.9 1 2.8 26 6.6 7 5.4 6 5.3 0 0.0 10 6.2 8 5.1 7 12.1 79 5.4 
   
Benign 11 13.4 126 44.2 5 13.9 58 14.7 31 24.0 24 21.2 9 20.0 47 29.0 73 46.2 11 19.0 395 27.0 
   
Estimated blood loss 
                         
<500ml 54 65.9 237 84.0 24 68.6 331 86.0 68 52.7 91 80.5 35 77.8 135 83.3 148 94.9 39 67.2 1,162 80.3 140.4 27 0.0000 
500ml-1000ml 20 24.4 25 8.9 8 22.9 35 9.1 46 35.7 14 12.4 5 11.1 21 13.0 4 2.6 17 29.3 195 13.5 
   
1000ml-2500ml 7 8.5 17 6.0 3 8.6 17 4.4 13 10.1 8 7.1 3 6.7 4 2.5 4 2.6 2 3.5 78 5.4 
   
>2500ml 1 1.2 3 1.1 0 0.0 2 0.5 2 1.6 0 0.0 2 4.4 2 1.2 0 0.0 0 0.0 12 0.8 
   
 
mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd F df* pvalue 
Age at surgery 59.6 12.2 60.5 14.4 62.1 12.8 62.8 12.8 63.1 11.7 63.8 12.3 59.1 11.8 64.5 14.8 62.0 12.9 65.4 13.3 62.4 13.3 2.4 9 0.0107 
BMI 27.8 7.8 28.8 6.7 31.1 8.8 28.5 6.8 29.7 6.6 28.3 5.5 30.2 10.0 29.2 6.9 29.1 6.3 28.6 6.3 28.9 6.9 1.2 9 0.2625 
Duration of surgery (hours) 148.9 60.6 110.6 51.3 146.1 91.2 161.8 80.8 110.3 51.0 121.3 55.4 138.8 53.4 122.6 56.6 95.1 42.6 114.4 34.8 128.9 66.2 23.7 9 0.0000 
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Table 30 Risk prediction model for postoperative complications 
Variables 
Lasso Maximum Likelihood 
Shrinkage 
OR p-value* L95% CI* U95% CI* OR p-value L95% CI U95% CI 
Age at surgery 0.997 0.552 0.986 1.008 0.991 0.160 0.979 1.003 -57.3% 
BMI 1.012 0.213 0.993 1.031 1.020 0.059 0.999 1.041 -38.6% 
Previous abdominal surgery 1.008 0.954 0.774 1.313 1.096 0.501 0.838 1.434 -90.4% 
Coagulation-thrombosis 1.510 0.202 0.802 2.842 2.130 0.022 1.115 4.072 -45.1% 
Diabetes 1.355 0.145 0.901 2.038 1.565 0.038 1.024 2.392 -31.3% 
Cardiac removed       1.036 0.878 0.660 1.627 -100.0% 
Respiratory removed       1.146 0.536 0.744 1.763 -100.0% 
Gastrointestinal 0.916 0.798 0.467 1.796 0.673 0.291 0.322 1.405 -77.4% 
Genitourinary removed       1.371 0.490 0.560 3.354 -100.0% 
Musculoskeletal 1.254 0.265 0.842 1.868 1.555 0.033 1.037 2.333 -50.3% 
Neurology-psychiatric 0.908 0.722 0.533 1.546 0.693 0.217 0.387 1.241 -69.0% 
Vascular 0.926 0.847 0.423 2.024 0.692 0.412 0.287 1.669 -78.6% 
Auto-immune removed       0.531 0.366 0.134 2.098 -100.0% 
Metabolic-endocrine removed       1.120 0.586 0.744 1.688 -100.0% 
Integumentary-dermatology removed       0.981 0.977 0.262 3.672 -100.0% 
Hypertension removed       1.129 0.431 0.834 1.530 -100.0% 
Smoking removed       1.341 0.467 0.609 2.955 -100.0% 
Other neoplasms removed       1.167 0.577 0.678 2.009 -100.0% 
Laparoscopic approach 0.739 0.084 0.525 1.042 0.649 0.020 0.451 0.935 -28.7% 
ASA                   
ASA grade 1 1                 
ASA grade 2 removed       0.942 0.745 0.659 1.348 -100.0% 
ASA grade 3+ removed       0.812 0.407 0.497 1.328 -100.0% 
Consultant 1                 
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Table 30 Risk prediction model for Postoperative complications continued… 
Variables 
Lasso Maximum Likelihood 
Shrinkage OR p-value* L95% CI* U95% CI* OR p-value L95% CI U95% CI 
Surgeon Grade          
Sub-specialty trainee removed       0.864 0.658 0.453 1.648 -100.0% 
General Obstetrics & Gynaecology Trainee removed       0.873 0.656 0.480 1.588 -100.0% 
Surgical complexity                   
Complexity score 1&2 1                 
Complexity score 3&4 1.112 0.437 0.851 1.454 1.322 0.078 0.969 1.804 -61.8% 
Complexity score 5&6 removed       1.054 0.819 0.670 1.659 -100.0% 
Complexity score 7&8 1.056 0.881 0.516 2.163 1.480 0.313 0.691 3.169 -83.3% 
Complexity score >8 1.004 0.970 0.828 1.217 1.748 0.322 0.579 5.279 -90.6% 
Final diagnosis                   
Ovarian  1                 
Uterine 0.982 0.911 0.719 1.343 0.951 0.790 0.658 1.376 -82.5% 
Cervical  1.606 0.094 0.923 2.794 2.099 0.016 1.148 3.836 -33.4% 
Vulval 1.779 0.030 1.056 2.999 2.274 0.003 1.311 3.943 -27.7% 
Benign removed       1.058 0.775 0.720 1.554 -100.0% 
Duration of surgery (hrs) 1.086 0.003 1.028 1.146 1.081 0.018 1.014 1.152 6.5% 
Estimated blood loss                   
<500ml 1                 
500ml-1000ml 1.267 0.208 0.876 1.833 1.405 0.077 0.963 2.048 -32.1% 
1000ml-2500ml 1.052 0.860 0.600 1.843 1.249 0.442 0.709 2.202 -76.4% 
>2500ml 0.997 0.962 0.867 1.146 0.506 0.417 0.098 2.623 -86.6% 
constant 0.167 0.000 0.066 0.422 0.179 0.003 0.057 0.564 -25.5% 
*for approximate guidance only; low albumin not included as only one instance in 1462 surgeries 
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Hospital rate adjustments 
Figure 10a compares the observed CRs of the 10 hospitals using a funnel plot. No 
hospital appears to have a postoperative CR that is worryingly high relative to the 
overall CR of 25.7%, although the postoperative CRs are generally considerably larger 
than for intraoperative. Hospital J has the CR of most concern (36.2%), though based 
on only 58 surgeries. Hospital C is the only other CR over 30% (33.3%, n=36).  
Hospitals G and I have an approximately equally low CR (15.6% and 17.0%) though it 
is for the latter that the evidence of an unusually low CR is stronger, given the larger 
sample size – only hospital I lies outside either 95% or 99% confidence bands. Figure 
10b shows the observed to expected postoperative CR ratio, with actual values found 
in Table 31 .The range of expected CRs was from 20.1% to 28.5%. None of the 
hospitals have a CR ratio significantly different from one. Figure 10c shows that 
hospital J is now a little further away from the average when considering the CR ratio. 
For the middle ranked hospitals there is some swapping of rankings using the CR 
ratio, but little real change in their relative rating. By contrast hospitals C, G and I 
maintain their original rankings but are the biggest movers in terms of standardised 
deviation. Notably, hospital I does not have a significantly low CR when factoring for 
the case-mix of their surgeries. 
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Figure 10 Observed and expected postoperative complication rates for individual hospitals 
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Table 31 Summary of postoperative complications by hospital 
Hospital 
Number 
of 
surgeries 
Number PO
1
 
complications 
Observed 
PO CR
2
 
Expected 
number PO 
complications 
Expected 
PO CR 
O/E
3 
PO 
CR ratio 
Lower 
95% CI
4
 
for O/E 
ratio 
Upper 
95% CI 
for O/E 
ratio 
A 82 20 24.4% 20.9 25.4% 0.958 0.616 1.325 
B 285 76 26.7% 69.7 24.4% 1.091 0.942 1.296 
C 36 12 33.3% 10.3 28.5% 1.171 0.688 1.723 
D 394 110 27.9% 108.2 27.5% 1.017 0.902 1.128 
E 129 30 23.3% 33.0 25.5% 0.910 0.638 1.157 
F 113 29 25.7% 28.2 24.9% 1.029 0.769 1.370 
G 45 7 15.6% 11.1 24.8% 0.628 0.265 1.098 
H 162 44 27.2% 40.5 25.0% 1.086 0.881 1.355 
I 158 27 17.1% 31.8 20.1% 0.850 0.562 1.099 
J 58 21 36.2% 15.4 26.6% 1.361 0.917 1.828 
1-Postoperative complications; 2-Complication Rate; 3-Observed/Expected ratio; 4-Confidence interval  
 
8.3 Discussion 
Published data comparing CRs across gynaecological oncology centres is sparse and 
limited to a small retrospective study from the United States, comparing outcomes of 
ovarian cancer surgery between three tertiary cancer centres. (44) However, such data 
is available nationally in other specialties such as cardiac surgery(50), colorectal(101), 
head and neck (88) and lung (87) cancer. 
This is the first large study in gynaecological oncology to develop risk-adjusted CRs for 
comparison of outcomes between gynaecological oncology centres. The overall 
intraoperative (≈5%) and postoperative (≈26%) CR derived from this study could be 
used to benchmark performance in gynaecological oncology. 
The main finding is that while adjustment for risk did not make a difference for majority 
of hospitals, it helped better delineate the outliers. The shaded funnel plots and 
observed versus expected ratios generated made comparisons easy to comprehend. It 
is important to note that where hospital under-reporting is common as for 
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postoperative complications, use of patient reported outcomes was crucial to ensure a 
valid comparison between institutions.  
By accounting for the prevalence of potential surgical complication risk factors it might 
be possible to (partially) mitigate an institution’s observed CR if it appears, say, 
unusually high. Likewise, it may also be found that a hospital’s CR is more concerning 
than it perhaps initially appears. For this dataset adjustment for confounding of risk 
resulted in only moderate differences to the crude CRs. Even with ML estimation not 
many of the proposed risk factors appeared strongly predictive of the outcome.  
Risk factors for intraoperative CR were largely different from that for postoperative CR 
and even after adjustment there was no concordance between hospital intraoperative 
and postoperative CR. Therefore for benchmarking hospitals, it may be important to 
calculate intraoperative and postoperative CRs separately.  
Based on the ML based p-values, for intraoperative CRs only surgical complexity, 
previous abdominal surgery, diabetes, metabolic-endocrine and final diagnosis were 
significant at the 5% level.  For postoperative CRs on the other hand, only duration of 
surgery, coagulation-thrombosis, diabetes, musculoskeletal, laparoscopic approach 
and final diagnosis were significant at the 5% level. Indeed, only diabetes had a 
consistent effect on both intraoperative and postoperative CR. With regards to final 
diagnosis, ovarian cancer was the riskiest diagnosis for intraoperative complications 
but cervical and vulval cancers were considerably riskier diagnoses for postoperative 
complications.  
These mitigating risk factors are by intention factors that are out of the hospital’s or 
surgeon’s control. It could be argued then, that surgeon grade should not be controlled 
for as the hospital could in theory have the highest graded surgeons always 
performing. There was, perhaps surprisingly, little evidence that surgeon grade was 
related to adverse surgical outcome though this could be due to more junior surgeons 
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being allocated ‘easier’ surgical procedures. All other intraoperative factors, regardless 
of their estimated risk implication, were entirely exogenous to the surgical 
environment. For postoperative complications, the additional factors duration of 
surgery and estimated blood loss of course may in part be reflective of surgical skill, 
but generally are proxies for the exogenous issue of surgical requirement and 
difficulty. Duration of surgery was in fact the one clearly important factor in predicting 
postoperative risk.  
Few of the factors appeared important across either model and this reflected the 
difficulty of the task in developing risk prediction models. The collection of data for 
2948 gynaecological surgeries was a major time-consuming undertaking, yet this still 
only meant 139 intraoperative complications which had significant implications for 
estimation given the large number of risk factors under consideration. The 
intraoperative EPV rate was far less than the usual guideline of 10 (=4.1), and any 
attempt to model the full set with standard methods would inevitably lead to over-fitting 
and poor predictions. The calibration statistic using the ML estimates demonstrated 
this clearly (0.712 for intraoperative; 0.689 for postoperative) showing the need for 
parameter shrinkage that would bias the estimates but improve predictions. In fact ML 
estimation only gives unbiased estimates asymptotically and for several of the 
comorbidity factors, where the prevalence was very low, a different cause of bias is 
introduced. Low predictor counts may lead to near perfect prediction (or ‘separation’) 
and greatly biased estimates, if estimation is even possible. In this scenario a different 
form of penalised regression (102) would be more suitable if well estimated odds ratios 
were the research goal. 
The lasso method was used to produce better predictions, but as can be seen from the 
diminished pseudo-R2 statistics, even less of the outcome is predicted and the 
observed to expected CR ratios will be typically less affected as a consequence. The 
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EPV (=9.9) for postoperative complications was considerably higher yet conversely 
there was more shrinkage performed (larger lambda). A different criterion to the 
generalised cross-validation statistic might have resulted in differing penalty terms, but 
the lack of association for the postoperative predictors will be a major cause of the 
greater shrinkage. It demonstrates effectively that the EPV is very much an 
approximate guideline, and in reality the requirement may be quite different from 
dataset to dataset. 
Given that most of the predictors appeared to have minimal impact on outcome it 
therefore might seem tempting to conclude that the adjustment process is not strictly 
necessary. However it is felt that where feasible, adjustment is still worthwhile in 
safeguarding against an excess of surgical complications at a given hospital, as it will 
help define that level of excess better. Hospital E only became flagged as having a 
statistically high intraoperative CR following adjustment. Figures 9c and 10c show that 
relative performances for most hospitals are moderately affected by the adjustment 
process, especially regarding postoperative complications, even if the overall 
conclusions and rankings seem unaffected. It was noted that statistically the 
intraoperative and postoperative CRs did not vary significantly between the ten 
hospitals, so that for the majority the observed CRs were comfortably inside the funnel 
plot confidence limits. In future scenarios, where hospitals may have a larger spread of 
CRs or quality control has been compromised at a certain hospital, this could mean 
more institutions close to or beyond the simple safety bounds, and therefore the need 
for a more exacting assessment of their performance. In stark contrast, nearly all the 
predictors varied considerably by hospital, especially those involving an element of 
surgical decision (laparoscopic approach, surgeon grade and surgical complexity). 
This by-hospital variability in risk factor prevalence is a strong argument in itself for the 
need to attempt adjustment for fairer comparison. That many of the factors were not 
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apparently important will partially be a result of the lack of statistical power, and with 
the accumulation of additional data it may well be shown that some of these factors 
make a telling contribution to CR prediction, both statistically and clinically. The lack of 
association between CR and certain factors like BMI, especially after open surgery, 
are contrary to previous reports (103, 104).  
The other important finding of this study was the difference in ranking order of 
hospitals for intraoperative and postoperative complications. Hospitals G and E had 
high intraoperative CRs (both crude and risk-adjusted) and low postoperative CRs. 
This discrepancy between intraoperative and postoperative CR ranking could be due 
to a variety of factors including surgical skill, postoperative care in wards and under 
reporting of postoperative complications. Analysis of only hospital-reported 
postoperative complications demonstrated that hospital D, which had contributed the 
largest number of surgeries, also had the highest postoperative CR (Figure 11). 
However, when the surgical subset with both hospital and patient-reported data was 
analysed, hospital D was no longer an outlier but hospital J’s rate had increased from 
close to the 50th to the 95th centile, suggesting that perhaps hospital D had been more 
diligent at recording all postoperative complications when compared to the other 
institutions. These findings substantiate the need for including patient-reported 
postoperative complications to overcome the issue of under reporting by hospitals. 
Despite limiting analysis to operations with both hospital and patient-reported 
postoperative complications to calculate the risk-adjusted rates, the reversal in the 
ranking for hospitals G and E persisted. This finding would suggest that intraoperative 
and postoperative complications are different entities as they have different 
contributing factors, as already shown. 
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Figure 11 Comparison of observed postoperative complication rates against colour-coded 
funnel plots. Bright colour-coding and circle markers represent patient-reported statistics and 
faded colour-coding and square markers represent hospital reported statistics only 
  
Therefore it is important to rank hospitals separately for intraoperative and 
postoperative complications and combining the two would perhaps mask the 
deficiencies inherent in the perioperative care in certain hospitals.  
Despite this recommendation it is evident that much of the outcome variability is 
related to unmeasured (and probably even unobservable) phenomena. This was 
anticipated, and it is not expected for a surgical complication to be ever predicted with 
a high degree of confidence. Individual surgeon scoring not based on status but 
hitherto historical performance may be one (though potentially unpopular), possibility 
in improving surgical risk prediction.  
A non-trivial issue for the funnel plots was that of the overall CR the confidence limits 
were built around. An internal measure (the observed overall rate) was used in lieu of 
a pre-specified target rate based on external data and expert opinion. Clearly, using 
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the observed overall rate is data-dependent and a hospital with a particularly high rate 
will help push up that value to which all hospitals are compared to. Unfortunately there 
was not sufficient data regarding gynaecological cancer surgery to utilise a prior target 
rate.  
A related issue was that the data used to estimate the prediction model was the same 
to which the model was then applied to. Cross-validation methods were used to 
determine the calibration and discrimination of the predictions, but not for the expected 
hospital CRs. Penalised regression methods help to limit the influence of the specific 
dataset the estimates were based upon, by not over-fitting to each ‘feature’ of the data. 
Ideally, there would be a validation set to demonstrate the model predictions, but even 
the full dataset had a limited EPV rate and proper validation of a risk prediction model 
requires a fully external dataset anyway. By using the same dataset a hospital’s own 
surgical history can influence the model parameters which are in turn used to mitigate 
their performance via the expected rate. However, this is analogous to the overall rate 
being used as the target rate; an expected rate based on a null model with no 
predictors would be the same for all hospitals and equal to the observed overall rate.  
By using a shrinkage method it may appear that the potential of this dataset and model 
forming the basis of a routine risk adjustment process in the future is limited. The EPV 
requirements deem all initial predictors as part of the variable count, so selection 
methods that appear to trim a model to a parsimonious and ‘useful’ subset do not 
obviate this need. In a limited event situation it is known that selection methods will 
drop some moderate predictors, and even include some noise predictors (95). It was 
therefore not preferable to produce a reduced-variable risk model with ‘nicely rounded’ 
coefficients that allow simple hand calculation, as for example the Risk of Malignancy 
index (RMI) used to preoperatively predict the nature of ovarian masses (105). However, 
it is straightforward to input predictor values into, say, an Excel sheet pre-prepared 
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with the necessary inverse logit formula to calculate risk scores (Appendix 9 and 10) 
and it would be easy for an appropriate hospital employee to perform this provided 
they are prepared to record the data. Admittedly, use of bootstrapping methods is not 
an easy proposition in a clinical setting, but for approximate inference it is simple 
enough to use the confidence limits described by DeLong et al, treating the expected 
rate as fixed.  
Since morbidity is the main yardstick being used to benchmark surgical performance, 
moving forwards, it would be important to have complete and accurate data in a 
national database. Although it would be more acceptable to clinicians, the main 
drawback of clinician-led databases is that they rely on voluntary data entry and 
therefore may not be complete. (4) Also, as demonstrated by Almoudaris et al, there is 
the possibility that centres with high rates of morbidity may be hesitant to voluntarily 
enter all their data into these databases. (106) The alternative might be to source 
information from an administrative database like Hospital Episode Statistics (HES) 
where all surgical episodes are automatically recorded. Although Nouraei et al (88) 
found complication rates derived from HES comparable to that in the clinician-led head 
and neck surgery database, this has not been the case with other surgical specialties 
(73). An audit of complications post UKGOSOC in one of the participating centres also 
demonstrated that the morbidity rates were higher than that reported on HES but 
comparable to that in UKGOSOC. (107) Therefore in future, a reasonable compromise 
may be to have a combination of the two so that the data fields requiring entry by 
surgeons is kept to a minimum to ensure completeness. In addition to disclosing 
outcomes data for hospitals it is now becoming a requirement to publish data for 
individual surgeons  as well (85) and it is hoped that this will act as an impetus for 
surgeons to ensure data on their surgical procedures is complete and accurate.  
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9 Discussion 
This study has demonstrated that multi-centred contemporaneous data collection on 
surgery and complications is feasible to allow calculation of crude and risk-adjusted 
complication rates for the purpose of benchmarking in gynaecological oncology 
surgery.  
The key findings of the study are as follows: 
 The overall unadjusted intraoperative complication rate was 4.7% (95% CI 4.0 - 
5.6).  
 The unadjusted hospital-reported postoperative complication rate was 14.4% 
(95% CI 13.2-15.7) which increased to 25.9% (95% CI 23.7-28.2) when both 
hospital and patient reported postoperative complications were included.  
 The predictors for intraoperative complications were different to that for 
postoperative complications, except for diabetes which was common to both.  
 The significant contributing factors for intraoperative complications were 
surgical complexity, diabetes, ovarian cancer diagnosis, previous abdominal 
surgery. 
 The significant contributing factors for postoperative complications were age, 
duration of surgery, open approach (compared to laparoscopic), vulval cancer 
diagnosis and diabetes.  
 Risk adjustment had a modest effect on the rankings of the individual centres 
based on their complication rates. However, the adjusted complication rates for 
individual centres ensured a fairer comparison. 
 There was no concordance between intraoperative and postoperative 
complications rates of the participating centres. Centres with high intraoperative 
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complication rates were found to have some of the lowest postoperative 
complication rates.  
Strengths of this study include prospective data collection using standard forms, large 
sample size and multi-centre design with ten participating gynaecological cancer 
centres. An online database, accessible to the clinical team whether they were in 
theatre, wards or outpatient departments facilitated capture of surgical data and 
complication events contemporaneously. Validity of the data was ensured by weekly 
review by an independent clinician at the coordinating centre, who contacted the 
teams on a regular basis to retrieve missing data and “clean” erroneous entries.  
Prior to UKGOSOC, data on surgical complications were limited to a single centre 
study from Australia (45) and a small three centre study from the US on ovarian cancer 
surgery. (44) This is the first time that such data on approximately 3000 surgeries 
involving ten centres has been collected. A database was specifically designed and 
refined to collect data on comorbidity, surgery and complications. To  account for the 
various procedures often performed for gynaecological cancers and to have a 
standardised approach to collect this data across the ten centres, a score to grade 
surgical complexity was developed based on Aletti’s surgical complexity score (43) for 
ovarian cancer surgery. This scoring system however requires validation in future 
studies. 
In order to define a complication, one of the definitions suggested by D Sokol was 
adopted which stated that a surgical complication was ‘an undesirable and unintended 
result of an operation affecting the patient that occurs as a direct result of the 
operation’. (6) However, in some instances it was not clear whether the event was a 
direct consequence of surgery. For example, an exacerbation of a pre-existing 
condition like atrial fibrillation (AF) which had been quiescent could have flared up after 
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surgery.  Although by definition, AF in this situation was not a direct consequence of 
the operation, surgery had certainly contributed to its exacerbation and therefore was 
included as a complication.   
The one intraoperative complication that was particularly difficult to define/determine 
was intraoperative haemorrhage. Some studies have used the need for intraoperative 
(45) or postoperative blood transfusion as a marker of significant intraoperative 
haemorrhage. This definition could not be used as there were women in this study 
having surgery soon after chemotherapy which often causes anaemia and such 
women would have been transfused during or soon after surgery. Therefore the 
indication for transfusion in these cases would not necessarily be intraoperative blood 
loss. Also, the threshold haemoglobin level for transfusion would not have been the 
same across the ten hospitals. Taking these issues into account, estimated 
intraoperative blood loss of >2500mls was defined as intraoperative haemorrhage in 
this study. Although a threshold of >2.5litres might seem a bit excessive for a simple 
hysterectomy it may not be so for a radical debulking surgery involving bowel 
resection, upper abdominal surgery etc. Various thresholds could have been used for 
individual procedures depending upon their complexity for a more accurate 
assessment of haemorrhage, but this would not have been easy to capture uniformly 
across the ten centres and would have been open to individual interpretations. For 
example, for an abdominal hysterectomy one would expect the blood loss to be 
<500mls but not all hysterectomies are the same and the blood loss could have varied 
depending on uterine size, presence of adhesions, endometriosis etc., and not just be 
a reflection of surgical skill.  
Comorbidity was captured according to the various organ systems. The advantage of 
this method was that the effect of individual comorbidity on complications could be 
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analysed. As a result, diabetes was identified as a key predictor. The disadvantage of 
this approach was that the severity of individual illnesses was not accounted for. In 
addition to the ASA grade which was easily available for all patients undergoing 
surgery, the ACE-27 score was built into the database to capture comorbidity. 
However this could not be used due to the issue with licensing for the individual 
centres. Towards the end of the study, the Charlson index was incorporated into the 
database. However, by the time it was tested and ready for use, the study was nearing 
to an end. Future studies in gynaecological oncology could use this index to capture 
comorbidity as it has been used to capture comorbidity in patients with gynaecological 
cancers and also in those undergoing surgery in other specialties. (108-110) Studies have 
also shown that it is feasible to derive Charlson scores from administrative databases 
like HES (111)  
Postoperative complications were defined as those complications occurring up to eight 
weeks after surgery although in reality there would have been some complications that 
occurred after this period. For e.g. incisional hernias from laparotomies could present 
months after an operation. Instead of a one off follow-up letter, a series of follow-up 
letters to patients at regular time intervals would have been necessary to capture 
these late complications.  
Patient follow-up was invaluable to this study and was a very efficient way of obtaining 
information on complications treated in primary care or the local hospital. Patient-
reported complications were found to significantly impact on the post-operative 
complication rate both overall and also for individual hospitals. (90) One of the hospitals 
which had contributed the most number of cases also had the highest hospital-
reported postoperative complication rate. However when patient reported data was 
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included the postoperative complication rate for this hospital was no longer the highest 
highlighting the need to include patient reported complications.  
The questions in the follow-up questionnaire (developed during the course of the 
study), were designed in such a way that complications could be easily graded 
according to the Clavien and Dindo system (8) which was used in the study. During the 
development of the questionnaire non-medical colleagues and lay volunteers were 
asked to choose between two versions of the questionnaire and the one with the most 
votes was chosen. Although in the patient feedback none of the women expressed any 
difficulty in understanding the questions, it would be important to include 
women/patients in the development of future versions. Also, complications have been 
traditionally defined by clinicians and this was the case in this study as well. However, 
as more emphasis is now being given to patient reporting and patient experience, 
there probably needs to be patient involvement in defining what a complication is, and, 
in determining which complications are important to patients. It is possible that 
complications which matter to patients may not always be the same as those which 
clinicians think are significant.   
Since prior consent had not been obtained from the women, it was not possible to 
contact their general practitioners (GPs) to verify the patient-reported complications. 
However when the centres were contacted, they were able to verify all the major 
complications with serious sequelae like re-operation/admission to intensive care and 
around half of those complications managed with medical therapy in primary care or 
the local hospital. Very few of the verified complications had been erroneously 
reported by patients suggesting that in most instances patients accurately report 
complications and therefore are a valuable resource.  
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The response rate for the follow-up letters was 68% which could perhaps have been 
improved by re-sending the letters to the non-responders.  However sending the 
follow-up letters was not always straight forward. Prior to sending the letters, the 
centres had to be contacted in cases of missing information, and for an update on 
whether any of the patients from the list had deceased, as a good proportion of the 
patients were elderly with co-morbidities and cancer. Despite adopting this policy, 
letters were inadvertently sent to some deceased patients causing distress to their 
families.  
Given the added value of patient reporting, it would be essential for future studies to 
incorporate this in addition to hospital data. However it requires additional resources, 
clinician input to analyse patients’ responses and may not be an easy undertaking on 
a larger scale. Use of a questionnaire format would help with easy interpretation and 
data entry, and, one way of routinely collecting this information might be to add the 
follow-up questionnaire to patient reported outcome measures (PROMs) 
questionnaires (18) which may become a requirement for cancer surgery in future.   
One of the main drivers of this study was the need for risk adjusted rates as there was 
much unease amongst the clinicians that patient comorbidity and surgical risk factors 
were not being accounted for when calculating complication rates for benchmarking 
purposes. Therefore the aim of creating a risk prediction model was to predict risk as 
accurately as possible, taking into account all the risk factors so that fair comparisons 
could be made between the centres. The problem with previous risk-prediction models 
like the POSSUM index has been that that they tend to over predict risk and therefore 
failed to be validated. (47) To avoid this problem, the Lasso method of penalised 
regression was used in this study. (67) Even though the relative performances for most 
hospitals were only  moderately affected by the adjustment process, adjustment was 
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still important as it helped to better define the level of excess surgical complications at 
a given hospital. With a larger dataset the findings might be different due to a wider 
variation in the patient cohort, skill mix of the surgeons and complication rates 
between hospitals.  
There was little concordance between the intraoperative and postoperative 
complication rates of individual centres. Centres with high rates for intraoperative 
complications were found to have low postoperative complication rates. This would 
suggest that they are two different entities and therefore should not be combined. This 
was further strengthened by the finding that the predictors for intraoperative 
complications were different from those for postoperative complications. Also, other 
factors such as perioperative management of the patient and the standard of 
postoperative care on the wards could vary from one hospital to another. Therefore it 
was felt that the two should not be combined and could in turn help in identifying the 
deficiencies in certain aspects of patient care in hospitals.  
This study was very much led by the clinicians. The advantage was that clinicians had 
control over the data that was entered and therefore there was less room for any 
errors that tend to happen with administrative databases where clinical coders have to 
rely on the operating notes and other patient records for information. However it 
heavily relied on junior doctors who had to enter data during their busy clinical 
schedules. Also, as the doctors changed firms every 4-6 months, new doctors had to 
be familiarised with the database, given passwords for access, all of which had a 
knock on effect on the continuity of data entry. Such heavy reliance on clinicians may 
not be feasible in the long run and could result in incomplete data entry which has 
been shown in a study comparing clinician-led database with HES for the purpose of 
revalidation of clinicians. (4)  The other disadvantage of a purely clinician led database 
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is that it could be open to manipulation by the clinicians. A study in colorectal cancers 
demonstrated that hospitals with higher morbidity rates were less likely to voluntarily 
enter complete data. (106)  
Morbidity rates for individual surgeons will soon be a requirement for all surgical 
specialties and will be accessible to the public.(86) This requirement is likely to 
encourage surgeons to ensure data on their individual operations is accurate and 
complete, but on the other hand, it could deter surgeons from entering all their 
complications into the database. It could also deter some surgeons from undertaking 
high risk surgery or surgery on patients with significant co-morbidities that could 
potentially impact on their complication rates. However this has not been the case with 
cardiac surgery which has a database that is very much clinician led and has 
published complications data for individual surgeons since 2004. (50) 
The National Surgical Quality Improvement Programme (NSQIP) in the US continues 
to be so successful from its inception in 1994 to this day due to its robust 
organisational structure and dedicated staff. (48) The trained clinical nurse reviewers at 
every centre work closely with the chief of surgery at that centre to ensure accurate 
collection and timely transmission of data to the coordinating centre. There is also 
regular contact between the coordinating centre and the medical centres to address 
any issues with data collection and transmission. To have a similar organisation to 
collect data in gynaecological oncology in the UK would require funding and may not 
be feasible in an already cash strapped NHS. The success of UKGOSOC was down to 
the determination of all the participating clinicians arising from their desire to have 
robust morbidity data for future benchmarking purposes. However in order for it to be 
successful in a large scale in the long term, it would be essential not to rely so heavily 
on clinicians. Some of the data fields like comorbidity could be automatically populated 
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from HES.  A study by Aylin et al found that the predictors for mortality derived from 
HES was comparable to that in clinician led databases. (111) Other data fields such as 
surgical procedures and intraoperative complications would still need to be entered by 
the surgeons. Instead of a long exhaustive list of complications, limiting the list to four 
or five key postoperative complications might help with completeness of data capture. 
It would also be essential to have a national body such as the National Cancer 
Intelligence Network (NCIN) or the British Gynaecological Cancer Society (BGCS) to 
coordinate, monitor, analyse and publish the outcomes data. The ultimate aim of such 
a national database would be to move the focus away from judgment towards 
improvement. Studies in other specialties have demonstrated that publishing 
outcomes data over a period of time actually helps in reducing morbidity and mortality 
rates. (49) In addition to being a national repository for outcomes data, such a database 
would also provide valuable information for future research.  
9.1 Conclusion  
This the first large multi-centre prospective study to investigate the morbidity 
associated with gynaecological oncology surgery. There are significant patient and 
surgical factors which influence the risk of developing a complication. Patient follow-up 
is vital to obtain a more realistic estimate of the postoperative complication rate. 
Although risk adjustment had a modest effect on the complication rate of individual 
centres, by accounting for the prevalence of potential risk factors for surgical 
complications we were able to estimate an adjusted institutional complication rate that 
ensured fairer comparison. The contributing risk factors for intraoperative and 
postoperative complications were different and in future studies it would be important 
to report on the intraoperative and postoperative complication rates separately. It is 
envisaged that the robust complications and risk-adjusted data generated from this 
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study will be utilised for future benchmarking of surgical practice in gynaecological 
oncology. 
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10 Appendices 
Appendix 1 Consent Form 
 
 
 
 
 
 
 
 
A national audit to assess outcomes of major gynaecological surgery is being undertaken in 
10 Gynaecological Oncology Centres in the NHS. The Trust where you are undergoing 
treatment is participating in this audit. The aim of the audit is to provide information that we 
can use to monitor the quality of surgery and improve the care we provide. To do this, the 
audit will collect information on the types of major gynaecological operations performed 
around the country, the severity and frequency of any complications and the effect of pre-
existing medical problems on surgical outcomes. 
What does this mean for you? 
In the course of the audit, information regarding the details of your surgery, any complications 
during or after your operation and final diagnosis will be forwarded to a central database, for 
analysis and comparison with patients from around the United Kingdom. Sometimes 
problems arise after discharge and in order to ensure a complete record of events is 
collected, we will send you a post card about 6-8 weeks after your surgery. It will ask you for 
details of any problems you may have had following your discharge from hospital. We would 
be grateful if you would ensure you complete this post card when it arrives, and return it to 
the address marked on the card.  
 
 
    Coordinating Centre Team 
R Iyer/ Prof Usha Menon / Dr Alex Gentry-Maharaj / Mr Robert Liston 
Gynaecological Cancer Research Centre, Maple House 1st Floor     
149 Tottenham Court Road 
London W1T 7DN; 020 7380 6925 (telephone) 
United Kingdom Gynaecological Oncology Surgical Outcomes and Complications (UKGOSOC) Your information will be held securely on a central NHS computer at Trent 
Cancer registry and will remain strictly confidential. In addition to your local 
team, the Gynaecological Cancer Research team at University College 
London who are conducting the audit will have access to the data. If you do 
not want information which can identify you to be made available to the audit 
team in London running the audit, please let your nurse/doctor know. We will 
then ensure that only data about your surgery, complications and diagnosis is 
sent to the national team with your identity concealed. Also do let the team 
know if you do not want any of your data to be included in this surgical audit. 
However, we hope that everyone will agree to all of the confidential 
information being sent to the national team, for this would make the audit more 
accurate and therefore more effective in improving the quality and standards 
of care for women in the future.  
The results of the audit will be available in due course. If you would like to see 
these, please ask your clinician who will provide you a summary of the report. 
If you have any queries, you could contact:  
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Consent :  Please tick appropriate option 
   I am willing for information which can be used to identify me in relation to my operation and any complications that may arise to be collected and analysed in 
the UKGOSOC audit by the University College London gynaecological oncology research team. I understand that I will receive a postcard in 6-8 weeks asking 
about any complications that I may have experienced following my operation. 
 
  I am willing to participate in the UKGOSOC audit of my operation and any complications that may arise BUT do not want any information that will identify me to 
be made known to the UKGOSOC audit team at University College London gynaecological oncology research team. 
 
  I do not want any of my data included in the national audit (UKGOSOC) of gynaecological oncology operations and any complications that may arise.  
 
SIGNED:     WITNESS: 
 
NAME:      NAME (WITNESS):     DATE:                                                          
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Appendix 2 Screen shot- Patient details 
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Appendix 3 Screen shot- Surgery details 
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Appendix 4 Screen shot- Intraoperative complications 
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Appendix 5 Screen shot- Diagnosis details 
 
MD Thesis RI Page 10-155 
  
 
Appendix 6 Screen shot- Patient report 
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Appendix 7 Free text format Follow-up letter 
 
                       United Kingdom Gynaecological Oncology Surgical Outcomes and Complications (UKGOSOC) 
 
  
 
Private and Confidential 
 
Ms «First_Name» «Last_Name» 
«Address1» 
«Address2» 
«Town» 
«County» 
 
Date  
 
Dear Ms «Last_Name», 
 
UKGOSOC Reference number: «UKGOSOC_Ref» 
 
Thank you for participating in this audit. 
 
You might recall your consultant (or one of the members of the team) mentioning that 
we would be writing to you following your surgery, to find out if you had any problems 
(complications) relating to your operation.   
 
We would be grateful if you could fill in the tear-off slip at the bottom of this letter and 
return it to us in the FREE POST envelope provided. We look forward to hearing from 
you. 
 
Yours sincerely, 
 
 
(On behalf of the co-ordinating centre team) 
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If you have any queries, please contact your local hospital on the following phone 
numbers:  
 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - - - - -  - - 
- - - - - - - - - - - - - -  
 
 
We would be grateful if you could provide a little more information about yourself.  
 
1. What is the main language spoken in your home? 
 English 
 Other, please specify…………………………  
 
2. Is this questionnaire in a language that you can easily understand? 
 Yes 
 No 
 No, I don’t understand the language but I had help from a friend or family member to fill 
in this questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name: «Patient_Name»      UKGOSOC Ref No:  
Please tick as appropriate 
 N , I id not have a c mplication following my gynaecological surgery   
 Yes, I had a complication following my gynaecological surgery 
If the answer is yes, please describe below the complication you had following your 
operation. Please use additional paper if you would like to. 
If you are willi g to be contact d for any clarification, please enter your telephone 
number below. ________________________ 
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Appendix 8 Questionnaire format of follow-up letter 
A surgical complication may be defined as ‘an undesirable and unintended result of an 
operation affecting the patient that occurs as a direct result of the operation’. 
 Below is a list of 11 common complications experienced by patients 
 Even though the list appears long, it should only take approximately five minutes of 
your time.   
 Please choose the complication/s that is most appropriate and indicate the treatment 
you required.  
 You may choose more than one option.  
 However if your complication is not on the list, please use the free text space provided. 
Please use additional paper if necessary 
1 Did the wound get infected or did it break down? Yes  No 
 If the answer is yes, how was it treated?   
 
a. Antibiotics 
Yes No 
 
b. Regular dressing of the wound 
Yes No 
 
c. Required re-admission to hospital  
Yes No 
 
d. Cleaning (debridement) in the operating theatre 
Yes No 
 
e. Re-suturing in the operating theatre 
Yes No 
 
f. Other (please give details) 
Yes  No 
2 Excluding a wound infection, have you had any other infection 
following your surgery? 
Yes No 
 
a. Urine infection 
Yes No 
 
b. Chest Infection or Pneumonia 
Yes No 
 
c. Other (please give details)  
Yes No 
 How was the infection treated?   
 
a. With antibiotics 
Yes No 
 
b. Required re-admission to hospital  
Yes No 
 
c. Required other treatment (please give details) 
Yes No 
3 Did you develop an abscess or a haematoma (collection of 
blood) in your pelvis or abdomen following surgery?  
Yes No 
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 If so how was this managed?   
 
a. Resolved spontaneously 
Yes No 
 
b. Treated with antibiotics 
Yes No 
 
c. Required drainage in the x-ray / radiology department 
Yes No 
 
d. Required drainage in the operating theatre 
Yes No 
 
e. Other (please give details) 
Yes No 
4 Light vaginal bleeding is common after most gynaecological 
procedures. Have you had heavy vaginal bleeding following 
surgery? 
 
Yes 
 
No 
 If so, how was this managed? Yes No 
 
a. It settled spontaneously 
Yes No 
 
b. It was treated with antibiotics  
Yes No 
 
c. It required re-admission to hospital 
Yes No 
 
d. It required packing of the vagina 
Yes No 
 
e. It required being taken back to the operating theatre 
Yes No 
 
f. Other (please give details) 
  
5 Lymphoedema is a build-up of lymph fluid which can occur as a 
result of lymph nodes being removed at surgery. It is commonly 
seen in the legs. 
Have you had lymphoedema following surgery? 
 
 
Yes 
 
 
No 
 If so, how was this managed?   
 
a. With compression stockings 
Yes No 
 
b. Other (please give details) 
Yes No 
7 Have you been troubled with constipation after surgery? (please 
do not fill this if you had this problem before surgery) 
If so how was this managed? 
Yes No 
 
a. Diet 
Yes No 
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b. Laxatives 
Yes No 
 
c. Required re-admission to hospital for treatment 
Yes No 
 
d. Other (please give details) 
Yes No 
8 Have you had any other problems related to your bowels?  
(please do not fill this if you had this problem before surgery) 
If so, please give details 
Yes No 
    
9 Have you had any problems with your bladder since the surgery 
(please do not fill this if you had this problem before surgery) 
Yes No 
 
a. Difficulty in emptying the bladder 
Yes No 
 
b. Loss of sensation to empty bladder 
Yes No 
 
c.  Leaking with coughing / sneezing / walking etc. (Stress 
incontinence) 
Yes No 
 
d. An urgent need to pass urine with occasional leakage of 
urine (urge incontinence) 
Yes  No 
 
e. Inability to pass urine requiring insertion of a catheter 
(urinary retention) 
Yes No 
 
f. Required re-admission to hospital for treatment 
Yes  No 
 
g. Other (please give details) 
 
 
Yes No 
    
10 Did you develop a blood clot in your legs (deep vein thrombosis) 
after surgery? 
If so, what sort of treatment did you receive? 
 
 
Yes 
 
 
No 
 
a. Daily injections for blood thinning (heparin) 
Yes No 
 
b. Blood thinning tablets (Warfarin) 
Yes No 
 
c. Required re-admission to the hospital for treatment 
Yes No 
 
d. Other (please give details)  
Yes No 
    
    
    
11 Did you develop a clot in the lung (pulmonary embolism) 
following surgery?  
If so, how was this treated?  
Yes No 
 
a. Daily injections for blood thinning (heparin) 
Yes No 
 
b. Blood thinning tablets (Warfarin) 
Yes No 
 
c. Required re-admission to hospital 
Yes No 
 
d. Other (please give details)  
Yes No 
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12 If you have had any other complication not listed here, please 
give details below regarding the nature of the complication, how 
this was treated and whether you required re-admission into 
hospital for this. Please use additional paper if necessary.  
Yes No 
  
 
 
 
  
We would be grateful if you could provide a little more information about yourself.  
 
1. What is the main language spoken in your home? 
 English 
 Other, please specify…………………………  
 
2. Is this questionnaire in a language that you can easily understand? 
 Yes 
 No 
 No, I don’t understand the language but I had help from a friend or family member to fill 
in this questionnaire 
 
3. What is the highest level of education you have achieved? 
 Finished school at or before the age of fifteen 
 Completed GCSEs, O-levels or equivalent 
 Completed A levels or equivalent 
 Completed further education but not a degree 
 Completed a Bachelor’s degree / master’s degree / PhD 
 Other, please specify……………………………….. 
 
4. If you are willing to be contacted for any clarification, please enter your telephone 
number below.  
…………………………………………………………………………………………………………
……… 
 
5. If you have any suggestions on how we could improve this questionnaire, please write 
your comments overleaf.   
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Appendix 9 Intraoperative risk prediction calculator 
Variables 
Odds Ratio Beta Coefficient 
INPUT VALUE                                         
(1 for categorical 
indicator)                   
  
  Age at surgery 1.000 0.000225974 50 0.011299 
  BMI removed 0 20 0 
  Previous abdominal surgery 1.426 0.354740775   0 
  Low albumin 3.916 1.365177205   0 
  Coagulation-thrombosis 1.052 0.050917424   0 
  Diabetes 1.804 0.590046332   0 
  Cardiac 1.462 0.380077554   0 
  Respiratory 0.676 -0.3910953   0 
  Gastrointestinal 1.065 0.062959776   0 
  Genitourinary 0.699 -0.357729071   0 
  Musculoskeletal removed 0   0 
  Neurology-psychiatric removed 0   0 
  Vascular 0.849 -0.163887984   0 
  Auto-immune 1.968 0.677039648   0 
  Metabolic-endocrine 0.412 -0.886688484   0 
  Integumentary-dermatology removed 0   0 
  Hypertension 1.239 0.214281196   0 
  Smoking 0.978 -0.022255732   0 
  Other neoplasms 1.506 0.409210751   0 
  Laparoscopic approach 1.021 0.021004846   0 
  ASA Grade         
  ASA grade 1 1 0   0 
  ASA grade 2 1.103 0.098371852   0 
  ASA grade 3+ 1.039 0.038729246   0 
  Surgeon grade         
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Consultant 1 0   0 
  
Sub-specialty trainee 
0.716 -0.334224145   0 
  
General Obstetrics & Gynaecology Trainee 
1.286 0.251685137   0 
  Surgical complexity         
  Complexity score 1&2 1 0   0 
  Complexity score 3&4 1.097 0.092363114   0 
  Complexity score 5&6 1.905 0.644478334   0 
  Complexity score 7&8 2.666 0.980736749   0 
  Complexity score >8 4.005 1.387667168   0 
  Final diagnosis         
  Ovarian  1 0   0 
  Uterine 0.600 -0.510855458   0 
  Cervical  0.834 -0.181421282   0 
  Vulval 0.289 -1.24149331   0 
  Benign 0.567 -0.567497568   0 
  
constant 
0.033 -3.420303751   -3.4203 
"=Linear 
prediction" 
 
   
-3.40901 "=Predicted Risk" 
 
   
0.032015 
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Appendix 10 Postoperative risk prediction calculator 
Variables 
  
Age at surgery Odds Ratio Beta Coefficient 
INPUT VALUE                                    
(1 for categorical 
indicator)   
  BMI 0.997 -0.003276361 50 -0.16382 
  Previous abdominal surgery 1.012 0.011984893 20 0.239698 
  Coagulation-thrombosis 1.008 0.007733023   0 
  Diabetes 1.510 0.412101042   0 
  Cardiac 1.355 0.303676723   0 
  Respiratory removed 0   0 
  Gastrointestinal removed 0   0 
  Genitourinary 0.916 -0.087944503   0 
  Musculoskeletal removed 0   0 
  Neurology-psychiatric 1.254 0.22645885   0 
  Vascular 0.908 -0.096767982   0 
  Auto-immune 0.926 -0.077126539   0 
  Metabolic-endocrine removed 0   0 
  Integumentary-dermatology removed 0   0 
  Hypertension removed 0   0 
  Smoking removed 0   0 
  Other neoplasms removed 0   0 
  Laparoscopic approach removed 0   0 
  ASA Grade 0.739 -0.302105458   0 
  ASA grade 1         
  ASA grade 2 1 0   0 
  ASA grade 3+ removed 0   0 
  Surgeon grade removed 0   0 
  Consultant       0 
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Sub-specialty trainee 1 0   0 
  General Obstetrics & Gynaecology 
Trainee removed 0   0 
  
Surgical complexity removed 0   0 
  
Complexity score 1&2         
  Complexity score 3&4 1 0   0 
  Complexity score 5&6 1.112 0.106170088   0 
  Complexity score 7&8 removed 0   0 
  Complexity score >8 1.056 0.054954932   0 
  Final diagnosis 1.004 0.00368819   0 
  Ovarian          
  Uterine 1 0   0 
  Cervical  0.982 -0.017798661   0 
  Vulval 1.606 0.473605883   0 
  Benign 1.779 0.5763077   0 
  Duration of surgery (hrs) removed 0   0 
  Estimated blood loss 1.086 0.082342284   0 
  <500ml         
  500ml-1000ml 1 0   0 
  1000ml-2500ml 1.267 0.236948621   0 
  >2500ml 1.052 0.050509637   0 
  constant 0.997 -0.003410308   0 
  
 
0.167 -1.788685997   -1.78869 
  
    
-1.71281 
"=Linear 
prediction" 
     "=Predicted Risk" 
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